{"title": "PDF", "author": "PDF", "url": "http://eprints.uanl.mx/9587/1/1080214971.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "id": "PDF", "license": "PDF", "body": "PDF", "comments": "PDF", "commentsbody": "PDF", "raw_text": "PDF", "text": " \nUNIVERSIDAD AUT\u00d3NOMA DE NUEVO LE\u00d3N \nFACULTAD DE MEDICINA \n \n \n \nTESIS \n \n\u201cDETERMINACI\u00d3N DE CAMBIOS EN LA PERFUSI\u00d3N TISULAR POSTERIOR \nAL TRATAMIENTO CON ACUPUNTURA, EN PACIENTES CON ENFERMEDAD \nARTERIAL PERIF\u00c9RICA \u201d. \n \nPresenta \n  Dra. Laura Alvarado Leyva  \n \n \n \n \nComo requisito parcial para obtener el Grado de Maestr\u00eda en Medicina \nTradicional China con Orientaci\u00f3n en Acupuntura y Moxibusti\u00f3 n. \n \n \n \n \n \n \n \nEnero 2015 \n\u00a0\n\u00a0\n\u00a0\nUNIVERSIDAD\u00a0AUT\u00d3NOMA\u00a0DE\u00a0NUEVO\u00a0LE\u00d3N \u00a0\nFACULTAD\u00a0DE\u00a0MEDICINA \u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u201cDETERMINACI\u00d3N\u00a0DE\u00a0CAMBIOS\u00a0EN\u00a0LA\u00a0PERFUSI\u00d3 N\u00a0TISULAR\u00a0POSTERIOR\u00a0AL\u00a0\nTRATAMIENTO\u00a0CON\u00a0ACUPUNTURA,\u00a0EN\u00a0PACIENTES\u00a0CON\u00a0ENFERMED AD\u00a0ARTERIAL\u00a0\nPERIF\u00c9RICA\u201d.\u00a0\npor\u00a0\nDra.\u00a0Laura\u00a0Alvarado\u00a0Leyva.\u00a0\nComo\u00a0requisito\u00a0p arcial\u00a0para\u00a0obtener\u00a0el\u00a0Grado\u00a0de\u00a0Maestr\u00eda\u00a0 en\u00a0Medicina\u00a0Tradicional\u00a0\nChina\u00a0con\u00a0Orientaci\u00f3n\u00a0en\u00a0Acupuntura\u00a0y\u00a0Moxibusti\u00f3n.\u00a0\nEnero\u00a02015 \u00a0\n\u00a0\"DETERMINACION DE CAMBIOS EN LA PERFUSION TISULAR POSTERIOR AL \nTRATAMIENTO CON ACUPUNTURA, EN PACIENTES CON ENFERMEDAD \nARTERIAL PERIFERICA\". \nAprobacion de la Tesis: \nDr. med. Carlos Alberto Montero Cantu \nDirector de Tesis \nDr. med. Gerardo Enriq e Munoz Maldonado \nCo-director de Tesis \nDr. C. Roberto Montes de Oca Luna \nMiembro de la Comision \nDr. med. Gerardo Enrique Munoz Maldonado \nSubdirector de Estudios de Posgrado \u00a0\u00a0\n\u00a0\n\u00a0\nAgradecimientos:\u00a0\nAgradezco\u00a0primeramente\u00a0a\u00a0Dios\u00a0por\u00a0haberme\u00a0permitido\u00a0termi nar\u00a0esta\u00a0Maestr\u00eda.\u00a0\nA\u00a0mi\u00a0esposo\u00a0que\u00a0siempre\u00a0me\u00a0ha\u00a0apoyado\u00a0y\u00a0motivado\u00a0para\u00a0es tar\u00a0en\u00a0constante\u00a0\nsuperaci\u00f3n. \u00a0\nA\u00a0mis\u00a0hijos\u00a0por\u00a0ser\u00a0el\u00a0motor\u00a0de\u00a0mi\u00a0vida.\u00a0\nA\u00a0mi\u00a0Madre\u00a0que\u00a0siempre\u00a0tiene\u00a0palabras\u00a0de\u00a0aliento\u00a0para\u00a0 m\u00ed.\u00a0\nA\u00a0mi\u00a0familia\u00a0por\u00a0siempre\u00a0creer\u00a0en\u00a0m\u00ed.\u00a0\nY\u00a0a\u00a0mis\u00a0amigos\u00a0y\u00a0amigas,\u00a0compa\u00f1eros\u00a0de\u00a0trabajo\u00a0que\u00a0de\u00a0u na\u00a0forma\u00a0u\u00a0otra\u00a0me\u00a0\napoyaron\u00a0para\u00a0que\u00a0pudiera\u00a0compaginar\u00a0estos\u00a0estudios\u00a0 con\u00a0mi\u00a0trabajo,\u00a0siempre\u00a0les\u00a0\nestar\u00e9\u00a0agradecida. \u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\u00a0\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\nEl\u00a0presente\u00a0trabajo\u00a0de\u00a0investigaci\u00f3n\u00a0se\u00a0reali z\u00f3\u00a0en\u00a0el\u00a0Hospital\u00a0Universitario,\u00a0bajo\u00a0la\u00a0\ndirecci\u00f3n\u00a0del\u00a0Dr.\u00a0med.\u00a0Carlos\u00a0Alberto\u00a0Montero\u00a0Cant\u00fa,\u00a0 la\u00a0co\u2010direcci\u00f3n\u00a0del\u00a0Dr.\u00a0med.\u00a0\nGerardo\u00a0Enrique\u00a0Mu\u00f1oz\u00a0Maldonado,\u00a0y\u00a0la\u00a0colaboraci\u00f3n\u00a0del\u00a0Dr.\u00a0C.\u00a0Roberto\u00a0Montes\u00a0de\u00a0\nOca\u00a0Luna\u00a0y\u00a0el\u00a0Dr.\u00a0Julio\u00a0C\u00e9sar\u00a0Delgadillo\u00a0Gonz\u00e1lez. \u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\u00a01.\u2010\u00a0INTRODUCCI\u00d3N \u00a0................................................................................................................................................. \u00a01\u00a0\n1.1\u00a0Antecedentes \u00a0................................................................................................................................................. \u00a01\u00a0\n1.2\u00a0Marco\u00a0Te\u00f3rico\u00a0Occidental. \u00a0....................................................................................................................... \u00a02\u00a0\n1.2.1\u00a0Factores\u00a0de\u00a0Riesgo \u00a0................................................................................................................................... \u00a03\u00a0\n1.2.2\u00a0\u00d3xido\u00a0N\u00edtrico \u00a0.............................................................................................................................................. \u00a05\u00a0\n1.2.3\u00a0Fisiopatolog\u00eda \u00a0............................................................................................................................................ \u00a05\u00a0\n1.2.4\u00a0Indice\u00a0Tobill o\u00a0Brazo\u00a0................................................................................................................................ \u00a07\u00a0\n1.2.5\u00a0Oximetr\u00eda\u00a0Transcut\u00e1nea\u00a0(TcO 2)\u00a0......................................................................................................... \u00a08\u00a0\n1.2.6\u00a0Clasificaci\u00f3n\u00a0de\u00a0la\u00a0Enfermedad\u00a0Arterial\u00a0Perif\u00e9rica. \u00a0.................................................................. \u00a09\u00a0\n1.2.7\u00a0Manejo\u00a0Conservador: \u00a0.......................................................................................................................... \u00a010\u00a0\n1.3\u00a0MARCO\u00a0TEORICO\u00a0ORIENTAL \u00a0.............................................................................................................. \u00a013\u00a0\n1.3.1\u00a0introducci\u00f3n \u00a0............................................................................................................................................ \u00a013\u00a0\n1.3.2\u00a0Conceptos. \u00a0................................................................................................................................................ \u00a014\u00a0\n1.3.3\u00a0Teor\u00eda\u00a0del\u00a0Yin\u00a0y\u00a0Yang. \u00a0.......................................................................................................................... \u00a015\u00a0\n1.3.4\u00a0Teor\u00eda\u00a0de\u00a0los\u00a0Cinco\u00a0Elementos: \u00a0....................................................................................................... \u00a016\u00a0\n1.3.5\u00a0Causas\u00a0de\u00a0Enfermedad: \u00a0...................................................................................................................... \u00a017\u00a0\n1.3.6\u00a0Meridianos \u00a0............................................................................................................................................... \u00a019\u00a0\n1.3.7\u00a0Fundamentos \u00a0.......................................................................................................................................... \u00a019\u00a0\n1.3.8\u00a0Etiolog\u00eda\u00a0y\u00a0Patolog\u00eda. \u00a0........................................................................................................................... \u00a020\u00a0\n1.4\u00a0Acupuntura \u00a0.................................................................................................................................................. \u00a022\u00a0\n1.4.1\u00a0T\u00e9cnica\u00a0de\u00a0punci\u00f3n: \u00a0............................................................................................................................. \u00a022\u00a0\n1.4.2\u00a0Puntos\u00a0a\u00a0utilizar \u00a0..................................................................................................................................... \u00a023\u00a0\n2.\u00a0JUSTIFICACI\u00d3N \u00a0................................................................................................................................................. \u00a026\u00a0\n3.\u00a0HIP\u00d3TESIS\u00a0DE\u00a0LA\u00a0INVESTIGACI\u00d3N \u00a0.......................................................................................................... \u00a026\u00a0\n4.\u00a0OBJETIVOS\u00a0DEL\u00a0ESTUDIO \u00a0............................................................................................................................ \u00a026\u00a0\n4.1\u00a0Objetivo\u00a0primario \u00a0..................................................................................................................................... \u00a026\u00a0\n4.2\u00a0Objetivos\u00a0Secundarios \u00a0............................................................................................................................ \u00a027\u00a0\n5.\u00a0DISE\u00d1O\u00a0DEL\u00a0ESTUDIO. \u00a0.................................................................................................................................. \u00a027\u00a0\n6.\u00a0PACIENTES\u00a0Y\u00a0M\u00c9TODOS \u00a0............................................................................................................................... \u00a028\u00a0\n6.1\u00a0Reclutamiento \u00a0............................................................................................................................................ \u00a028\u00a0\n6.2\u00a0Criterios\u00a0de\u00a0Inclusi\u00f3n \u00a0.............................................................................................................................. \u00a029\u00a0\n6.3\u00a0Criterios\u00a0de\u00a0exclusi\u00f3n \u00a0............................................................................................................................. \u00a029\u00a0\n6.4\u00a0M\u00e9todos \u00a0........................................................................................................................................................ \u00a030\u00a0\u00a06.5\u00a0Suspensi\u00f3n\u00a0temporal\u00a0del\u00a0estudio \u00a0...................................................................................................... \u00a031\u00a0\n6.6\u00a0Suspensi\u00f3n\u00a0permanente\u00a0del\u00a0estudio. \u00a0............................................................................................... \u00a031\u00a0\n7.\u00a0RESULTADOS \u00a0..................................................................................................................................................... \u00a032\u00a0\n8.\u00a0DATOS\u00a0DEMOGR\u00c1FICOS \u00a0............................................................................................................................... \u00a035\u00a0\n9.\u00a0DISCUSI\u00d3N \u00a0.......................................................................................................................................................... \u00a036\u00a0\n10.\u00a0CONCLUSIONES \u00a0.............................................................................................................................................. \u00a038\u00a0\n11.\u00a0REFERENCIAS \u00a0................................................................................................................................................. \u00a039\u00a0\n12.\u00a0ANEXOS \u00a0.............................................................................................................................................................. \u00a041\u00a0\n\u00a0 \u00a0\u00a0\u00a0\nRESUMEN\u00a0\n\u00a0\nLaura\u00a0Alvarado\u00a0Leyva \u00a0\nFecha\u00a0de\u00a0graduaci\u00f3n:\u00a0Febrero,\u00a02015\u00a0\nUniversidad\u00a0Aut\u00f3noma\u00a0de\u00a0Nuevo\u00a0Le\u00f3n\u00a0\nFacultad\u00a0de\u00a0Medicina \u00a0\n\u00a0\nTitulo\u00a0del\u00a0estudio:\u00a0\u00a0 DETERMINACI\u00d3N\u00a0DE\u00a0CAMBIOS\u00a0EN\u00a0LA\u00a0PERFUSI\u00d3N\u00a0\nTISULAR\u00a0POSTERIOR\u00a0AL\u00a0TRATAMIENTO\u00a0CON\u00a0\nACUPUNTURA,\u00a0EN\u00a0PACIENTES\u00a0CON\u00a0ENFERMEDAD\u00a0\nARTERIAL\u00a0PERIF\u00c9RICA. \u00a0\nN\u00famero\u00a0de\u00a0p\u00e1ginas:\u00a047\u00a0 Candidata\u00a0para\u00a0el\u00a0grado\u00a0de\u00a0Maestr \u00eda\u00a0en\u00a0Medicina\u00a0\nTradicional\u00a0China\u00a0con\u00a0Orientaci\u00f3n\u00a0en\u00a0Acupuntura\u00a0y\u00a0\nMoxibustion.\u00a0\n\u00c1rea\u00a0de\u00a0estudio:\u00a0Ciencias\u00a0de\u00a0la\u00a0Salud.\u00a0\u00a0\n\u00a0\nProp\u00f3sito\u00a0y\u00a0M\u00e9todo\u00a0de\u00a0Estudio:\u00a0\u00a0\nEl\u00a0objetivo\u00a0primario\u00a0del\u00a0estudio\u00a0es\u00a0determinar\u00a0cam bios\u00a0en\u00a0la\u00a0perfusi\u00f3n\u00a0tisular\u00a0\nposterior\u00a0al\u00a0tratamiento\u00a0con\u00a0acupuntura\u00a0en\u00a0pacientes \u00a0con\u00a0EAP,\u00a0medido\u00a0con\u00a0el\u00a0\n\u00cdndice\u00a0Tobillo\u00a0Brazo\u00a0y\u00a0Oximetr\u00eda\u00a0Transcut\u00e1nea.\u00a0Utili zando\u00a0el\u00a0tratamiento\u00a0con\u00a0\nacupuntura\u00a0sobre\u00a0los\u00a0puntos\u00a0Qihai,\u00a0\u00a0 Zusanli,\u00a0Yanglingquan,\u00a0 Sanyinjiao\u00a0y\u00a0Fenglong\u00a0\nmejorar\u00e1\u00a0los\u00a0par\u00e1metros\u00a0de\u00a0\u00cdndice\u00a0Tobillo\u00a0Brazo,\u00a0\u00a0Oxi metr\u00eda\u00a0Transcut\u00e1nea,\u00a0adem\u00e1s\u00a0\nse\u00a0intentar\u00e1\u00a0disminuir\u00a0la\u00a0incidencia\u00a0de\u00a0s\u00edntomas\u00a0isqu\u00e9micos\u00a0tradu ci\u00e9ndose\u00a0esto\u00a0\ncomo\u00a0una\u00a0mejor\u00eda\u00a0en\u00a0la\u00a0microcirculaci\u00f3n\u00a0perif\u00e9rica\u00a0en\u00a0 pacientes\u00a0con\u00a0Enfermedad\u00a0\nArterial\u00a0Perif\u00e9rica.\u00a0\nSe\u00a0reclutaron\u00a0\u00a0pacientes\u00a0sin\u00a0restricci\u00f3n\u00a0de\u00a0g\u00e9nero\u00a0 mayores\u00a0de\u00a040\u00a0a\u00f1os\u00a0de\u00a0edad\u00a0con\u00a0\nEAP.\u00a0Hubo\u00a0pacientes\u00a0con\u00a0antecedentes\u00a0de\u00a0Enfermedad\u00a0Art erial\u00a0Coronaria\u00a0(EAC)\u00a0\nsintom\u00e1tica\u00a0 (es\u00a0 decir,\u00a0 infarto\u00a0 del\u00a0 miocardio,\u00a0 s\u00edndrome \u00a0 coronario\u00a0 agudo\u00a0 o\u00a0\nrevascularizaci\u00f3n\u00a0coronaria),\u00a0sin\u00a0embargo,\u00a0la\u00a0EAP\u00a0ser \u00e1\u00a0su\u00a0manifestaci\u00f3n\u00a0cl\u00ednica\u00a0\nprincipal.\u00a0 Se\u00a0 reclutararon\u00a0 16\u00a0 pacientes\u00a0 sintom\u00e1ticos \u00a0 y\u00a0 no\u00a0 sintom\u00e1ticos\u00a0\nrepresentativos\u00a0de\u00a0EAP\u00a0que\u00a0tengan\u00a0un\u00a0\u00cdndice\u00a0Tobillo\u00a0 Brazo\u00a0<0.8,\u00a0\u00cdndice\u00a0Dedo\u00a0Brazo\u00a0\n(IDB)\u00a0<\u00a00.6\u00a0y\u00a0que\u00a0est\u00e9n \u00a0llevando\u00a0tratamiento\u00a0convencional\u00a0con\u00a0aspirina\u00a0o\u00a0ci lostazol\u00a0\no\u00a0clopidogrel,\u00a0ser\u00e1n\u00a0pacientes\u00a0que\u00a0acudan\u00a0a\u00a0la\u00a0consulta\u00a0de\u00a0Cirug\u00eda\u00a0General\u00a0del\u00a0\nHospital\u00a0Universitario\u00a0de\u00a0los\u00a0cuales\u00a08\u00a0(Grupo\u00a01,\u00a0co ntrol)\u00a0continuar\u00e1n\u00a0este\u00a0manejo.\u00a0\nLos\u00a0otros\u00a08\u00a0pacientes\u00a0(Grupo\u00a02,\u00a0c asos)\u00a0adicionalmente\u00a0al\u00a0tratamiento\u00a0convencional\u00a0\nse\u00a0trataron\u00a0con\u00a010\u00a0sesiones\u00a0de\u00a0Acupuntura\u00a0con\u00a0una\u00a0se si\u00f3n\u00a0cada\u00a0tercer\u00a0d\u00eda.\u00a0El\u00a0\ntama\u00f1o\u00a0de\u00a0la\u00a0muestra\u00a0se\u00a0bas\u00f3\u00a0en\u00a0la\u00a0incidencia\u00a0y\u00a0preva lencia\u00a0de\u00a0la\u00a0Enfermedad\u00a0\u00a0Arterial\u00a0 Perif\u00e9rica\u00a0 en\u00a0 el\u00a0 Hospital\u00a0 Universitario\u00a0 \u201cDr .\u00a0Jos\u00e9\u00a0 Eleuterio\u00a0 Gonz\u00e1lez\u201d\u00a0\nutilizando\u00a0una\u00a0f\u00f3rmula\u00a0para\u00a0prueba\u00a0de\u00a0hip\u00f3tesis\u00a0y\u00a0di ferencia\u00a0de\u00a0dos\u00a0medias\u00a0con\u00a0\nvalor\u00a0de\u00a0valor\u00a0z\u03b1\u00a0de\u00a01.96\u00a0con\u00a0nivel\u00a0de\u00a0significancia\u00a0del\u00a095%\u00a0para\u00a0dos\u00a0colas,\u00a0y\u00a0un\u00a0\nvalor\u00a0z\u03b2\u00a0de\u00a00.84\u00a0con\u00a0una\u00a0potencia\u00a0de\u00a080%. \u00a0\nDentro\u00a0de\u00a0los\u00a0Criterios\u00a0de\u00a0 Inclusi\u00f3n\u00a0se\u00a0encontraban\u00a0los\u00a0siguientes: \u00a0\n1. Pacientes\u00a0varones\u00a0y\u00a0mujeres\u00a0\u2265 40\u00a0a\u00f1os\u00a0de\u00a0edad. \u00a0\n2. Determinaci\u00f3n\u00a0del\u00a0\u00cdndice\u00a0Tobillo\u00a0Brazo\u00a0(ITB)\u00a0\u22640.80\u00a0e n\u00a0la\u00a0visita\u00a01.\u00a0\u00a0Si\u00a0el\u00a0ITB\u00a0\nes\u00a0\u22651.40\u00a0entonces\u00a0el\u00a0\u00edndice\u00a0dedo\u00a0brazo\u00a0(IDB)\u00a0debe\u00a0ser\u00a0\u22640.60\u00a0en\u00a0la\u00a0visita\u00a01.\u00a0Se\u00a0\nrealiz\u00f3\u00a0con\u00a0apoyo\u00a0de\u00a0ultrasonido\u00a0doppler. \u00a0\n3. Firma\u00a0del\u00a0Consentimiento\u00a0Informado.\u00a0\nDentro\u00a0de\u00a0los\u00a0Criterios\u00a0de\u00a0Exclusi\u00f3n\u00a0se\u00a0encontraban\u00a0los\u00a0siguientes: \u00a0\n1. Pacientes\u00a0que\u00a0requieren\u00a0tratamiento\u00a0antiplaquetario\u00a0 doble\u00a0al\u00a0ingresar\u00a0al\u00a0\nestudio.\u00a0\n2. Necesidad\u00a0de\u00a0tratamiento\u00a0cr\u00f3nico\u00a0con\u00a0ant icoagulante\u00a0oral\u00a0cr\u00f3nico. \u00a0\n3. Uso\u00a0actual\u00a0de\u00a0Ginkgo\u00a0biloba. \u00a0\n4. Cualquier\u00a0padecimiento\u00a0que\u00a0en\u00a0opini\u00f3n\u00a0del\u00a0investigad or\u00a0har\u00eda\u00a0inseguro\u00a0e\u00a0\ninadecuado\u00a0que\u00a0el\u00a0paciente\u00a0participe\u00a0en\u00a0\u00e9ste. \u00a0\n5. Expectativa\u00a0de\u00a0vida\u00a0<6\u00a0meses\u00a0con\u00a0base\u00a0en\u00a0la\u00a0opini\u00f3n\u00a0 del\u00a0investigador.\u00a0\n6. Pacientes\u00a0que \u00a0han\u00a0sufrido\u00a0una\u00a0enfermedad\u00a0vascular\u00a0cerebral\u00a0durant e\u00a0los\u00a0\n\u00faltimos\u00a03\u00a0meses.\u00a0\n7. Demencia\u00a0con\u00a0probabilidad\u00a0de\u00a0arriesgar\u00a0la\u00a0comprensi\u00f3n \u00a0de\u00a0la\u00a0informaci\u00f3n\u00a0\ncorrespondiente\u00a0a\u00a0la\u00a0realizaci\u00f3n\u00a0del\u00a0estudio\u00a0o\u00a0apeg o\u00a0a\u00a0los\u00a0procedimientos\u00a0\ndel\u00a0estudio.\u00a0\n8. Hipertensi\u00f3n\u00a0arterial\u00a0 severa.\u00a0\n9. S\u00edndrome\u00a0Isqu\u00e9mico\u00a0Coronario\u00a0Agudo\u00a0(SICA).\u00a0\n10. Di\u00e1tesis\u00a0 hemorr\u00e1gica\u00a0 confirmada,\u00a0 trastorno\u00a0 de\u00a0 coagula ci\u00f3n\u00a0 o\u00a0 sangrado\u00a0\nsist\u00e9mico,\u00a0resuelto\u00a0o\u00a0en\u00a0curso.\u00a0\n11. Antecedentes\u00a0de\u00a0trombocitopenia\u00a0o\u00a0neutropenia.\u00a0\n12. Mujeres\u00a0 en\u00a0 edad\u00a0 f\u00e9rtil\u00a0 que\u00a0 no\u00a0 est\u00e9n\u00a0 dispuestas\u00a0 a\u00a0 usar\u00a0 un\u00a0 m\u00e9todo\u00a0\nanticonceptivo\u00a0o\u00a0mujeres\u00a0que\u00a0tengan\u00a0un\u00a0resultado\u00a0pos itivo\u00a0en\u00a0una\u00a0prueba\u00a0de\u00a0\nembarazo\u00a0en\u00a0la\u00a0visita\u00a01.\u00a0\n\u00a0\u00a0En\u00a0relaci\u00f3n\u00a0a\u00a0los\u00a0m\u00e9todos:\u00a0En\u00a0la\u00a0primera\u00a0visita\u00a0se\u00a0le s\u00a0hizo\u00a0una\u00a0toma\u00a0de\u00a0sus\u00a0signos\u00a0\nvitales,\u00a0electrocardiograma\u00a0y\u00a0oximetr\u00eda\u00a0transcut\u00e1nea, \u00a0adem\u00e1s\u00a0de\u00a0que\u00a0contestaron\u00a0el\u00a0\nCuestionario\u00a0DE\u00a0\u201cCALIDAD\u00a0DE\u00a0VIDA\u00a0(EQ\u20105D)\u201d\u00a0y\u00a0Cuestionari o\u00a0Walking\u00a0Impairment\u00a0\nQuiestionaire\u00a0 (WIQ). \u00a0 Los\u00a0 dos\u00a0 primeros\u00a0 par a\u00a0 descartar\u00a0 alguna\u00a0 condici\u00f3n\u00a0 que\u00a0\npredisponga\u00a0al\u00a0paciente\u00a0a\u00a0una\u00a0complicaci\u00f3n,\u00a0como\u00a0s\u00ednd rome\u00a0isqu\u00e9mico\u00a0coronario\u00a0o\u00a0\nhipertensi\u00f3n\u00a0arterial\u00a0descontrolada.\u00a0En\u00a0cada\u00a0una\u00a0de \u00a0las\u00a010\u00a0visitas\u00a0se\u00a0tomaron\u00a0los\u00a0\nsignos\u00a0 vitales\u00a0 para\u00a0 posteriormente\u00a0 realizar\u00a0 asepsia\u00a0 del\u00a0 \u00e1rea\u00a0a\u00a0 puncionar\u00a0\nprimeramente\u00a0con\u00a0una\u00a0torunda\u00a0alcoholada\u00a0seguida\u00a0de\u00a0is odine.\u00a0Se\u00a0puncionaron\u00a0los\u00a0\npuntos\u00a0 Qihai,\u00a0 Yanglingquan,\u00a0 Zusanli,\u00a0 Fenglong\u00a0 y \u00a0Sanyinjiao,\u00a0 con\u00a0 aguja\u00a0 para\u00a0\nacupuntura\u00a0\u00a0longitud\u00a040mm\u00a0de\u00a0largo,\u00a0calibre\u00a022,\u00a0por\u00a02 0\u00a0minutos.\u00a0\nEn\u00a0la\u00a0quinta\u00a0visita,\u00a0se\u00a0le s\u00a0tom\u00f3\u00a0nuevamente\u00a0el\u00a0\u00cdndice\u00a0Tobillo\u00a0Brazo,\u00a0el\u00a0Cuestio nario\u00a0\nEQ\u20105D\u00a0y\u00a0el\u00a0Cuestionario\u00a0WIQ\u00a0para\u00a0asegurar\u00a0que\u00a0no\u00a0hubie ra\u00a0empeoramiento\u00a0de\u00a0la\u00a0\nperfusi\u00f3n\u00a0y\u00a0pusiera\u00a0en\u00a0riesgo\u00a0la\u00a0integridad\u00a0del\u00a0pac iente.\u00a0En\u00a0la\u00a0d\u00e9cima\u00a0y\u00a0posterior\u00a0a\u00a0\nla\u00a0\u00faltima\u00a0sesi\u00f3n\u00a0de\u00a0acupuntura\u00a0se\u00a0realizaron\u00a0el\u00a0\u00cdndi ce\u00a0Tobillo\u00a0Brazo,\u00a0Oximetr\u00eda\u00a0\nTranscut\u00e1nea,\u00a0Encuesta\u00a0EQ \u20105D\u00a0y\u00a0Cuestionario\u00a0WIQ.\u00a0La\u00a0 pen\u00faltima\u00a0Visita\u00a0(once)\u00a0 Se\u00a0\nllev\u00f3\u00a0a\u00a0cabo\u00a07\u00a0d\u00edas\u00a0despu\u00e9s\u00a0de\u00a0la\u00a0\u00faltima\u00a0sesi\u00f3n\u00a0de\u00a0a cupuntura\u00a0realiz\u00e1ndose\u00a0una\u00a0\nmedici\u00f3n\u00a0del\u00a0\u00cdndice\u00a0Tobillo/Brazo\u00a0con\u00a0apoyo\u00a0de\u00a0ultra sonido\u00a0Doppler.\u00a0 En\u00a0la\u00a0visita\u00a0de\u00a0\nCierre\u00a0 del\u00a0 Estudio,\u00a0 30\u00a0 d\u00edas\u00a0 posteriores\u00a0 a\u00a0 la\u00a0 \u00faltima\u00a0 sesi\u00f3n\u00a0 de\u00a0 acupuntura,\u00a0 se\u00a0\nrealizaron\u00a0Medici\u00f3n\u00a0del\u00a0\u00cdndice\u00a0Tobillo/Brazo\u00a0o\u00a0Dedo/Brazo\u00a0con\u00a0ecograf\u00eda\u00a0Doppler\u00a0\nde\u00a0extremidades\u00a0inferiores,\u00a0Oximetr\u00eda\u00a0Transcut\u00e1nea,\u00a0 Cuestionario\u00a0DE\u00a0 \u201cCALIDAD\u00a0DE\u00a0\nVIDA\u00a0(EQ\u20105D)\u201d\u00a0y\u00a0Cuestionario\u00a0de\u00a0EAP.\u00a0\nContribuciones\u00a0y\u00a0Conclusiones:\u00a0 \u00a0\nEste\u00a0trabajo\u00a0busca\u00a0determinar\u00a0objetivamente\u00a0los\u00a0benef icios\u00a0que\u00a0puede\u00a0tener\u00a0la\u00a0\nacupuntura\u00a0en\u00a0la\u00a0enfermedad\u00a0arterial\u00a0perif\u00e9rica\u00a0para \u00a0lograr\u00a0el\u00a0posible\u00a0uso\u00a0como\u00a0\nterapia\u00a0coadyuvante\u00a0en\u00a0el\u00a0primer\u00a0nivel\u00a0de\u00a0atenci\u00f3n\u00a0del\u00a0trata miento\u00a0convencional,\u00a0la\u00a0\nque\u00a0esencialmente\u00a0se\u00a0basa\u00a0en\u00a0la\u00a0realizaci\u00f3n\u00a0de\u00a0camina ta.\u00a0\nEl\u00a0tratamiento\u00a0con\u00a0acupuntura\u00a0en\u00a0los\u00a0puntos\u00a0Qihai,\u00a0Z usanli,\u00a0Yanglingquan,\u00a0Fenglong\u00a0\ny\u00a0 Sanyinjiao,\u00a0 complementa\u00a0 de\u00a0 manera\u00a0 significativa\u00a0 en\u00a0 e l\u00a0 tratamiento\u00a0 no\u00a0\nfarmacol\u00f3gico\u00a0de\u00a0la\u00a0enfermedad\u00a0arterial\u00a0perif\u00e9rica,\u00a0d onde\u00a0una\u00a0de\u00a0las\u00a0indicaciones\u00a0\ncoadyuvantes,\u00a0es\u00a0la\u00a0realizaci\u00f3n\u00a0de\u00a0caminata\u00a0supervis ada\u00a0en\u00a0una\u00a0banda\u00a0sin\u00a0fin\u00a0por\u00a0\n30\u00a0a\u00a060\u00a0minutos,\u00a0tres\u00a0veces\u00a0por\u00a0semana\u00a0durante\u00a0tres\u00a0me ses.\u00a0\nSi\u00a0bien\u00a0los\u00a0resultados\u00a0del\u00a0grupo\u00a02\u00a0mostraron\u00a0una\u00a0mejor\u00eda \u00a0mas\u00a0significativa\u00a0en\u00a0el\u00a0ITB\u00a0\nas\u00ed\u00a0como\u00a0en\u00a0la\u00a0escala\u00a0EQ5D,\u00a0EQ\u2010EVA\u00a0y\u00a0en\u00a0el\u00a0cuestionar io\u00a0WIQ\u00a0en\u00a0dolor\u00a0y\u00a0velocidad,\u00a0\nno\u00a0 podemos\u00a0 asegurar\u00a0 que\u00a0 con\u00a0 la\u00a0 acupuntura\u00a0 se\u00a0 reviert a\u00a0 el\u00a0 proceso\u00a0 de\u00a0\nateroesclerosis\u00a0ya\u00a0insta lado,\u00a0mas\u00a0sin\u00a0embargo,\u00a0ante\u00a0los\u00a0resultados\u00a0positivos\u00a0 con\u00a0\nrespecto\u00a0a\u00a0la\u00a0reducci\u00f3n\u00a0de\u00a0sintomatolog\u00eda,\u00a0considera mos\u00a0que\u00a0se\u00a0puede\u00a0utilizar\u00a0\ncomo\u00a0una\u00a0herramienta\u00a0m\u00e1s\u00a0en\u00a0el\u00a0manejo\u00a0de\u00a0primer\u00a0nivel,\u00a0y a\u00a0que\u00a0ayuda\u00a0a\u00a0lograr\u00a0una\u00a0\ndeambulaci\u00f3n\u00a0m\u00e1s\u00a0pronta,\u00a0y\u00a0as\u00ed\u00a0apegarse\u00a0al\u00a0tratamiento \u00a0convencional\u00a0de\u00a0una\u00a0\nmanera\u00a0\u00f3ptima.\u00a0\n\u00a0\n\u00a0DIRECTOR DE TESTS \nDr. Med. Carlos Alberto Montero Cantti \u00a0\n1\u00a0\u00a01.\u2010\u00a0INTRODUCCI\u00d3N \u00a0\n1.1\u00a0Antecedentes \u00a0\nEn\u00a0una\u00a0revisi\u00f3n\u00a0exhaustiva\u00a0en\u00a0literatura\u00a0m\u00e9dica\u00a0en\u00a0E stados\u00a0Unidos,\u00a0se\u00a0estima\u00a0que\u00a0la\u00a0\nEnfermedad\u00a0Arterial\u00a0Perif\u00e9rica\u00a0(EAP)\u00a0afecta\u00a0al\u00a010%\u00a0de\u00a0 los\u00a0pacientes\u00a0mayores\u00a0de\u00a070\u00a0\na\u00f1os.\u00a0La\u00a0 presentaci\u00f3n\u00a0 asintom\u00e1tica\u00a0 es\u00a0 la\u00a0 m\u00e1s\u00a0 frecuente,\u00a0 en\u00a0 cambio\u00a0 en\u00a0 la\u00a0\npresentaci\u00f3n\u00a0sintom\u00e1tica\u00a0se\u00a0observa\u00a0que\u00a0en\u00a0el\u00a025\u00a0%\u00a0d e\u00a0los\u00a0casos\u00a0reportan\u00a0un\u00a0\nempeoramiento\u00a0de\u00a0la\u00a0sintomatolog\u00eda\u00a0en\u00a0la\u00a0evoluci\u00f3n\u00a0del \u00a0padecimiento\u00a0y\u00a0adem\u00e1s\u00a0\nque\u00a0la\u00a0revascularizaci\u00f3n\u00a0es\u00a0mandatoria\u00a0en\u00a0menos\u00a0del\u00a02 0\u00a0%\u00a0de\u00a0los\u00a0pacientes\u00a0a\u00a0los\u00a010\u00a0\na\u00f1os\u00a0de\u00a0establecido\u00a0el\u00a0diagn\u00f3stico.\u00a0Por\u00a0otra\u00a0parte, \u00a0la\u00a0frecuencia\u00a0de\u00a0amputaciones\u00a0\nvar\u00eda\u00a0desde\u00a0el\u00a01%\u00a0al\u00a07%\u00a0a\u00a0los\u00a05 \u201010\u00a0a\u00f1os\u00a0de\u00a0evoluci\u00f3n.\u00a0Dentro\u00a0de\u00a0los\u00a0factores\u00a0que\u00a0se\u00a0\nconsideran\u00a0de\u00a0mal\u00a0pron\u00f3stico\u00a0se\u00a0encuentran\u00a0el\u00a0tabaqu ismo,\u00a0tener\u00a0un\u00a0\u00edndice\u00a0tobillo\u00a0\nbrazo\u00a0(ITB)\u00a0menor\u00a0de\u00a00.6\u00a0y\u00a0la\u00a0presencia\u00a0de\u00a0\u00a0Diabetes \u00a0Mellitus.\u00a0\u00a0\nSe\u00a0ha\u00a0observado\u00a0que\u00a0cuando\u00a0se\u00a0comparan\u00a0pacientes\u00a0con \u00a0EAP\u00a0y\u00a0controles\u00a0de\u00a0igual\u00a0\nedad,\u00a0el\u00a0\u00edndice\u00a0\u00a0de\u00a0mortalidad\u00a0cardiovascular\u00a0es\u00a0del \u00a00.5%\u00a0en\u00a0controles\u00a0y\u00a0de\u00a0 2.5%\u00a0en\u00a0\npacientes\u00a0con\u00a0EAP.\u00a0Adem\u00e1s,\u00a0en\u00a0los\u00a0pacientes\u00a0con\u00a0enferme dad\u00a0coronaria\u00a0conocida,\u00a0la\u00a0\npresencia\u00a0de\u00a0EAP\u00a0eleva\u00a0el\u00a0riesgo\u00a0de\u00a0muerte\u00a0en\u00a0un\u00a025%\u00a0 con\u00a0respecto\u00a0a\u00a0los\u00a0controles.\u00a0\u00a0\nLa\u00a0aterosclerosis\u00a0con\u00a0trombosis\u00a0arterial\u00a0asociada\u00a0es \u00a0una\u00a0enfermedad\u00a0sist\u00e9mica\u00a0que\u00a0\npuede\u00a0afectar\u00a0el\u00a0sistema\u00a0cardiovascular,\u00a0cerebrovasc ular\u00a0y\u00a0vascular\u00a0perif\u00e9rico.\u00a0\u00a0A\u00a0la\u00a0\naterosclerosis\u00a0de\u00a0las\u00a0arterias\u00a0que\u00a0irrigan\u00a0las\u00a0extr emidades\u00a0inferiores\u00a0se\u00a0le\u00a0denomina\u00a0\nenfermedad\u00a0arterial\u00a0perif\u00e9rica\u00a0(EAP).\u00a0\u00a0La\u00a0EAP\u00a0tambi\u00e9n\u00a0p uede\u00a0incluir\u00a0a\u00a0las\u00a0arterias\u00a0\ncar\u00f3tidas,\u00a0 extremidades\u00a0 superiores,\u00a0 viscerales\u00a0 y\u00a0 ren ales.\u00a0 La\u00a0 EAP\u00a0 surge\u00a0 de\u00a0 la\u00a0\naterosclerosis\u00a0 sist\u00e9mica\u00a0 y\u00a0 es\u00a0 parte\u00a0 del\u00a0 proceso\u00a0 cont inuo\u00a0 de\u00a0 la\u00a0 enfermedad\u00a0\ncardiovascular,\u00a0adem\u00e1s\u00a0los\u00a0pacientes\u00a0con\u00a0EAP\u00a0tienen\u00a0u na\u00a0carga\u00a0significativa\u00a0de\u00a0\nenfermedad\u00a0ateroscler\u00f3tica\u00a0sist\u00e9mica\u00a0y\u00a0las\u00a0manifestaci ones\u00a0cl\u00ednicas\u00a0asociadas\u00a0con\u00a0\nEAP\u00a0de\u00a0extremidades\u00a0p\u00e9lvicas\u00a0incluyen\u00a0alteraci\u00f3n\u00a0de\u00a0l a\u00a0capacidad\u00a0funcional\u00a0y\u00a0\ncalidad\u00a0de\u00a0vida. \u00a0\n\u00a0En\u00a0estudios\u00a0cl\u00ednicos\u00a0bien\u00a0controlados\u00a0se\u00a0ha\u00a0identi ficado\u00a0que\u00a0los\u00a0pacientes\u00a0\u00a0con\u00a0EAP\u00a0\ntienen\u00a0niveles\u00a0elevado s\u00a0de\u00a0actividad\u00a0plaquetaria\u00a0y\u00a0est\u00e1n\u00a0en\u00a0un\u00a0riesgo\u00a0sus tancial\u00a0m\u00e1s\u00a0\u00a0\n\u00a0 2\u00a0alto\u00a0de\u00a0eventos\u00a0adversos\u00a0mediados\u00a0por\u00a0plaquetas\u00a0que\u00a0 en\u00a0los\u00a0grupos\u00a0controles,\u00a0entr e\u00a0\nlos\u00a0que\u00a0se\u00a0encuentran\u00a0el\u00a0infarto\u00a0del\u00a0miocardio\u00a0(IM), \u00a0el\u00a0evento\u00a0vascular\u00a0cerebral\u00a0y\u00a0\nmuerte\u00a0asociada\u00a0a\u00a0evento\u00a0ca rdiovascular.\u00a0 \u00a0\nA\u00a0pesar\u00a0de\u00a0los\u00a0avances\u00a0m\u00e9dicos\u00a0en\u00a0las\u00a0t\u00e9cnicas\u00a0quir\u00far gicas\u00a0y\u00a0de\u00a0intervenci\u00f3n\u00a0para\u00a0el\u00a0\nmanejo\u00a0sintom\u00e1tico\u00a0de\u00a0la\u00a0EAP,\u00a0no\u00a0existe\u00a0un\u00a0tratamiento\u00a0 eficaz\u00a0para\u00a0su\u00a0erradicaci\u00f3n\u00a0\no\u00a0control,\u00a0\u00a0pero\u00a0si\u00a0se\u00a0requiere\u00a0de\u00a0una\u00a0necesidad\u00a0m\u00e9d ica\u00a0insatisfecha\u00a0por\u00a0 avances\u00a0en\u00a0\nel\u00a0tratamiento\u00a0integral\u00a0del\u00a0paciente.\u00a0\nUno\u00a0de\u00a0los\u00a0factores\u00a0m\u00e1s\u00a0importantes\u00a0que\u00a0impactan\u00a0en\u00a0es te\u00a0tratamiento\u00a0integral\u00a0es\u00a0\nla\u00a0modificaci\u00f3n\u00a0en\u00a0el\u00a0estilo\u00a0de\u00a0vida\u00a0de\u00a0factores\u00a0de\u00a0 riesgo\u00a0tales\u00a0como\u00a0dejar\u00a0fumar,\u00a0\nhacer\u00a0ejercicio\u00a0y\u00a0bajar\u00a0de\u00a0peso\u00a0as\u00ed\u00a0como\u00a0el\u00a0tratamient o\u00a0m\u00e9dico\u00a0de\u00a0factores\u00a0de\u00a0riesgo\u00a0\ntangibles\u00a0 como\u00a0 la\u00a0 diabetes\u00a0 mellitus,\u00a0 la\u00a0 hipertensi\u00f3n\u00a0 arterial\u00a0 e\u00a0 hiperlipidemia,\u00a0\npueden\u00a0retrasar\u00a0la\u00a0progresi\u00f3n\u00a0de\u00a0la\u00a0enfermedad\u00a0atero scler\u00f3tica\u00a0y\u00a0mejorar\u00a0la\u00a0\nsintomatolog\u00eda\u00a0general.\u00a0\u00a0No\u00a0se\u00a0ha\u00a0demostrado\u00a0que\u00a0esta s\u00a0intervenciones\u00a0afecten\u00a0los\u00a0\ns\u00edntomas\u00a0o\u00a0modifiquen\u00a0el\u00a0proceso\u00a0de\u00a0enfermedad\u00a0de\u00a0EAP,\u00a0 excepto\u00a0que\u00a0el\u00a0ejercicio\u00a0y\u00a0\nciertos\u00a0medicamentos\u00a0como\u00a0el\u00a0cilostazol\u00a0aumentan\u00a0la\u00a0dis tancia\u00a0de\u00a0marcha\u00a0en\u00a0\npacientes\u00a0con\u00a0claudicaci\u00f3n\u00a0intermitente.\u00a0\u00a0\u00a0\n1.2\u00a0Marco\u00a0Te\u00f3rico\u00a0Occidental. \u00a0\u00a0\nLa\u00a0 insuficiencia\u00a0 arterial\u00a0 perif\u00e9rica\u00a0 (EAP)\u00a0 es\u00a0 una\u00a0 man ifestaci\u00f3n\u00a0 de\u00a0 la\u00a0\narterioesclerosis\u00a0sist\u00e9mica,\u00a0que\u00a0afecta\u00a0a\u00a0la\u00a0aorta\u00a0a bdominal\u00a0y\u00a0sus\u00a0ramas\u00a0terminales.\u00a0\nSe\u00a0caracteriza\u00a0por\u00a0estenosis\u00a0u\u00a0obstrucci\u00f3n\u00a0de\u00a0la\u00a0luz\u00a0arterial\u00a0debido\u00a0a\u00a0las\u00a0placas\u00a0de\u00a0\nateroma\u00a0 que\u00a0 originadas\u00a0 en\u00a0 la\u00a0 capa\u00a0 \u00edntima,\u00a0 proliferan\u00a0 hacia\u00a0 la\u00a0 luz\u00a0 arterial\u00a0\nprovocando\u00a0cambios\u00a0hemodin\u00e1micos\u00a0a\u00a0nivel\u00a0del\u00a0flujo\u00a0san gu\u00edneo\u00a0arterial\u00a0que\u00a0se\u00a0\ntraducen\u00a0en\u00a0disminuci\u00f3n\u00a0de\u00a0la\u00a0presi\u00f3n\u00a0de\u00a0perfusi\u00f3n\u00a0y \u00a0dan\u00a0lugar\u00a0a\u00a0la\u00a0isquemia\u00a0de\u00a0los\u00a0\ntejidos.\u00a0La\u00a0isquemia\u00a0que\u00a0amenaza\u00a0la\u00a0extremidad,\u00a0es\u00a0con secuencia\u00a0de\u00a0un\u00a0flujo\u00a0\nsangu\u00edneo\u00a0insuficiente\u00a0para\u00a0cubrir\u00a0las\u00a0necesidades\u00a0 metab\u00f3licas\u00a0del\u00a0tejido\u00a0en\u00a0reposo\u00a0\no\u00a0sometido\u00a0a\u00a0esfuerzo.\u00a0El\u00a0s\u00edntoma\u00a0predominante\u00a0es\u00a0el\u00a0d olor\u00a0al\u00a0ejercicio,\u00a0tambi\u00e9n\u00a0\nllamado\u00a0claudicaci\u00f3n\u00a0intermitente,\u00a0caracterizado\u00a0por\u00a0 la\u00a0presencia\u00a0de\u00a0calambres\u00a0\ndolor\u00a0o\u00a0fatiga\u00a0que\u00a0t\u00edpicamente\u00a0involucra\u00a0los\u00a0m\u00fasculos \u00a0de\u00a0la\u00a0pantorrilla,\u00a0muslos\u00a0y\u00a0\ngl\u00fateos\u00a0y\u00a0en\u00a0etapas\u00a0mas\u00a0avanzadas\u00a0el\u00a0dolor\u00a0en\u00a0reposo ,\u00a0que\u00a0se\u00a0vuelve\u00a0intolerable\u00a0\u00a0\n\u00a0 3\u00a0progresivamente.\u00a0Adem\u00e1s\u00a0hay\u00a0sensaci\u00f3n\u00a0de\u00a0fr\u00edo\u00a0y\u00a0adormec imiento.\u00a0En\u00a0 un\u00a0per\u00edodo\u00a0\ntard\u00edo\u00a0 existe\u00a0 necrosis\u00a0 de\u00a0 los\u00a0 segmentos\u00a0 mas\u00a0 distales. \u00a0 La\u00a0 enfermedad\u00a0 arterial\u00a0\nperif\u00e9rica\u00a0se\u00a0asocia\u00a0con\u00a0una\u00a0disfunci\u00f3n\u00a0de\u00a0la\u00a0vasodilataci\u00f3n\u00a0dependiente\u00a0de\u00a0los\u00a0\nvasos\u00a0perif\u00e9ricos\u00a0endotelio\u00a0y\u00a0de\u00a0una\u00a0expresi\u00f3n\u00a0aumen tada\u00a0de\u00a0la\u00a0adhesi\u00f3n\u00a0de\u00a0\nmol\u00e9culas,\u00a0la\u00a0 agregaci\u00f3n\u00a0plaquetaria\u00a0y\u00a0liberaci\u00f3n \u00a0de\u00a0mol\u00e9culas\u00a0proinflamatorias.\u00a0\n1.2.1\u00a0Factores\u00a0de\u00a0Riesgo\u00a0\nLa\u00a0enfermedad\u00a0arterial\u00a0perif\u00e9rica\u00a0se\u00a0asocia\u00a0a\u00a0los\u00a0fa ctores\u00a0de\u00a0riesgo\u00a0cardiovascular\u00a0\ntales\u00a0como\u00a0el\u00a0tabaquismo,\u00a0diabetes\u00a0mellitus,\u00a0hipertens i\u00f3n\u00a0arterial,\u00a0dislipidemi a\u00a0y\u00a0\nniveles\u00a0elevados\u00a0de\u00a0homociste\u00edna\u00a0en\u00a0sangre.\u00a0Se\u00a0puede n\u00a0dividir\u00a0en\u00a0mayores\u00a0y\u00a0\nmenores,\u00a0los\u00a0mayores\u00a0son\u00a0los\u00a0que\u00a0han\u00a0sido\u00a0determinados \u00a0a\u00a0partir\u00a0de\u00a0grandes\u00a0\nestudios\u00a0epidemiol\u00f3gicos\u00a0\u00a0y\u00a0est\u00e1n\u00a0implicados\u00a0en\u00a0un\u00a080 \u201090%\u00a0de\u00a0los\u00a0enfermedades\u00a0\ncardiovasculares\u00a0 [1].\u00a0\nSexo\u00a0\nLa\u00a0prevalencia\u00a0de\u00a0la\u00a0EAP,\u00a0tanto\u00a0sintom\u00e1tica\u00a0como\u00a0asint om\u00e1tica,\u00a0es\u00a0mayor\u00a0en\u00a0\nvarones\u00a0que\u00a0en\u00a0mujeres,\u00a0sobre\u00a0todo\u00a0en\u00a0la\u00a0poblaci\u00f3n\u00a0m\u00e1 s\u00a0joven,\u00a0ya\u00a0que\u00a0en\u00a0edades\u00a0\nmuy\u00a0avanzadas\u00a0pr\u00e1cticamente\u00a0no\u00a0se\u00a0alcanzan\u00a0diferencia s\u00a0entre\u00a0ambos\u00a0grupos.\u00a0\nAdem\u00e1s,\u00a0la\u00a0prevalencia\u00a0en\u00a0los\u00a0varones\u00a0es\u00a0mayor\u00a0en\u00a0los\u00a0 grados\u00a0de\u00a0afectaci\u00f3n\u00a0m\u00e1s\u00a0\nsevera\u00a0(isquemia\u00a0cr\u00edtica).\u00a0\nEdad\u00a0\nEs\u00a0el\u00a0principal\u00a0marcador\u00a0de\u00a0riesgo\u00a0de\u00a0EAP.\u00a0Se\u00a0estima\u00a0qu e\u00a0la\u00a0prevalencia\u00a0de\u00a0\nclaudicaci\u00f3n\u00a0intermitente\u00a0en\u00a0el\u00a0grupo\u00a0de\u00a060\u201065\u00a0a\u00f1os\u00a0e s\u00a0del\u00a035%.\u00a0Sin\u00a0embargo,\u00a0en\u00a0la\u00a0\npoblaci\u00f3n\u00a01 0\u00a0a\u00f1os\u00a0mayor\u00a0(70\u2010 75\u00a0a\u00f1os),\u00a0la\u00a0prevalencia\u00a0se\u00a0i ncrementa\u00a0hasta\u00a0alcanzar\u00a0\nun\u00a070%\u00a0(2).\u00a0\nTabaco\u00a0\nEn\u00a0algunos\u00a0estudios\u00a0se\u00a0ha\u00a0encontrado\u00a0una\u00a0asociaci\u00f3n \u00a0m\u00e1s\u00a0fuerte\u00a0entre\u00a0el\u00a0abuso\u00a0de\u00a0\ntabaco\u00a0y\u00a0la\u00a0EAP\u00a0que\u00a0en\u00a0la\u00a0cardiopat\u00eda\u00a0isqu\u00e9mica,\u00a0adem\u00e1 s\u00a0se\u00a0ha\u00a0observado\u00a0que\u00a0los\u00a0\nfumadores\u00a0m\u00e1s\u00a0severos\u00a0no\u00a0s\u00f3lo\u00a0tienen\u00a0un\u00a0mayor\u00a0riesgo\u00a0d e\u00a0EAP,\u00a0sino\u00a0que\u00a0presentan\u00a0\nlas\u00a0formas\u00a0m\u00e1s\u00a0graves\u00a0que\u00a0ocasionan\u00a0isquemia\u00a0cr\u00edtica.\u00a0 El\u00a0abandono\u00a0del\u00a0tabaco\u00a0se\u00a0ha\u00a0\u00a0\n\u00a0 4\u00a0acompa\u00f1ado\u00a0de\u00a0una\u00a0reducci\u00f3n\u00a0en\u00a0el\u00a0riesgo\u00a0de\u00a0EAP\u00a0y\u00a0se\u00a0 ha\u00a0comprobado\u00a0que,\u00a0aunque\u00a0\nel\u00a0riesgo\u00a0de\u00a0experi mentar\u00a0EAP\u00a0en\u00a0ex\u00a0fumadores\u00a0es\u00a07\u00a0veces\u00a0mayor\u00a0que\u00a0en\u00a0no\u00a0\nfumadores,\u00a0en\u00a0los\u00a0fumadores\u00a0activos\u00a0es\u00a016\u00a0veces\u00a0m\u00e1s\u00a0el evado.\u00a0Por\u00a0otra\u00a0parte,\u00a0la\u00a0\npermeabilidad\u00a0tanto\u00a0de\u00a0los\u00a0injertos\u00a0de\u00a0derivaci\u00f3n\u00a0ao rtocoronaria\u00a0venosos\u00a0como\u00a0de\u00a0\nlos\u00a0prot\u00e9sicos\u00a0se\u00a0reduce\u00a0en\u00a0pacientes\u00a0fum adores.\u00a0La\u00a0tasa\u00a0de\u00a0amputaciones\u00a0y\u00a0la\u00a0\nmortalidad\u00a0tambi\u00e9n\u00a0son\u00a0mayores\u00a0en\u00a0sujetos\u00a0fumadores\u00a0(3, \u00a04).\u00a0\nDiabetes\u00a0\nLa\u00a0diabetes\u00a0es\u00a0un\u00a0factor\u00a0de\u00a0riesgo\u00a0no\u00a0s\u00f3lo\u00a0cualitativo,\u00a0sino\u00a0cuantitativo,\u00a0ya\u00a0que\u00a0por\u00a0\ncada\u00a0aumento\u00a0del\u00a01%\u00a0de\u00a0la\u00a0hemoglobina\u00a0glucosilada\u00a0se\u00a0 produce\u00a0un\u00a0incremento\u00a0del\u00a0\n25%\u00a0en\u00a0el\u00a0riesgo\u00a0de\u00a0EAP.\u00a0La\u00a0afectaci\u00f3n\u00a0de\u00a0vasos\u00a0dist ales\u00a0de\u00a0las\u00a0extremidades\u00a0es\u00a0\nt\u00edpica\u00a0y,\u00a0junto\u00a0con\u00a0la\u00a0microangiopat\u00eda\u00a0y\u00a0la\u00a0neuropat \u00eda,\u00a0que\u00a0implican\u00a0una\u00a0mala\u00a0\nrespuesta\u00a0a\u00a0la\u00a0infecci\u00f3n\u00a0y\u00a0un\u00a0trastorno\u00a0espec\u00edfico\u00a0de\u00a0la\u00a0cicatrizaci\u00f3n,\u00a0condicionan \u00a0un\u00a0\nriesgo\u00a0de\u00a0amputaci\u00f3n\u00a0hasta\u00a010\u00a0veces\u00a0superior\u00a0al\u00a0de\u00a0l os\u00a0pacientes\u00a0no\u00a0diab\u00e9ticos.\u00a0\nCabe\u00a0 destacar\u00a0 que\u00a0 en\u00a0 los\u00a0 pacientes\u00a0 diab\u00e9ticos\u00a0 pueden\u00a0 obtenerse\u00a0 valores\u00a0\nanormalmente\u00a0altos\u00a0en\u00a0el\u00a0\u00cdndice\u00a0Tobillo\u00a0Brazo\u00a0(ITB)\u00a0y \u00a0por\u00a0tanto,\u00a0falsos\u00a0negat ivos\u00a0en\u00a0\nla\u00a0valoraci\u00f3n\u00a0del\u00a0ITB\u00a0 (5).\u00a0\nHipertensi\u00f3n \u00a0\nSu\u00a0importancia\u00a0como\u00a0factor\u00a0de\u00a0riesgo\u00a0es\u00a0inferior\u00a0a\u00a0la \u00a0diabetes\u00a0o\u00a0el\u00a0tabaquismo.\u00a0No\u00a0\nobstante,\u00a0se\u00a0considera\u00a0que\u00a0el\u00a0riesgo\u00a0de\u00a0EAP\u00a0es\u00a0el\u00a0do ble\u00a0en\u00a0los\u00a0pacientes\u00a0hi pertensos\u00a0\nque\u00a0en\u00a0los\u00a0controles\u00a0 (5).\u00a0\nDislipidemia\u00a0\nEn\u00a0 varios\u00a0 estudios\u00a0 epidem iol\u00f3gicos\u00a0 se\u00a0 ha\u00a0 demostrado\u00a0 que\u00a0 la\u00a0 elevaci\u00f3n\u00a0 del\u00a0\ncolesterol\u00a0total\u00a0y\u00a0el\u00a0colesterol\u00a0unido\u00a0a\u00a0lipoprote\u00ednas\u00a0de\u00a0baja\u00a0densidad\u00a0(cLDL)\u00a0y\u00a0el\u00a0\ndescenso\u00a0del\u00a0colesterol\u00a0unido\u00a0a\u00a0lipoprote\u00ednas\u00a0de\u00a0alta\u00a0densidad\u00a0(cHDL)\u00a0se\u00a0asocian\u00a0\ncon\u00a0una\u00a0mayor\u00a0mortalidad\u00a0cardiovascular.\u00a0Fa ctores\u00a0de\u00a0riesgo\u00a0independientes\u00a0para\u00a0\nel\u00a0 desarrollo\u00a0 de\u00a0 EAP\u00a0 son\u00a0 el\u00a0 colesterol\u00a0 total,\u00a0 el\u00a0 cLD L,\u00a0 los\u00a0 triglic\u00e9ridos\u00a0 y\u00a0 la\u00a0\nlipoprote\u00edna .\u00a0En\u00a0el\u00a0estudio\u00a0de\u00a0Framingham\u00a0se\u00a0comprob\u00f3\u00a0que\u00a0el\u00a0cocie nte\u00a0colesterol\u00a0\ntotal/cHDL\u00a0fue\u00a0el\u00a0mejor\u00a0predictor\u00a0de\u00a0EAP.\u00a0Se\u00a0ha\u00a0compro bado\u00a0que\u00a0el\u00a0tratamiento\u00a0de\u00a0\u00a0\n\u00a0 5\u00a0la\u00a0hiperlipemia\u00a0reduce\u00a0la\u00a0progresi\u00f3n\u00a0de\u00a0la\u00a0EAP\u00a0y\u00a0el\u00a0d esarrollo\u00a0de\u00a0isquemia\u00a0cr\u00edtica\u00a0\n(6).\u00a0\n1.2.2\u00a0\u00d3xido\u00a0N\u00edtrico \u00a0\nEl\u00a0\u00f3xido\u00a0n\u00edtrico\u00a0desempe\u00f1a\u00a0un\u00a0importante\u00a0papel\u00a0en\u00a0la\u00a0 regulaci\u00f3n\u00a0de\u00a0la\u00a0presi\u00f3n\u00a0\nsangu\u00ednea.\u00a0Produce\u00a0una\u00a0relajaci\u00f3n\u00a0de\u00a0la\u00a0musculatu ra\u00a0lisa\u00a0vascular.\u00a0Esto\u00a0provoca\u00a0\nvasodilataci\u00f3n\u00a0arterial\u00a0y\u00a0por\u00a0consiguiente\u00a0una\u00a0reducci\u00f3n\u00a0de\u00a0la\u00a0resistencia\u00a0vascular\u00a0y\u00a0\nde\u00a0la\u00a0presi\u00f3n\u00a0arterial.\u00a0Este\u00a0es\u00a0el\u00a0principal\u00a0papel\u00a0del\u00a0\u00f3xido\u00a0n\u00edtrico\u00a0endotelial.\u00a0Se\u00a0sabe\u00a0\nque\u00a0en\u00a0la\u00a0hipertensi\u00f3n\u00a0arterial\u00a0la\u00a0producci\u00f3n\u00a0de\u00a0\u00f3 xido\u00a0n\u00edtrico\u00a0est\u00e1\u00a0deteriorada. \u00a0\nSabemos\u00a0adem\u00e1s\u00a0que\u00a0es\u00a0capaz\u00a0de\u00a0 indusir\u00a0la\u00a0producci\u00f3n\u00a0de\u00a0GMP\u00a0C\u00edclico,\u00a0a\u00a0trav\u00e9s\u00a0de\u00a0\nguanilato\u00a0 ciclasa.\u00a0 Este\u00a0 segundo\u00a0 mensajero\u00a0 tiene\u00a0 la\u00a0 c apacidad\u00a0 de\u00a0 inhibir\u00a0 la\u00a0\nagregaci\u00f3n\u00a0plaquetaria\u00a0y,\u00a0por\u00a0lo\u00a0tanto,\u00a0prevenir\u00a0la \u00a0formaci\u00f3n\u00a0del\u00a0trombo.\u00a0\u00a0\nAl\u00a0 ejercer\u00a0 un\u00a0 papel\u00a0 tan\u00a0 destacado\u00a0 en\u00a0 el\u00a0 organismo\u00a0 no\u00a0 solo\u00a0 como\u00a0 agente\u00a0\nvasodilatador\u00a0sino\u00a0como\u00a0un\u00a0inhibidor\u00a0de\u00a0la\u00a0funci\u00f3n\u00a0p laquetaria\u00a0y\u00a0la\u00a0trombosis.\u00a0El\u00a0\n\u00f3xido\u00a0 n\u00edtrico\u00a0 aumenta\u00a0 el\u00a0 GMP\u00a0 c\u00edclico\u00a0 inhibiendo,\u00a0 por \u00a0 tanto,\u00a0 la\u00a0 agregaci\u00f3n\u00a0\nplaquetaria\u00a0y\u00a0la\u00a0adhesi\u00f3 n\u00a0de\u00a0las\u00a0plaquetas\u00a0a\u00a0la\u00a0capa\u00a0intima\u00a0de\u00a0los\u00a0vasos.\u00a0Co mo\u00a0el\u00a0\n\u00f3xido\u00a0n\u00edtrico\u00a0proviene\u00a0de\u00a0las\u00a0c\u00e9lulas\u00a0endoteliales\u00a0es\u00a0necesario\u00a0un\u00a0endotelio\u00a0sano\u00a0\npara\u00a0el\u00a0desempe\u00f1o\u00a0de\u00a0esta\u00a0acci\u00f3n.\u00a0Cualquier\u00a0acci\u00f3n\u00a0q ue\u00a0aumente\u00a0la\u00a0s\u00edntesis\u00a0o\u00a0\nliberaci\u00f3n\u00a0de\u00a0\u00f3xido\u00a0n\u00edtrico\u00a0tendr\u00e1\u00a0el\u00a0m ismo\u00a0efecto\u00a0en\u00a0la\u00a0inhibici\u00f3n\u00a0de\u00a0la\u00a0funci\u00f3n\u00a0\nplaquetaria.\u00a0(7) \u00a0\u00a0\n1.2.3\u00a0Fisiopatolog\u00eda \u00a0\nDesde\u00a0el\u00a0punto\u00a0de\u00a0vista\u00a0fi siopatol\u00f3gico,\u00a0la\u00a0isquemia\u00a0de\u00a0las\u00a0extremidades\u00a0inferi ores\u00a0\npuede\u00a0clasificarse\u00a0en\u00a0funcional\u00a0y\u00a0cr\u00edtica.\u00a0La\u00a0isque mia\u00a0funcional\u00a0ocurre\u00a0cuando\u00a0el\u00a0\nflujo\u00a0 sangu\u00edneo\u00a0 es\u00a0 normal\u00a0 en\u00a0 reposo\u00a0 pero\u00a0 insuficiente\u00a0 durant e\u00a0 el\u00a0 ejercicio,\u00a0\nmanifest\u00e1ndose\u00a0cl\u00ednicamente\u00a0como\u00a0claudicaci\u00f3n\u00a0intermite nte.\u00a0La\u00a0isquemia\u00a0cr\u00edtica\u00a0\nse\u00a0produce\u00a0cuando\u00a0la\u00a0reducci\u00f3n\u00a0del\u00a0flujo\u00a0sangu\u00edneo\u00a0ocasiona\u00a0u n\u00a0d\u00e9ficit\u00a0de\u00a0perfusi\u00f3n\u00a0\ntisular\u00a0y\u00a0se\u00a0define\u00a0por\u00a0 la\u00a0presencia\u00a0de\u00a0dolor\u00a0en\u00a0reposo\u00a0o\u00a0lesiones\u00a0tr\u00f3ficas\u00a0en\u00a0la\u00a0\nextremidad.\u00a0En\u00a0estas\u00a0circunstancias,\u00a0el\u00a0diagn\u00f3stico\u00a0 preciso\u00a0es\u00a0fundamental,\u00a0ya\u00a0que\u00a0\nhay\u00a0un\u00a0claro\u00a0riesgo\u00a0de\u00a0p\u00e9rdida\u00a0de\u00a0extremidad\u00a0si\u00a0no\u00a0s e\u00a0restablece\u00a0un\u00a0flujo\u00a0sangu\u00edneo\u00a0\u00a0\n\u00a0 6\u00a0adecuado,\u00a0 mediante\u00a0 cir ug\u00eda\u00a0 o\u00a0 tratamiento\u00a0 endovascular;\u00a0 diferenciar\u00a0 ambos\u00a0\nconceptos\u00a0es\u00a0importante\u00a0para\u00a0establecer\u00a0la\u00a0indicaci\u00f3 n\u00a0terap\u00e9utica\u00a0y\u00a0el\u00a0pron\u00f3 stico\u00a0\nde\u00a0los\u00a0pacientes\u00a0con\u00a0EAP\u00a0 (8).\u00a0\n\u00a0\n\u00a0\nEl\u00a0mecanismo\u00a0fisiopatol\u00f3gico\u00a0por\u00a0el\u00a0que\u00a0se\u00a0desarrolla \u00a0la\u00a0insuficiencia\u00a0arterial\u00a0se\u00a0\nbasa\u00a0en\u00a0la\u00a0prese ncia\u00a0de\u00a0estenosis\u00a0arteriales\u00a0que\u00a0progresan\u00a0en\u00a0su\u00a0historia\u00a0natural\u00a0\nhasta\u00a0provocar\u00a0una\u00a0oclusi\u00f3n\u00a0arterial\u00a0completa.\u00a0Ello\u00a0 se\u00a0traduce\u00a0en\u00a0un\u00a0mayor\u00a0o\u00a0\nmenor\u00a0grado\u00a0de\u00a0desarrollo\u00a0de\u00a0las\u00a0v\u00edas\u00a0colaterales\u00a0de \u00a0suplencia.\u00a0Cuando\u00a0el\u00a0desajuste\u00a0\nentre\u00a0las\u00a0necesidades\u00a0de\u00a0los\u00a0 tejidos\u00a0perif\u00e9ricos\u00a0y\u00a0el\u00a0aporte\u00a0de\u00a0sangre\u00a0se\u00a0produce\u00a0de\u00a0\nmanera\u00a0m\u00e1s\u00a0o\u00a0menos\u00a0abrupta\u00a0(placa\u00a0de\u00a0alto\u00a0riesgo),\u00a0est aremos\u00a0ante\u00a0un\u00a0cuadro\u00a0de\u00a0\nisquemia\u00a0aguda\u00a0de\u00a0origen\u00a0tromb\u00f3tico.\u00a0Se\u00a0han\u00a0podido\u00a0de tectar\u00a0diferencias\u00a0en\u00a0el\u00a0\ncomportamiento\u00a0de\u00a0la\u00a0placa\u00a0ateromatosa\u00a0en\u00a0relaci\u00f3n\u00a0con \u00a0la\u00a0localizaci\u00f3n\u00a0anat\u00f3mica.\u00a0\nLas\u00a0placas\u00a0de\u00a0alto\u00a0riesgo\u00a0de\u00a0las\u00a0arterias\u00a0de\u00a0las\u00a0ex tremidades\u00a0inferiores\u00a0son\u00a0muy\u00a0\nesten\u00f3ticas\u00a0y\u00a0fibrosas. \u00a0\n\u00a0\n\u00a0\n\u00a0 7\u00a0Dicha\u00a0estenosis,\u00a0asociada\u00a0con\u00a0un\u00a0estado\u00a0de\u00a0hipercoagulabilidad,\u00a0contribuye\u00a0de\u00a0\nmanera\u00a0decisiva\u00a0al\u00a0desarrollo\u00a0de\u00a0 eventos\u00a0agudos.\u00a0Este\u00a0tipo\u00a0de\u00a0placas\u00a0contrasta\u00a0\nclaramente\u00a0con\u00a0las\u00a0lesiones\u00a0presentes\u00a0en\u00a0las\u00a0arteria s\u00a0coronarias,\u00a0que\u00a0con\u00a0frecuencia\u00a0\nest\u00e1n\u00a0compuestas\u00a0por\u00a0un\u00a0gran\u00a0n\u00facleo\u00a0lip\u00eddico\u00a0extrace lular\u00a0y\u00a0un\u00a0gran\u00a0n\u00famero\u00a0de\u00a0\nc\u00e9lulas\u00a0espumosas,\u00a0recubierto\u00a0por\u00a0una\u00a0fina\u00a0cubi erta\u00a0fibrosa\u00a0susceptible\u00a0de\u00a0rotura.\u00a0\nEn\u00a0esta\u00a0situaci\u00f3n,\u00a0la\u00a0vulnerabilidad\u00a0de\u00a0la\u00a0placa\u00a0en \u00a0los\u00a0puntos\u00a0m\u00e1s\u00a0fr\u00e1giles\u00a0(mayor\u00a0\nn\u00famero\u00a0de\u00a0c\u00e9lulas\u00a0espumosas\u00a0y\u00a0capa\u00a0fibrosa\u00a0m\u00e1s\u00a0delgada )\u00a0es\u00a0la\u00a0causa\u00a0de\u00a0los\u00a0\neventos\u00a0agudos. \u00a0\nCuando\u00a0se\u00a0produce\u00a0la\u00a0rotura\u00a0de\u00a0la\u00a0placa,\u00a0tiene \u00a0lugar\u00a0una\u00a0trombosis\u00a0que\u00a0oblitera\u00a0la\u00a0\nluz\u00a0vascular,\u00a0desencadenando\u00a0los\u00a0cuadros\u00a0agudos.\u00a0Debido\u00a0a\u00a0que,\u00a0con\u00a0frecuencia,\u00a0\nantes\u00a0de\u00a0la\u00a0rotura\u00a0de\u00a0la\u00a0placa\u00a0se\u00a0ha\u00a0neoformado\u00a0circ ulaci\u00f3n\u00a0colateral,\u00a0la\u00a0cl\u00ednica\u00a0de\u00a0la\u00a0\nisquemia\u00a0aguda\u00a0es\u00a0mejor\u00a0tolerada\u00a0que\u00a0la\u00a0que\u00a0acontece\u00a0 cuando\u00a0el\u00a0cuadro\u00a0de\u00a0base\u00a0de\u00a0\nla\u00a0isquemia\u00a0aguda\u00a0es\u00a0de\u00a0origen\u00a0emb\u00f3lico\u00a0(8).\u00a0\nUno\u00a0de\u00a0los\u00a0factores\u00a0m\u00e1s\u00a0importantes\u00a0que\u00a0impactan\u00a0en\u00a0es te\u00a0tratamiento\u00a0integral\u00a0es\u00a0\nla\u00a0modificaci\u00f3n\u00a0en\u00a0el\u00a0estilo\u00a0de\u00a0vida,\u00a0disminuyendo\u00a0fa ctores\u00a0de\u00a0riesgo\u00a0tales\u00a0como\u00a0\ndejar\u00a0fumar,\u00a0hacer\u00a0ejercicio\u00a0y\u00a0bajar\u00a0de\u00a0peso\u00a0as\u00ed\u00a0como \u00a0el\u00a0tratamiento\u00a0m\u00e9dico\u00a0de\u00a0\nfactores\u00a0de\u00a0riesgo\u00a0tangibles\u00a0como\u00a0la\u00a0diabetes\u00a0mellitu s,\u00a0la\u00a0hipertensi\u00f3n\u00a0arterial\u00a0e\u00a0\nhiperlipidemia.\u00a0Esto\u00a0puede\u00a0retrasar\u00a0la\u00a0progresi\u00f3n\u00a0de \u00a0la\u00a0enfermedad\u00a0ateroscler\u00f3tica\u00a0\ny\u00a0mejorar\u00a0la\u00a0sintomatolog\u00eda\u00a0gen eral.\u00a0No\u00a0se\u00a0ha\u00a0demostrado\u00a0que\u00a0estas\u00a0intervenciones\u00a0\nafecten\u00a0los\u00a0s\u00edntomas\u00a0o\u00a0modifiquen\u00a0el\u00a0proceso\u00a0de\u00a0enfer medad\u00a0de\u00a0EAP,\u00a0excepto\u00a0que\u00a0el\u00a0\nejercicio\u00a0y\u00a0ciertos\u00a0medicamentos\u00a0como\u00a0el\u00a0cilostazol\u00a0au mentan\u00a0la\u00a0distancia\u00a0de\u00a0\nmarcha\u00a0en\u00a0pacientes\u00a0con\u00a0claudicaci\u00f3n\u00a0intermite nte.\u00a0\u00a0(3,\u00a04).\u00a0\n1.2.4\u00a0Indice\u00a0Tobillo\u00a0Brazo \u00a0\nPara\u00a0detectar\u00a0la\u00a0existencia\u00a0de\u00a0enfermedad\u00a0arterial\u00a0p erif\u00e9rica\u00a0cuando\u00a0a\u00fan\u00a0no\u00a0existe\u00a0\nsintomatolog\u00eda,\u00a0existe\u00a0el\u00a0par\u00e1metro\u00a0denominado:\u00a0\u00cd ndice\u00a0Tobillo \u2010Brazo\u00a0(ITB): \u00a0\n\u00a0 \u00a0 \u00a0 ITB=\u00a0Presi\u00f3n\u00a0arterial\u00a0Sist\u00f3lica\u00a0en\u00a0Tobillo\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0=\u00a01.0\u00a0\n\u00a0 \u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Presi\u00f3n\u00a0Arterial\u00a0Sist\u00f3lica\u00a0en\u00a0Brazo\u00a0\n\u00a0 \u00a0\u00a0\n\u00a0 8\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\nEste\u00a0se\u00a0utiliza\u00a0en\u00a0el\u00a0diagn\u00f3stico\u00a0diferencial\u00a0de\u00a0s\u00edntomas\u00a0de \u00a0extremidades\u00a0inferiores\u00a0\npara\u00a0 identificar\u00a0 s\u00edntomas\u00a0 vasculares,\u00a0 identifica\u00a0 pac ientes\u00a0 con\u00a0 incapacidad\u00a0 de\u00a0\ncaminar\u00a0distancias\u00a0definidas\u00a0o\u00a0caminar\u00a0a\u00a0una\u00a0velocida d\u00a0habitual.\u00a0Proporciona\u00a0\ninformaci\u00f3n\u00a0clave\u00a0y\u00a0pron\u00f3stica,\u00a0cuando\u00a0existe\u00a0un\u00a0ITB \u00a0bajo.\u00a0Tiene\u00a0asociaci\u00f3n\u00a0con\u00a0\nenfermedad\u00a0coronaria\u00a0y\u00a0cerebral.\u00a0Debe\u00a0realiz\u00e1rsele\u00a0a \u00a0pacientes\u00a0con\u00a0claudicaci\u00f3n\u00a0\nintermitente\u00a0o\u00a0asintom\u00e1ticos\u00a0con\u00a0el\u00a0obj eto\u00a0de\u00a0ofrecer\u00a0intervenciones\u00a0terap\u00e9uticas.\u00a0\nUn\u00a0ITB\u00a0de\u00a0<0.9\u00a0sugiere\u00a0la\u00a0presencia\u00a0de\u00a0EAP.\u00a0\u00a0\n\u00a0\n1.2.5\u00a0Oximetr\u00eda\u00a0Transcut\u00e1nea\u00a0(TcO 2)\u00a0\u00a0\u00a0\nEs\u00a0una\u00a0herramienta\u00a0diagn\u00f3stica\u00a0 que\u00a0eval\u00faa\u00a0la\u00a0respuesta\u00a0al\u00a0ox\u00edgeno\u00a0que\u00a0el\u00a0paciente\u00a0\nrespira\u00a0con\u00a0un\u00a0uso\u00a0creciente\u00a0para\u00a0evaluar\u00a0la\u00a0 perfusi\u00f3n\u00a0perif\u00e9rica\u00a0adyacente .\u00a0\u00a0\n\u00a0\nMediante\u00a0esta \u00a0herramienta\u00a0de\u00a0medici\u00f3n,\u00a0encontramos\u00a0que:\u00a0\u00a0\na)\u00a0La\u00a0hipoxia\u00a0tisular\u00a0se\u00a0 identifica\u00a0cuando \u00a0la\u00a0presi\u00f3n\u00a0de\u00a0ox\u00edgeno\u00a0transcut\u00e1neo \u00a0\n(PTcO2)\u00a0<40mmHg.\u00a0\u00a0\n\u00a0\nb)\u00a0 En\u00a0 pacientes\u00a0 sin\u00a0 enfermedad\u00a0 vascular\u00a0 perif\u00e9rica,\u00a0 los\u00a0 valores\u00a0 de\u00a0 la \u00a0PTcO2\u00a0\naumentan\u00a0a\u00a0>\u00a0100mH g,\u00a0con\u00a0el\u00a0paciente\u00a0respirando\u00a0ox\u00edgeno\u00a0al\u00a0100%\u00a0bajo\u00a0presiones\u00a0\nnormob\u00e1ricas.\u00a0\u00a0\n\u00a0\nc)\u00a0Los\u00a0pacientes\u00a0con\u00a0isquemia\u00a0cr\u00edtica\u00a0de\u00a0la\u00a0extremida d\u00a0(presi\u00f3n\u00a0arter ial\u00a0sist\u00f3lica\u00a0del\u00a0\ntobillo\u00a0de\u00a0<\u00a0\u00f3 \u00a0=\u00a050\u00a0mm\u00a0H g\u00a0o\u00a0de\u00a0presi\u00f3n\u00a0a rterial\u00a0sist\u00f3lica\u00a0de\u00a0tobill o\u00a0<\u00a0\u00f3\u00a0=\u00a030\u00a0mm\u00a0H g)\u00a0\nrespirando\u00a0aire\u00a0del\u00a0ambiente,\u00a0usualmente\u00a0te ndr\u00e1\u00a0una\u00a0PTCO2\u00a0<\u00a030mmH g.\u00a0\u00a0\n\u00a0 9\u00a0\u00a0d)\u00a0Valores\u00a0de\u00a0PTCO2\u00a0bajos\u00a0obten idos\u00a0mientras\u00a0se\u00a0respira\u00a0aire\u00a0normob\u00e1rico\u00a0pueden\u00a0\nser\u00a0causados\u00a0por\u00a0una\u00a0barrera\u00a0de\u00a0difusi\u00f3n .\u00a0\u00a0\ne)\u00a0Una\u00a0PTcO2\u00a0<\u00a040\u00a0mm\u00a0H g\u00a0obtenida\u00a0respirando\u00a0ai re\u00a0normob\u00e1rico\u00a0est\u00e1\u00a0asociado\u00a0con\u00a0\nuna\u00a0reducida\u00a0probabilidad\u00a0de\u00a0necesidad\u00a0de\u00a0amputaci\u00f3n .\u00a0\u00a0\nf)\u00a0Si\u00a0la\u00a0l\u00ednea\u00a0basal\u00a0de\u00a0la\u00a0oximetr\u00eda\u00a0transcut\u00e1nea\u00a0aumenta \u00a0a\u00a0<10mmHg\u00a0mientras\u00a0se\u00a0\nrespira\u00a0ox\u00edgeno\u00a0normob\u00e1rico\u00a0al\u00a0100%,\u00a0esto\u00a0tiene\u00a0una\u00a0 probabilidad\u00a0del\u00a068%\u00a0de\u00a0\nfracaso\u00a0post erior\u00a0a\u00a0la\u00a0amputaci\u00f3n.\u00a0\u00a0\ng)\u00a0Un\u00a0incremento\u00a0en\u00a0el\u00a0valor\u00a0de\u00a0la\u00a0oximetr\u00eda\u00a0transcut\u00e1nea \u00a0>40mmHg\u00a0durante\u00a0la\u00a0\nrespiraci\u00f3n\u00a0de\u00a0aire\u00a0normob\u00e1rico\u00a0despu\u00e9s\u00a0de\u00a0la\u00a0revasc ularizaci\u00f3n\u00a0generalmente\u00a0se\u00a0\nasocia\u00a0a\u00a0curaci\u00f3n,\u00a0aunque\u00a0el\u00a0aumento\u00a0no\u00a0es\u00a0inmediato. \u00a0\nh)\u00a0La\u00a0oximetr\u00eda\u00a0trans cut\u00e1nea\u00a0puede\u00a0ayudar\u00a0a\u00a0identificar\u00a0a\u00a0aquellos\u00a0pacientes\u00a0que\u00a0\nno\u00a0se\u00a0beneficiar\u00e1n\u00a0con\u00a0el\u00a0manejo\u00a0 (9).\u00a0\n\u00a0\n1.2.6\u00a0Clasificaci\u00f3n\u00a0de\u00a0la\u00a0Enfermedad\u00a0Arterial\u00a0Perif\u00e9rica. \u00a0\nClasificaci\u00f3n\u00a0de\u00a0 Ruttherford :\u00a0Se\u00a0define\u00a0por\u00a0el\u00a0grado\u00a0de\u00a0p\u00e9rdida\u00a0de\u00a0la\u00a0sensbilidad,\u00a0\ndebilidad\u00a0muscul ar,\u00a0audici\u00f3n\u00a0del\u00a0flujo\u00a0sangu\u00edneo\u00a0arterial\u00a0y\u00a0venoso\u00a0por\u00a0Ecograf\u00eda\u00a0\nDoppler.\u00a0\nLa\u00a0Clasificaci\u00f3n\u00a0de\u00a0Ruttherford\u00a0para\u00a0la\u00a0insuficiencia\u00a0arterial\u00a0aguda\u00a0consta\u00a0de\u00a04\u00a0\u00a0\ncategor\u00edas\u00a0(I,\u00a0IIa,\u00a0IIb,\u00a0III)\u00a0en\u00a0las\u00a0que\u00a0los \u00a0s\u00edntomas\u00a0del\u00a0paciente\u00a0como\u00a0la\u00a0p\u00e9 rdida\u00a0de\u00a0la\u00a0\nsensibilidad,\u00a0 debilidad\u00a0 muscular\u00a0 y\u00a0 signos\u00a0 cl\u00ednicos\u00a0 como\u00a0 la\u00a0 audic i\u00f3n\u00a0 del\u00a0 flujo\u00a0\nsangu\u00edneo\u00a0arterial\u00a0y\u00a0venoso\u00a0por\u00a0ecograf\u00eda\u00a0doppler\u00a0definir\u00e1n\u00a0en\u00a0que\u00a0estadio\u00a0se\u00a0\nencuentra.\u00a0\u00a0Esta\u00a0escala\u00a0engloba\u00a0a\u00a0la\u00a0extremidad\u00a0infe rior\u00a0con\u00a0insuficiencia\u00a0arterial\u00a0\naguda\u00a0en:\u00a0 Viable\u00a0(I)\u00a0en\u00a0la\u00a0 cual\u00a0no\u00a0requiere\u00a0tratamiento\u00a0quir\u00fargico,\u00a0Amenaza\u00a0\nmarginal\u00a0(IIa)\u00a0en\u00a0la\u00a0que\u00a0el\u00a0tratamiento\u00a0quir\u00fargico\u00a0de be\u00a0ser\u00a0pronto,\u00a0Amenaza\u00a0\ninmediata\u00a0(IIb)\u00a0en\u00a0la\u00a0que\u00a0el\u00a0tratamiento\u00a0quir\u00fargico\u00a0d ebe\u00a0ser\u00a0inmediato\u00a0y\u00a0por\u00a0\u00faltimo\u00a0\nla\u00a0Irreversible\u00a0(III)\u00a0en\u00a0la\u00a0que\u00a0el\u00a0tratamiento\u00a0debe\u00a0 ser\u00a0la\u00a0amputaci\u00f3n.\u00a0\u00a0\u00a0\n\u00a0 10\u00a0I\u00a0Viable\u00a0 No\u00a0requiere\u00a0tratamiento\u00a0quir\u00fargico.\u00a0\nIIA\u00a0Amenaza\u00a0Marginal\u00a0 Tratamiento\u00a0quir\u00fargico\u00a0debe\u00a0ser\u00a0pronto.\u00a0\nIIB\u00a0Amenaza\u00a0Inmediata\u00a0 Tratamiento\u00a0quir\u00fargico\u00a0debe\u00a0ser\u00a0inmediato.\u00a0\nIII\u00a0Da\u00f1o\u00a0Irreversible \u00a0Amputaci\u00f3n.\u00a0\n\u00a0\n\u00a0\nClasificaci\u00f3n\u00a0de\u00a0 Fontaine/\u00a0Leriche: \u00a0\u00a0\u00a0\u00a0Eval\u00faa\u00a0la\u00a0isquemia\u00a0cr\u00f3nica\u00a0en\u00a0extremidades\u00a0\ninferiores.\u00a0\nLa\u00a0clasificaci\u00f3n\u00a0funcional\u00a0de\u00a0Leriche\u00a0y\u00a0Fontaine\u00a0ev al\u00faa\u00a0la\u00a0isquemia\u00a0cr\u00f3nica\u00a0en\u00a0\nextremidades\u00a0inferiores,\u00a0defini\u00e9ndola\u00a0en\u00a0grados\u00a0(I\u2010 IV)\u00a0en\u00a0la\u00a0cual\u00a0el\u00a0grado\u00a0I\u00a0son\u00a0las\u00a0\nlesiones\u00a0asintom\u00e1ticas,\u00a0el\u00a0grado\u00a0II\u00a0es\u00a0la\u00a0claudicaci \u00f3n\u00a0intermitente\u00a0esta\u00a0se\u00a0divide\u00a0en\u00a0\nIIa\u00a0si\u00a0el\u00a0paciente\u00a0claudica\u00a0despu\u00e9s\u00a0de\u00a0150\u00a0metros\u00a0y\u00a0 IIb\u00a0si\u00a0claudica\u00a0antes,\u00a0el\u00a0grado\u00a0III\u00a0\nes\u00a0el\u00a0dolor\u00a0en\u00a0reposo\u00a0y\u00a0el\u00a0grado\u00a0IV\u00a0habla\u00a0de\u00a0las\u00a0lesiones\u00a0necr\u00f3ticas\u00a0o\u00a0gangrenosas.\u00a0 \u00a0\nI\u00a0 Lesiones\u00a0asin tom\u00e1ticas\u00a0\nII\u00a0 Claudicaci\u00f3n\u00a0Intermitente\u00a0\nIIA\u00a0Claudicaci\u00f3n\u00a0despu\u00e9s\u00a0de\u00a0150\u00a0metros.\u00a0\nIIB\u00a0Claudicaci\u00f3n\u00a0antes\u00a0de\u00a0150\u00a0metros.\u00a0\nIII\u00a0Dolor\u00a0en\u00a0reposo \u00a0\nIV\u00a0Presencia\u00a0de\u00a0lesiones\u00a0necr\u00f3ticas. \u00a0\n\u00a0\n1.2.7\u00a0Manejo\u00a0Conservador:\u00a0 \u00a0\nEn\u00a0pacientes\u00a0con\u00a0s\u00edntomas\u00a0leves\u00a0a\u00a0moderados\u00a0(est ad\u00edo\u00a0Fontaine\u00a0II),\u00a0el \u00a0tratamiento\u00a0\nconservador\u00a0mejora\u00a0mucho\u00a0la\u00a0funci\u00f3n\u00a0endotelial\u00a0y\u00a0la\u00a0c irculaci\u00f3n\u00a0perif\u00e9rica.\u00a0\u00a0\n\u00a0 11\u00a0El\u00a0 tratamiento\u00a0 conservador\u00a0 de\u00a0 primer\u00a0 nivel\u00a0 incluye\u00a0 ca mbios\u00a0 en\u00a0 la\u00a0 dieta,\u00a0\nmodificaci\u00f3n\u00a0 farmacol\u00f3gica\u00a0 de\u00a0 los\u00a0 factores\u00a0 de\u00a0 riesgo\u00a0 como\u00a0 las\u00a0 drogas\u00a0\nhipolipemiantes,\u00a0 el\u00a0 control\u00a0 glic\u00e9mico,\u00a0 antihipertensivos\u00a0 y \u00a0antiagregantes\u00a0\nplaquetarios,\u00a0adem\u00e1s\u00a0de\u00a0la\u00a0terapia\u00a0de\u00a0ejercicio.\u00a0Est os\u00a0abordajes,\u00a0en\u00a0las\u00a0gu\u00edas\u00a0de\u00a0\npr\u00e1ctica\u00a0cl\u00ednica,\u00a0tienen\u00a0nivel\u00a0de\u00a0evidencia\u00a0y\u00a0recome ndaci\u00f3n\u00a0IA,\u00a0en\u00a0el\u00a0primer\u00a0nivel\u00a0de\u00a0\natenci\u00f3n\u00a0(10).\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0 12\u00a0Enfermedad\u00a0Arterial\u00a0Perif\u00e9rica.\u00a0Manejo\u00a01er.\u00a0Nivel\u00a0\nTratamiento\u00a0No\u00a0Farmacol\u00f3gico\u00a0 Tratamiento\u00a0Farmacol\u00f3gico\u00a0\nDisminuir\u00a0\ntabaquismo.\u00a0\n\u00a0IA\u00a0 ACC/AHA\u00a0\n2005\u00a0\u00c1cido\u00a0 acetilsalic\u00edlico\u00a0 80\u2010\n100mg/24hr.\u00a0IA\u00a0 \u00a0 \u00a0 ACC/AHA\u00a0\n2005\u00a0\nEjercicio\u00a0\nregular\u00a0\nsupervisado \u00a0IA\u00a0 ACC/AHA\u00a0\n2005\u00a0\u00a0 \u00a0\nDieta\u00a0 baja\u00a0 en\u00a0\ngrasa.\u00a0\u00a0\n\u00a0IA\u00a0 Pentoxifilina\u00a0400\u00a0mg/8\u00a0hr\u00a0 IIbC\u00a0 \u00a0 ACC/AHA\u00a0\n2005\u00a0\n\u00a0 \u00a0 Cilostazol\u00a0100\u00a0mg/12hr.\u00a0 IA\u00a0 \u00a0 \u00a0 ACC/AHA\u00a0\n2005\u00a0\n\u00a0 \u00a0 Clopidogrel\u00a075\u00a0mg/24\u00a0hr.\u00a0 IB\u00a0 \u00a0 \u00a0 ACC/AHA\u00a0\n2005\u00a0\n\u00a0 \u00a0 Hipolipemiantes.\u00a0\n\u00a0IA\u00a0\n\u00a0\nGu\u00edas\u00a0de\u00a0Pr\u00e1ctica\u00a0Cl\u00ednica,\u00a0Diagn\u00f3stico\u00a0y\u00a0Tratamiento\u00a0 de\u00a0la\u00a0Enfermed ad\u00a0Arterial\u00a0Perif\u00e9rica.\u00a0\nIMSS\u00a0007\u201008.\u00a0\n\u00a0\n\u00a0\nEl\u00a0ejercicio\u00a0supervisado\u00a0debe\u00a0estar\u00a0disponible\u00a0como\u00a0 parte\u00a0del\u00a0tratamiento\u00a0inicial\u00a0de\u00a0\ntodos\u00a0los\u00a0pacientes\u00a0con\u00a0enfermedad\u00a0arterial\u00a0perif\u00e9ri ca\u00a0para\u00a0potenciar\u00a0el\u00a0desarrollo\u00a0\nde\u00a0circulaci\u00f3n\u00a0colateral.\u00a0Los\u00a0programas\u00a0m\u00e1s\u00a0efe ctivos\u00a0emplean\u00a0una\u00a0banda\u00a0sin\u00a0fin\u00a0o\u00a0\ncaminadora\u00a0que\u00a0sean\u00a0de\u00a0intensidad\u00a0suficiente\u00a0para\u00a0in ducir\u00a0la\u00a0claudicaci\u00f3n,\u00a0seguida\u00a0\u00a0\n\u00a0 13\u00a0del\u00a0reposo,\u00a0en\u00a0el\u00a0transcurso\u00a0de\u00a0una\u00a0sesi\u00f3n\u00a0de\u00a030 \u201060\u00a0minutos.\u00a0La\u00a0evidencia\u00a0muestra\u00a0\nque\u00a0el\u00a0ejercicio\u00a0incrementa\u00a0la\u00a0habilidad\u00a0para\u00a0caminar \u00a0en\u00a0un\u00a0150%,\u00a0por\u00a0lo\u00a0que\u00a0un\u00a0\nprograma\u00a0de\u00a0ejercicio\u00a0regular\u00a0supervisado,\u00a030\u201060\u00a0minut os,\u00a03\u00a0veces\u00a0por\u00a0semana\u00a0\ndurante\u00a03\u00a0meses,\u00a0disminuye\u00a0los\u00a0s\u00edntomas\u00a0de\u00a0claudicaci\u00f3n.\u00a0\u00a0 Esta\u00a0indicado\u00a0realizar\u00a0las\u00a0\nsesiones\u00a0de\u00a0ejercicios\u00a03\u00a0vece s\u00a0por\u00a0semana\u00a0durante\u00a03\u00a0meses\u00a0 (10).\u00a0\n\u00a0\n1.3\u00a0MARCO\u00a0TEORICO\u00a0ORIENTAL \u00a0\n1.3.1\u00a0introducci\u00f3n \u00a0\nLa\u00a0acupuntura\u00a0es\u00a0una\u00a0modalidad\u00a0terap\u00e9utica\u00a0m\u00e9dica\u00a0que \u00a0existe\u00a0desde\u00a0\u00e9pocas\u00a0muy\u00a0\nantiguas\u00a0de\u00a0la\u00a0Medicina\u00a0Tradicional\u00a0China\u00a0(MTC).\u00a0Se\u00a0describi\u00f3\u00a0en\u00a0el\u00a0libro\u00a0Huang\u00a0Di\u00a0\nNei\u00a0Jing\u00a0(Cl\u00e1sicos\u00a0del\u00a0Emperador\u00a0Amarillo)\u00a0que\u00a0es\u00a0un a\u00a0recopilaci\u00f3n\u00a0de\u00a0escritos\u00a0\nrealizados\u00a0desde\u00a0el\u00a0per\u00edodo\u00a0de\u00a0los\u00a0Reinos\u00a0Combatient es\u00a0del\u00a0a\u00f1o\u00a0475\u2010\u00a0 221\u00a0antes\u00a0de\u00a0\nCristo\u00a0(a.C.)\u00a0hasta\u00a0los\u00a0primeros\u00a0a\u00f1os\u00a0de\u00a0la\u00a0Dinast\u00eda \u00a0Han\u00a0del\u00a0a\u00f1o\u00a0206\u00a0a.C.\u00a0al\u00a090\u00a0d.C.\u00a0La\u00a0\npr\u00e1ctica\u00a0de\u00a0la\u00a0MTC\u00a0tambi\u00e9n\u00a0incluye\u00a0otras\u00a0t\u00e9cnicas\u00a0co mo\u00a0la\u00a0herbolaria,\u00a0tuina,\u00a0\nmoxibusti\u00f3n \u00a0y\u00a0en\u00a0tiempos\u00a0modernos,\u00a0se\u00a0ha\u00a0agregado\u00a0la\u00a0electroacup untura.\u00a0En\u00a0el\u00a0a\u00f1o\u00a0\nde\u00a01800\u00a0es\u00a0introducida\u00a0en\u00a0occidente\u00a0por\u00a0Souli\u00e9\u00a0de\u00a0Morant\u00a0en\u00a0Francia.\u00a0En\u00a01970,\u00a0\nposterior\u00a0de\u00a0un\u00a0viaje\u00a0del\u00a0presidente\u00a0Nixon\u00a0a\u00a0China,\u00a0inicia\u00a0su\u00a0auge\u00a0en\u00a0los\u00a0EEUU. \u00a0En\u00a0\n1990\u00a0la\u00a0Organizaci\u00f3n\u00a0Mundial\u00a0de\u00a0la\u00a0Salud\u00a0unifica\u00a0y\u00a0 estandariza\u00a0por\u00a0primera\u00a0vez\u00a0los\u00a0\ncriterios\u00a0del\u00a0uso\u00a0de\u00a0la\u00a0acupuntura\u00a0en\u00a0Asia,\u00a0Europa\u00a0y \u00a0Am\u00e9rica,\u00a0dando\u00a0a\u00a0los\u00a0puntos\u00a0de\u00a0\nAcupuntura\u00a0una\u00a0denominaci\u00f3n\u00a0oficial\u00a0con\u00a0las\u00a0siglas\u00a0de \u00a0la\u00a0primera\u00a0letra\u00a0del\u00a0\u00f3rgano\u00a0o\u00a0\nv\u00edscera\u00a0en\u00a0el\u00a0idioma\u00a0correspondiente\u00a0y\u00a0el\u00a0n\u00famero\u00a0del\u00a0 acupunto\u00a0que\u00a0ocupa\u00a0en\u00a0el\u00a0\ntrayecto\u00a0del\u00a0meridiano,\u00a0as\u00ed\u00a0como\u00a0la\u00a0correspondencia\u00a0c on\u00a0los\u00a0nombres\u00a0chinos.\u00a0\u00a0\nCon\u00a0el\u00a0paso\u00a0del\u00a0tiempo,\u00a0el\u00a0uso\u00a0de\u00a0la\u00a0acupuntura\u00a0se\u00a0h a\u00a0aceptado\u00a0cada\u00a0vez\u00a0mas\u00a0en\u00a0la\u00a0\nMedicina\u00a0Occidental\u00a0 y\u00a0forma\u00a0parte\u00a0de\u00a0las\u00a0disciplinas\u00a0a\u00a0las\u00a0que\u00a0se\u00a0les\u00a0deno mina\u00a0\nMedicina\u00a0Complementaria\u00a0(CAM).\u00a0\u00a0La\u00a0CAM\u00a0cubre\u00a0un\u00a0rango\u00a0a mplio\u00a0de\u00a0pr\u00e1cticas\u00a0\ncomo\u00a0la\u00a0acupuntura,\u00a0la\u00a0herbolaria,\u00a0la\u00a0homeopat\u00eda\u00a0y\u00a0 la\u00a0Medicina\u00a0Tradicional\u00a0China,\u00a0\nentre\u00a0otros\u00a0(11, 12).\u00a0\u00a0\n\u00a0 14\u00a0Utiliz\u00e1ndose\u00a0 en\u00a0 dive rsas\u00a0 enfermedades\u00a0 y\u00a0 condiciones,\u00a0 entre\u00a0 sus\u00a0 efectos\u00a0 s e\u00a0\nencuentra\u00a0la\u00a0 mejor\u00eda\u00a0 en\u00a0 la\u00a0 microcirculaci\u00f3n\u00a0 (mediada\u00a0 por\u00a0 vasodil ataci\u00f3n\u00a0 de\u00a0\ncapilares\u00a0y\u00a0arteriolas)\u00a0alivio\u00a0del\u00a0dolor\u00a0 relajaci\u00f3n\u00a0de\u00a0espasmos\u00a0musculares;\u00a0alivio\u00a0de\u00a0\nla\u00a0 hipersen sibilidad\u00a0 de\u00a0 la\u00a0 piel\u00a0 y\u00a0 mucosas\u00a0 disminuci\u00f3n\u00a0 de\u00a0 la\u00a0 pres i\u00f3n\u00a0 arterial,\u00a0\ndisminuci\u00f3n\u00a0de\u00a0los\u00a0triglic\u00e9ridos\u00a0s\u00e9ricos,\u00a0regulaci\u00f3n \u00a0de\u00a0la\u00a0funci\u00f3n\u00a0gastrointestinal,\u00a0\nestimulaci\u00f3n\u00a0de\u00a0la\u00a0lip\u00f3lisis,\u00a0alivio\u00a0de\u00a0s\u00edntomas\u00a0de\u00a0a bstinencias\u00a0en\u00a0pacien tes\u00a0con\u00a0\nadicciones\u00a0y\u00a0 mejor\u00eda\u00a0en\u00a0la\u00a0respuesta\u00a0inmune\u00a0 (13).\u00a0\n\u00a0\n1.3.2\u00a0Conceptos. \u00a0\nLa\u00a0Medicina\u00a0Tradicional \u00a0China\u00a0se\u00a0basa\u00a0en\u00a02\u00a0principios:\u00a0 el\u00a0Holismo\u00a0y\u00a0la\u00a0Diferenciaci\u00f3n\u00a0\ndel\u00a0S\u00edndrome .\u00a0\u00a0\nEl\u00a0Holismo\u00a0conceptualiza\u00a0el\u00a0cuerpo\u00a0humano\u00a0como\u00a0un\u00a0todo\u00a0org\u00e1nico \u00a0y\u00a0que\u00a0los\u00a0seres\u00a0\nhumanos\u00a0est\u00e1n\u00a0interrelacionados\u00a0con\u00a0la\u00a0naturaleza,\u00a0e xteriormente\u00a0con\u00a0los\u00a0cambios\u00a0\nnaturales\u00a0de\u00a0las\u00a0cuatro\u00a0estaciones,\u00a0los\u00a0puntos\u00a0card inales\u00a0y\u00a0el\u00a0h\u00e1bitat.\u00a0Interiormente,\u00a0\nest\u00e1\u00a0formado\u00a0por\u00a0\u00f3rganos\u00a0y\u00a0v\u00eds ceras,\u00a0estructuras\u00a0corporales\u00a0( huesos,\u00a0tendones,\u00a0\nm\u00fasculos,\u00a0vasos\u00a0sangu\u00edneos,\u00a0piel)\u00a0los\u00a0meridanos,\u00a0los\u00a0 \u00f3rganos\u00a0de\u00a0los\u00a0 sentidos,\u00a0los\u00a09\u00a0\norificios\u00a0y\u00a0siete\u00a0emociones.\u00a0\nEstos\u00a0 est\u00e1n\u00a0 reunidos\u00a0 entre\u00a0 s\u00ed\u00a0 como\u00a0 un\u00a0 todo,\u00a0 estrecha mente\u00a0 relacionados,\u00a0 en\u00a0\nestructura,\u00a0fisiolog\u00eda\u00a0y\u00a0patolog\u00eda.\u00a0 \u00a0\nEn\u00a0estructura:\u00a0 el\u00a0cuerpo\u00a0se\u00a0centra\u00a0alrededor\u00a0de\u00a05\u00a0\u00f3rganos\u00a0que\u00a0son\u00a0el\u00a0coraz\u00f3n,\u00a0el\u00a0\nbazo,\u00a0el\u00a0pulm\u00f3n,\u00a0e l\u00a0ri\u00f1\u00f3n,\u00a0el\u00a0h\u00edgado\u00a0y\u00a0el\u00a0pericardio,\u00a0quienes\u00a0se\u00a0unen\u00a0a\u00a0las\u00a0actividades\u00a0\nfuncionales\u00a0de\u00a0las\u00a0v\u00edsceras\u00a0que\u00a0son\u00a0el\u00a0intestino\u00a0de lgado,\u00a0est\u00f3mago,\u00a0intestino\u00a0grueso,\u00a0\nvejiga,\u00a0ves\u00edcula\u00a0biliar\u00a0y\u00a0tripl e\u00a0energizador;\u00a0los\u00a05\u00a0sentidos\u00a0( ver,\u00a0oler,\u00a0oir,\u00a0tocar \u00a0y\u00a0\nsaborear)\u00a0y\u00a0los\u00a09\u00a0orificios;\u00a0 el\u00a0cuerpo\u00a0se\u00a0vuelve\u00a0un\u00a0todo\u00a0unificado\u00a0que\u00a0est\u00e1\u00a0conect ado\u00a0\nlo\u00a0superior\u00a0con\u00a0lo\u00a0inferior\u00a0 y\u00a0lo\u00a0externo\u00a0con\u00a0lo\u00a0interno.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\nEn\u00a0fisiolog\u00eda:\u00a0Las\u00a0v\u00edsceras,\u00a0aunque\u00a0con\u00a0diferentes\u00a0actividades\u00a0funcionales,\u00a0cooperan\u00a0\ncon\u00a0la\u00a0funci\u00f3n\u00a0de\u00a0cada\u00a0uno\u00a0del\u00a0resto \u00a0de\u00a0los\u00a0\u00f3rganos. \u00a0\u00a0\n\u00a0 15\u00a0En\u00a0patolog\u00eda:\u00a0el\u00a0cambio\u00a0m\u00f3rbido\u00a0de\u00a0cualquier\u00a0parte\u00a0de l\u00a0cuerpo\u00a0afectar\u00e1\u00a0a\u00a0otras\u00a0\nv\u00edsceras\u00a0y\u00a0tejidos\u00a0o\u00a0inclusive\u00a0al\u00a0cuerpo\u00a0entero.\u00a0As\u00ed \u00a0mismo,\u00a0el\u00a0cambio\u00a0m\u00f3rbido\u00a0en\u00a0\ngeneral\u00a0del\u00a0cuerpo,\u00a0afectar\u00e1\u00a0las\u00a0 funciones\u00a0de\u00a0una\u00a0v\u00edscera\u00a0local\u00a0 (14).\u00a0\nDiferenciaci\u00f3n\u00a0del\u00a0S\u00edndrome :\u00a0Significa\u00a0analizar,\u00a0inducir,\u00a0sintetizar,\u00a0juzgar,\u00a0 resumir\u00a0\nlos\u00a0datos\u00a0cl\u00ednicos,\u00a0como\u00a0los\u00a0signos\u00a0y\u00a0s\u00edntomas\u00a0obteni dos\u00a0por\u00a0los\u00a0cuatro\u00a0m\u00e9todos\u00a0\ndiagn\u00f3sticos:\u00a0a)\u00a0Observaci\u00f3n,\u00a0b)\u00a0Anamnesis\u00a0por\u00a0o\u00eddo\u00a0y \u00a0olfato;\u00a0c)\u00a0Interrogatorio;\u00a04)\u00a0\nPalpaci\u00f3n.\u00a0Se\u00a0a nalizan\u00a0varias\u00a0teor\u00edas\u00a0\u00a0que\u00a0explican\u00a0la\u00a0aparici\u00f3n\u00a0d e\u00a0la\u00a0enfermedad,\u00a0\nestas\u00a0son\u00a0la\u00a0Teor\u00eda\u00a0del\u00a0Yin\u00a0y\u00a0el\u00a0Yang,\u00a0as\u00ed\u00a0como\u00a0la\u00a0T eor\u00eda\u00a0de\u00a0los\u00a0Elementos,\u00a0entre\u00a0\notros.\u00a0 Los\u00a0 m\u00e9todos\u00a0 terap\u00e9uticos\u00a0 se\u00a0 deciden\u00a0 de\u00a0 acuerd o\u00a0 al\u00a0 resultado\u00a0 de\u00a0 esta\u00a0\ndiferenciaci\u00f3n. \u00a0\n1.3.3\u00a0Teor\u00eda\u00a0de l\u00a0Yin\u00a0y\u00a0Yang.\u00a0 \u00a0\nLos\u00a0m\u00e9dicos\u00a0y\u00a0fil\u00f3sofos\u00a0en\u00a0la\u00a0China\u00a0antigua\u00a0explicab an\u00a0todos\u00a0los\u00a0fen\u00f3menos\u00a0y\u00a0la\u00a0\nnaturaleza\u00a0del\u00a0Universo\u00a0y\u00a0la\u00a0vida\u00a0con\u00a0la\u00a0Teor\u00eda\u00a0del\u00a0Yin\u00a0y\u00a0Yang.\u00a0\u00a0Esta\u00a0teor\u00eda\u00a0sostiene\u00a0\nque\u00a0el\u00a0estado\u00a0original\u00a0del\u00a0Universo\u00a0era\u00a0 Qi,\u00a0y\u00a0que\u00a0el\u00a0movimiento\u00a0y\u00a0la\u00a0variac i\u00f3n\u00a0de\u00a0\n\u00e9ste\u00a0produjo\u00a02\u00a0polos\u00a0conocidos\u00a0como\u00a0Yin\u00a0y\u00a0Yang.\u00a0Y\u00a0como\u00a0tod o\u00a0lo\u00a0que\u00a0existe\u00a0se\u00a0\nproduce\u00a0mediante\u00a0el\u00a0movimiento\u00a0y\u00a0la\u00a0variaci\u00f3n,\u00a0por\u00a0lo\u00a0 tanto,\u00a0todas\u00a0las\u00a0cosas\u00a0del\u00a0\nUniverso\u00a0se\u00a0pueden\u00a0dividir\u00a0en\u00a0dos\u00a0aspectos,\u00a0el\u00a0Yin\u00a0y\u00a0el\u00a0Yang. \u00a0\nSe\u00a0establece\u00a0que\u00a0el\u00a0cuerpo\u00a0hu mano\u00a0es\u00a0un\u00a0todo\u00a0y\u00a0que\u00a0todos\u00a0los\u00a0tejidos\u00a0y\u00a0\u00f3rganos\u00a0en \u00a0\nel\u00a0cuerpo\u00a0dependen\u00a0funcionalmente\u00a0de\u00a0cada\u00a0uno.\u00a0La\u00a0te or\u00eda\u00a0del\u00a0Yin\u00a0y\u00a0Yang\u00a0sostiene\u00a0\nque\u00a0las\u00a0actividades\u00a0normales\u00a0de\u00a0la\u00a0vida\u00a0resultan\u00a0del \u00a0balance\u00a0entre\u00a0\u00e9stos\u00a0y\u00a0que\u00a0la\u00a0\nrelaci\u00f3n\u00a0 estrecha\u00a0 entre\u00a0 la\u00a0 estructura\u00a0 hi stol\u00f3gica\u00a0 y\u00a0 las\u00a0 funciones\u00a0 fisiol\u00f3gicas\u00a0\nsignifican\u00a0la\u00a0oposici\u00f3n\u00a0y\u00a0la\u00a0unidad\u00a0que\u00a0existe\u00a0entre\u00a0el\u00a0Yin\u00a0y\u00a0el\u00a0Yang.\u00a0Cada\u00a0\u00f3rgano\u00a0por\u00a0\ns\u00ed\u00a0mismo\u00a0cuenta\u00a0con\u00a0aspectos\u00a0Yin\u00a0y\u00a0Yang.\u00a0\n\u00a0\n\u00a0\n\u00a0\u00a0\n\u00a0 16\u00a0PROPIEDADES\u00a0YIN\u00a0\nFr\u00edo,\u00a0 est\u00e1tico,\u00a0 obscuro,\u00a0 descendente\u00a0 y\u00a0\nastringente. \u00a0\nCaptar,\u00a0 conservar, \u00a0 almacenar\u00a0 y\u00a0\ndistribuci\u00f3n\u00a0de\u00a0nutrientes .\u00a0PROPIEDADES\u00a0YANG\u00a0\nCaliente,\u00a0 activo,\u00a0 brillante,\u00a0 eleva\u00a0 y\u00a0\ndispersa.\u00a0\nReceptores\u00a0 temporales\u00a0 que\u00a0\ntransforman,\u00a0 transportan,\u00a0 digieren,\u00a0\nabsorben\u00a0y\u00a0eliminan.\u00a0\n\u00a0\n1.3.4\u00a0Teor\u00eda\u00a0de\u00a0los\u00a0Cinco\u00a0Elementos: \u00a0\nTambi\u00e9n\u00a0originada\u00a0en\u00a0la\u00a0China\u00a0Antigua,\u00a0explica\u00a0y\u00a0anal iza\u00a0las\u00a0cosas\u00a0y\u00a0sus\u00a0cambios\u00a0en\u00a0\nla\u00a0naturaleza.\u00a0Establece\u00a0que\u00a0la\u00a0madera,\u00a0el\u00a0fuego,\u00a0la \u00a0tierra,\u00a0el\u00a0metal\u00a0y\u00a0el\u00a0agua\u00a0son\u00a0\nindispensables\u00a0en\u00a0la\u00a0vida\u00a0diaria,\u00a0que\u00a0todas\u00a0las\u00a0cos as\u00a0en\u00a0el\u00a0mundo\u00a0natural\u00a0se\u00a0derivan\u00a0\nde\u00a0estos\u00a0adem\u00e1s\u00a0de\u00a0que\u00a0tienen\u00a0sus\u00a0propiedades\u00a0b\u00e1sica s,\u00a0manteniendo\u00a0un\u00a0balance\u00a0\narmonioso\u00a0a\u00a0trav\u00e9s\u00a0de\u00a0una\u00a0constante\u00a0inter\u2010promoci\u00f3n\u00a0o\u00a0 una\u00a0inter\u2010restricci\u00f3n\u00a0entre\u00a0\nestos\u00a05\u00a0elementos.\u00a0A\u00a0cada\u00a0\u00f3rgano\u00a0del\u00a0cuerpo\u00a0se\u00a0le\u00a0asi gna\u00a0una\u00a0funci\u00f3n\u00a0f\u00edsica\u00a0u\u00a0\norg\u00e1nica,\u00a0un\u00a0elemento\u00a0de\u00a0la\u00a0naturaleza,\u00a0una\u00a0emoci\u00f3 n,\u00a0una\u00a0actividad\u00a0espiritual\u00a0 e\u00a0\nincluso\u00a0un\u00a0determinado\u00a0sabor\u00a0 (14).\u00a0\n\u00a0 \u00a0\n\u00a0\n\u00a0 17\u00a01.3.5\u00a0Causas\u00a0de\u00a0Enfermedad:\u00a0 \u00a0\nEstablece\u00a0que\u00a0hay\u00a0varios\u00a0factores\u00a0pat\u00f3genos,\u00a0y\u00a0que\u00a0de\u00a0la\u00a0diferenciaci\u00f3n\u00a0de\u00a0\u00e9stos,\u00a0se\u00a0\ndefine\u00a0el\u00a0s\u00edndrome\u00a0a\u00a0tratar,\u00a0el\u00a0reconocimiento\u00a0de\u00a0la\u00a0 enfermedad\u00a0y\u00a0la\u00a0selec ci\u00f3n\u00a0de\u00a0\nlos\u00a0m\u00e9todos\u00a0terap\u00e9uticos\u00a0correctos.\u00a0Existen\u00a04\u00a0catego r\u00edas:\u00a0\n1) Factores\u00a0pat\u00f3genos\u00a0ex\u00f3genos :\u00a0Los\u00a0cambios\u00a0que\u00a0existan\u00a0en\u00a0la\u00a0naturaleza\u00a0\npueden\u00a0 afectar\u00a0 directa\u00a0 o\u00a0 indirectamente\u00a0 al\u00a0 ser\u00a0 humano \u00a0 y\u00a0 traer\u00a0 la\u00a0\nconsecuente\u00a0respuesta\u00a0fisiol\u00f3gica\u00a0o\u00a0patol\u00f3gica.\u00a0Son\u00a0 factores\u00a0clim\u00e1ticos \u00a0como\u00a0\nel\u00a0viento,\u00a0el\u00a0fr\u00edo,\u00a0calor,\u00a0la\u00a0sequedad,\u00a0humedad\u00a0y\u00a0fu ego.\u00a0Los\u00a0seres\u00a0humanos\u00a0\nviven\u00a0en\u00a0contacto\u00a0constante\u00a0con\u00a0los\u00a0factores\u00a0mencion ados\u00a0y,\u00a0en\u00a0condiciones\u00a0\nnormales,\u00a0pueden\u00a0adaptarse\u00a0a\u00a0los\u00a0cambios\u00a0de\u00a0\u00e9stos.\u00a0Si \u00a0esta\u00a0armon\u00eda\u00a0se\u00a0\nrompe,\u00a0entonces\u00a0llega\u00a0la\u00a0enfermedad.\u00a0En\u00a0tales\u00a0condici ones,\u00a0los\u00a0factores\u00a0\nclim\u00e1ticos\u00a0se\u00a0vuelven\u00a0factores\u00a0pat\u00f3genos.\u00a0\n2) Disfunci\u00f3n\u00a0Interna\u00a0debido\u00a0a\u00a0las\u00a07\u00a0emociones. \u00a0Estas\u00a0normalmente\u00a0no\u00a0causan\u00a0\nenfermedad,\u00a0 pero\u00a0 un\u00a0 est\u00edmulo\u00a0 s\u00fabito,\u00a0 violento\u00a0 o\u00a0 prolo ngado\u00a0 puede\u00a0\ntraspasar\u00a0 el\u00a0 rango \u00a0de\u00a0 las\u00a0 actividades\u00a0 fisiol\u00f3gicas.\u00a0 Son\u00a0 la\u00a0 alegr\u00eda,\u00a0 ira,\u00a0\nansiedad,\u00a0 contemplaci\u00f3n,\u00a0 preocupaci\u00f3n,\u00a0 tristeza,\u00a0 mied o\u00a0 y\u00a0 terror.\u00a0 Estas\u00a0\ntienen\u00a0correspondencia\u00a0con\u00a0la\u00a0funci\u00f3n\u00a0energ \u00e9tica\u00a0de\u00a0los\u00a0diferentes\u00a0\u00f3rganos\u00a0\n(14).\u00a0\nEmoci\u00f3n\u00a0 \u00d3rgano\u00a0correspondiente\u00a0\nAlegr\u00eda\u00a0 Coraz\u00f3n\u00a0\nIra\u00a0 H\u00edgado\u00a0\nPreocupaci\u00f3n \u00a0 Pulm\u00f3n\u00a0\nPensar\u00a0y\u00a0meditar\u00a0demasiado.\u00a0 Bazo\u00a0\nTristeza\u00a0 Pulm\u00f3n\u00a0\nMiedo\u00a0 Ri\u00f1\u00f3n\u00a0\nSusto,\u00a0Pavor \u00a0 Coraz\u00f3n\u00a0y\u00a0Ri\u00f1\u00f3n \u00a0\n\u00a0\n3) Factores\u00a0pat\u00f3genos\u00a0end\u00f3genos \u00a0que\u00a0incluyen\u00a0viento\u00a0en d\u00f3geno,\u00a0fr\u00edo\u00a0end\u00f3geno,\u00a0\nhumedad,\u00a0flema\u00a0end\u00f3gena,\u00a0sequedad\u00a0y\u00a0calor\u00a0end\u00f3genos,\u00a0 la\u00a0retenci\u00f3n\u00a0de\u00a0\nl\u00edquidos\u00a0y\u00a0la\u00a0estasis\u00a0sangu\u00ednea.\u00a0La\u00a0flema\u00a0est\u00e1\u00a0formad a\u00a0por\u00a0disturbios\u00a0en\u00a0los\u00a0\u00a0\n\u00a0 18\u00a0l\u00edquidos.\u00a0Puede\u00a0ser\u00a0visible\u00a0(esputo,\u00a0n\u00f3dulos,\u00a0adenitis)\u00a0o\u00a0invisible,\u00a0no\u00a0s e\u00a0palpa\u00a0\nni\u00a0se\u00a0toca\u00a0pero\u00a0tiene\u00a0manifestaciones\u00a0patol\u00f3gicas\u00a0y\u00a0 cuando\u00a0se\u00a0acumula,\u00a0se\u00a0\nvuelve\u00a0visible.\u00a0Si\u00a0fluye\u00a0por\u00a0los\u00a0meridianos,\u00a0tender\u00e1\u00a0a\u00a0bloque arlos\u00a0y\u00a0obstruir\u00e1\u00a0\nel\u00a0flujo\u00a0del\u00a0Qi\u00a0y\u00a0de\u00a0la\u00a0Sangre. \u00a0\n4) Otros\u00a0factores \u00a0pat\u00f3genos\u00a0que\u00a0incluyen\u00a0lesiones\u00a0traum\u00e1ticas,\u00a0lesiones \u00a0debidas\u00a0\na\u00a0 factores\u00a0 f\u00edsicos\u00a0 o\u00a0 qu\u00edmicos\u00a0 adem\u00e1s\u00a0 de\u00a0 los\u00a0 causados\u00a0 por\u00a0 insectos\u00a0 y\u00a0\nanimales.\u00a0\n\u00a0\nSe\u00a0puede\u00a0concluir\u00a0que\u00a0el\u00a0estado\u00a0de\u00a0salud\u00a0implica\u00a0una \u00a0gran\u00a0coordinaci\u00f3n\u00a0y\u00a0unidad\u00a0\nentre\u00a0los\u00a0\u00f3rganos,\u00a0las\u00a0v\u00edsceras,\u00a0los\u00a0meridianos,\u00a0el\u00a0 qi,\u00a0la\u00a0sangre\u00a0y\u00a0los\u00a0l\u00edquidos\u00a0\ncorporales,\u00a0tanto\u00a0como\u00a0la\u00a0relaci\u00f3n\u00a0entre\u00a0el\u00a0cuerpo\u00a0y \u00a0el\u00a0medio\u00a0ambiente\u00a0externo\u00a0\n(15).\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0 19\u00a01.3.6\u00a0Meridianos \u00a0\nLos\u00a0Meridianos\u00a0tienen\u00a02\u00a0funciones\u00a0b\u00e1sicas:\u00a0 \u00a0\na)\u00a0Conectar\u00a0lo\u00a0externo\u00a0con\u00a0lo\u00a0interno\u00a0as\u00ed\u00a0como\u00a0conectar\u00a0 las\u00a0v\u00edsceras\u00a0con\u00a0los\u00a0\n\u00f3rganos.\u00a0\nb)\u00a0Transportar\u00a0Q i,\u00a0sangre,\u00a0yin\u00a0 y\u00a0yang\u00a0para\u00a0nutrir\u00a0las\u00a0v\u00edsceras\u00a0del\u00a0cuerpo. \u00a0\u00a0En\u00a0\nfisiolog\u00eda,\u00a0 patolog\u00eda\u00a0 y\u00a0 tratamiento\u00a0 son\u00a0 los\u00a0 responsa bles\u00a0 de\u00a0 la\u00a0 transmisi\u00f3n\u00a0 y\u00a0\nconducci\u00f3n\u00a0de\u00a0la\u00a0informaci\u00f3n\u00a0patol\u00f3gica\u00a0y\u00a0fisiol\u00f3gic a\u00a0para\u00a0las\u00a0funciones\u00a0del\u00a0cuerpo.\u00a0\u00a0\n\u00a0\nLa\u00a0Medicina\u00a0Tradicional\u00a0China\u00a0denomina\u00a0a\u00a0los\u00a0Meridia nos\u00a0de\u00a0acuerdo\u00a0al\u00a0\u00f3rgano\u00a0\ninterno\u00a0con\u00a0el\u00a0que\u00a0se\u00a0relacionan: \u00a0\n\u00a0\nMeridianos\u00a0con\u00a0 \u00a0Funci\u00f3n\u00a0Yin \u00a0 Meridianos\u00a0con\u00a0\u00a0Funci\u00f3n\u00a0Yang \u00a0\n\u2010Pulm\u00f3n.\u00a0 Intestino\u00a0Grueso \u00a0\n\u2010Coraz\u00f3n.\u00a0 Intestino\u00a0Delgado. \u00a0\n\u2010Pericardio\u00a0 Triple\u00a0Energizador \u00a0\n\u2010Bazo\u00a0 Est\u00f3mago.\u00a0\n\u2010H\u00edgado.\u00a0 Ves\u00edcula\u00a0Biliar. \u00a0\n\u2010Ri\u00f1\u00f3n.\u00a0 Vejiga.\u00a0\n\u00a0\n1.3.7\u00a0Fundamentos \u00a0\nEl\u00a0cuerpo\u00a0es\u00a0visto\u00a0como\u00a0un\u00a0sistema\u00a0din\u00e1mico\u00a0 de\u00a0\u00f3rganos\u00a0conectados\u00a0por\u00a0el\u00a0flujo\u00a0de\u00a0\nQi\u00a0a\u00a0trav\u00e9s\u00a0de\u00a0los\u00a0 meridianos\u00a0 y\u00a0sus\u00a0colaterales.\u00a0Estos\u00a0meridianos\u00a0tienden\u00a0a\u00a0estar\u00a0\nlocalizados\u00a0a\u00a0lo\u00a0largo\u00a0de\u00a0los\u00a0planos\u00a0en\u00a0las\u00a0fascias \u00a0o\u00a0entre\u00a0un\u00a0m\u00fasculo\u00a0y\u00a0hueso\u00a0o\u00a0entre\u00a0\u00a0\n\u00a0 20\u00a0un\u00a0m\u00fasculo\u00a0y\u00a0tend\u00f3n.\u00a0La\u00a0aguja\u00a0insertada\u00a0en\u00a0una\u00a0es cisi\u00f3n\u00a0de\u00a0tejido\u00a0conectivo,\u00a0\npenetrar\u00e1\u00a0primero\u00a0la\u00a0dermis\u00a0y\u00a0el\u00a0tejido\u00a0subcut\u00e1neo\u00a0y\u00a0 luego\u00a0mas\u00a0profundamente\u00a0el\u00a0\ntejido\u00a0conectivo\u00a0intersticial.\u00a0Esta\u00a0red\u00a0tisular\u00a0se\u00a0 contin\u00faa\u00a0con\u00a0tejido\u00a0conectivo\u00a0mas\u00a0\nespecializado\u00a0tal\u00a0como\u00a0el\u00a0periosteo,\u00a0perimisio,\u00a0perin eurio,\u00a0pleura,\u00a0peritoneo\u00a0y\u00a0\nmeninges.\u00a0 Una\u00a0 forma\u00a0 de\u00a0 se\u00f1alizaci\u00f3n\u00a0 mec\u00e1nica,\u00a0 bioel\u00e9ct rica\u00a0 y/o\u00a0 biomec\u00e1nica\u00a0\ntransmitida\u00a0entre\u00a0y\u00a0a\u00a0trav\u00e9s\u00a0del\u00a0tejido\u00a0conectivo\u00a0in tersticial\u00a0puede,\u00a0por\u00a0lo\u00a0tanto,\u00a0\ntener\u00a0funciones\u00a0integrativas\u00a0potencialmente\u00a0poderosa s,\u00a0conectando\u00a0tanto\u00a0diversas\u00a0\npartes\u00a0del\u00a0cuer po,\u00a0como\u00a0sistemas\u00a0fisiol\u00f3gicos\u00a0 (16).\u00a0\nEl\u00a0Qi\u00a0es\u00a0la\u00a0energ\u00eda\u00a0que\u00a0fluye\u00a0a\u00a0trav\u00e9s\u00a0de\u00a0toda\u00a0esta\u00a0red.\u00a0Cuando\u00a0existe\u00a0un\u00a0flujo\u00a0\ninadecuado\u00a0o\u00a0estancamiento\u00a0del\u00a0 Qi\u00a0en\u00a0el\u00a0trayecto\u00a0de\u00a0los\u00a0 meridianos,\u00a0puede\u00a0esto\u00a0\nresultar\u00a0en\u00a0dolor\u00a0o\u00a0enfermedad.\u00a0\u00a0\nSe\u00a0ha\u00a0propu esto\u00a0que\u00a0el\u00a0est\u00edmulo\u00a0de\u00a0acupuntura\u00a0es\u00a0capaz\u00a0de\u00a0influ ir\u00a0en\u00a0el\u00a0tejido\u00a0\nconectivo\u00a0como\u00a0una\u00a0fuerza\u00a0mec\u00e1nica\u00a0dirigida\u00a0a\u00a0la\u00a0matri z\u00a0extracelular\u00a0y\u00a0a\u00a0trav\u00e9s\u00a0de\u00a0\n\u00e9sta\u00a0el\u00a0est\u00edmulo\u00a0viaja\u00a0hacia\u00a0el\u00a0punto\u00a0de\u00a0acupuntura\u00a0 involucrando\u00a0el\u00a0tejido\u00a0local\u00a0y\u00a0\nsus\u00a0c\u00e9lulas.\u00a0\u00a0La\u00a0teor\u00ed a\u00a0de\u00a0la\u00a0acupuntura\u00a0tradicional\u00a0propone\u00a0que\u00a0la\u00a0inserci\u00f3n\u00a0de\u00a0\nagujas\u00a0en\u00a0los\u00a0puntos\u00a0seleccionados\u00a0apropiadamente\u00a0ta mbi\u00e9n\u00a0tienen\u00a0efectos\u00a0lejanos\u00a0\nal\u00a0 sitio\u00a0 de\u00a0 la\u00a0 inserci\u00f3n\u00a0 de\u00a0 la\u00a0 aguja,\u00a0 lo\u00a0 cual\u00a0 est\u00e1\u00a0 mediado\u00a0 por\u00a0 el\u00a0 sistem a\u00a0 de\u00a0\nMeridianos\u00a0 (17).\u00a0\nMuchos\u00a0estudios\u00a0han\u00a0in dicado\u00a0que\u00a0la\u00a0acupuntura\u00a0es\u00a0capaz\u00a0de\u00a0aumentar\u00a0el\u00a0flu jo\u00a0\nsangu\u00edneo\u00a0mediante\u00a0la\u00a0liberaci\u00f3n\u00a0de\u00a0\u00f3xido\u00a0n\u00edtrico\u00a0en \u00a0el\u00a0\u00e1rea\u00a0local\u00a0y\u00a0adyacente\u00a0al\u00a0\nsitio\u00a0de\u00a0punci\u00f3n \u00a0(18),\u00a0que\u00a0los\u00a0puntos\u00a0de\u00a0acupuntura\u00a0tienen\u00a0conductancia\u00a0el\u00e9ctrica,\u00a0\nadem\u00e1s\u00a0de\u00a0la\u00a0relaci\u00f3n\u00a0de\u00a0los\u00a0puntos\u00a0de\u00a0acupuntura\u00a0y\u00a0 los\u00a0meridianos\u00a0con\u00a0los\u00a0planos\u00a0\nde\u00a0tejido\u00a0conecti vo\u00a0y\u00a0el\u00a0espacio\u00a0perivascular\u00a0 (17).\u00a0\n1.3.8\u00a0Etiolog\u00eda\u00a0y\u00a0Patolog\u00eda. \u00a0\nPor\u00a0cada\u00a0extremidad\u00a0inferior\u00a0pasan\u00a03\u00a0meridianos\u00a0yang\u00a0 del\u00a0pie\u00a0y\u00a03\u00a0meridianos\u00a0yin\u00a0\ndel\u00a0pie.\u00a0Cualquier\u00a0alteraci\u00f3n\u00a0en\u00a0estos\u00a0meridianos ,\u00a0ya\u00a0sea\u00a0por\u00a0invasi\u00f3n\u00a0de\u00a0factores\u00a0\nexternos\u00a0o\u00a0por\u00a0trastornos\u00a0internos \u00a0,\u00a0puede\u00a0causar\u00a0dolor\u00a0en\u00a0la\u00a0extremidad\u00a0inferior.\u00a0\u00a0\u00a0\n\u00a0 21\u00a0Seg\u00fan\u00a0los\u00a0fundamentos\u00a0de\u00a0 la\u00a0MTC,\u00a0el\u00a0dolor\u00a0en\u00a0la\u00a0extremidad\u00a0inferior\u00a0puede\u00a0ser\u00a0\ncausado\u00a0por\u00a0invasi\u00f3n\u00a0de\u00a0Viento,\u00a0Fr\u00edo\u00a0o\u00a0Humedad;\u00a0el\u00a0e stancamiento\u00a0o\u00a0la\u00a0deficiencia\u00a0\nde\u00a0Qi\u00a0y\u00a0Sangre;\u00a0el\u00a0flujo\u00a0descendente\u00a0de\u00a0Humedad\u2010 Calor,\u00a0la\u00a0acu mulaci\u00f3n\u00a0de\u00a0Flema\u00a0y\u00a0\nHumedad\u00a0en\u00a0los\u00a0meridianos\u00a0y\u00a0colaterales\u00a0(18).\u00a0\na)\u00a0Invasi\u00f3n\u00a0por\u00a0fr\u00edo,\u00a0viento\u00a0y\u00a0humedad.\u2010\u00a0 El\u00a0fr\u00edo\u00a0se\u00a0caracteriza\u00a0por\u00a0contracci\u00f3n\u00a0y\u00a0\nestancamiento;\u00a0la\u00a0humedad\u00a0est\u00e1\u00a0marcada\u00a0por\u00a0pesantez.\u00a0S i\u00a0el\u00a0fr\u00edo\u00a0y\u00a0la\u00a0humedad\u00a0\ninvaden\u00a0las\u00a0extremidades\u00a0inferiores\u00a0se\u00a0produce\u00a0const ricci\u00f3n\u00a0de\u00a0la\u00a0colateral\u00a0y\u00a0los\u00a0\nm\u00fasculos\u00a0de\u00a0la\u00a0extremidad\u00a0inferior,\u00a0dando\u00a0lugar\u00a0a\u00a0un\u00a0 estancamiento\u00a0de\u00a0Qi\u00a0y\u00a0Sangre,\u00a0\ncausando\u00a0dolor\u00a0en\u00a0\u00e9sta.\u00a0Este\u00a0tipo\u00a0de\u00a0do lor\u00a0tiene\u00a0la\u00a0caracter\u00edstica\u00a0de\u00a0que\u00a0se\u00a0agrava\u00a0\nen\u00a0el\u00a0tiempo\u00a0fr\u00edo\u00a0y\u00a0h\u00famedo.\u00a0En\u00a0el\u00a0caso\u00a0de\u00a0invasi\u00f3n\u00a0de \u00a0viento,\u00a0en\u00a0el\u00a0organismo\u00a0y\u00a0las\u00a0\nextremidades\u00a0inferiores\u00a0puede\u00a0producirse\u00a0el\u00a0estancami ento\u00a0de\u00a0la\u00a0circulaci\u00f3n\u00a0de\u00a0Qi\u00a0\ny\u00a0Sangre\u00a0en\u00a0los\u00a0meridianos\u00a0y\u00a0el\u00a0bloqueo\u00a0de\u00a0los\u00a0,merid ianos\u00a0por\u00a0Humedad\u00a0Calor\u00a0lo\u00a0\nque\u00a0desmboca\u00a0en\u00a0dolor\u00a0de\u00a0la\u00a0extremidad\u00a0inferior.\u00a0\nb)\u00a0Dieta\u00a0inadecuada:\u00a0Los\u00a0errores\u00a0de\u00a0la\u00a0dieta,\u00a0con\u00a0una\u00a0ingesta\u00a0inadecuada\u00a0de\u00a0\nalimentos\u00a0dulces\u00a0y\u00a0grasosos,\u00a0contribuyen\u00a0a\u00a0la\u00a0formaci \u00f3n\u00a0de\u00a0humedad\u00a0y\u00a0flema\u00a0en\u00a0el\u00a0\norganismo\u00a0lo\u00a0qu e\u00a0predispone\u00a0al\u00a0 bloqueo\u00a0de\u00a0los\u00a0meridianos\u00a0y\u00a0colaterales\u00a0de\u00a0las\u00a0\nextremidades\u00a0inferiores,\u00a0con\u00a0el\u00a0subsecuente\u00a0dolor.\u00a0\nc)\u00a0Trastornos\u00a0emocionales\u00a0y\u00a0traumatismos\u00a0f\u00edsicos.\u00a0El\u00a0Qi\u00a0y \u00a0la\u00a0Sangre\u00a0\u00a0debe\u00a0circular\u00a0\nlibremente\u00a0a\u00a0trav\u00e9s\u00a0de\u00a0los\u00a0meridianos.\u00a0Si\u00a0hay\u00a0estanca miento\u00a0de\u00a0estos\u00a0ya\u00a0sea\u00a0por\u00a0\ncuestiones\u00a0 emocionales\u00a0 como\u00a0 el\u00a0 exceso\u00a0 de\u00a0 estr\u00e9s,\u00a0 ,\u00a0 tr isteza,\u00a0 c\u00f3lera,\u00a0 etc.,\u00a0\ntraumatismos\u00a0f\u00edsicos\u00a0o\u00a0intervenciones\u00a0inadecuadas\u00a0en\u00a0 la\u00a0extremidad\u00a0inferior\u00a0o\u00a0la\u00a0\nzona\u00a0lumbar,\u00a0se\u00a0produce\u00a0dolor\u00a0en\u00a0la\u00a0extremidad\u00a0inferi or.\u00a0\nd)\u00a0Sobreesfuerzo,\u00a0 cons tituci\u00f3n\u00a0 d\u00e9bil\u00a0 y\u00a0 enfermedad\u00a0 prolongada.\u00a0 En\u00a0 caso\u00a0 de\u00a0\nmalnutrici\u00f3n\u00a0de\u00a0los\u00a0meridianos,\u00a0colaterales,\u00a0articula ciones,\u00a0m\u00fasculos,\u00a0tendones\u00a0y\u00a0\nhuesos\u00a0en\u00a0la\u00a0extremidad\u00a0inferior,\u00a0se\u00a0producir\u00e1\u00a0dolor \u00a0en\u00a0\u00e9sta.\u00a0En\u00a0enfermedades\u00a0\nprolongadas,\u00a0una\u00a0constituci\u00f3n\u00a0d\u00e9bil\u00a0y\u00a0la\u00a0mala\u00a0dieta\u00a0 pueden\u00a0consumir\u00a0o\u00a0disminuir\u00a0la\u00a0\nproducci\u00f3n\u00a0de\u00a0Qi\u00a0y\u00a0Sangre. \u00a0\u00a0\n\u00a0 22\u00a0La\u00a0instauraci\u00f3n\u00a0gradual\u00a0de\u00a0dolor\u00a0en\u00a0la\u00a0extremidad\u00a0in ferior,\u00a0que\u00a0se\u00a0acompa\u00f1a\u00a0de\u00a0\nalgunos\u00a0 s\u00edntomas\u00a0 interno\u00a0 a\u00a0 causa\u00a0 de\u00a0 trastornos\u00a0 inter nos,\u00a0 suele\u00a0 deberse\u00a0 \u00a0 a\u00a0\nestancamiento\u00a0de\u00a0qi\u00a0y\u00a0sangre,\u00a0el\u00a0flujo\u00a0descendente\u00a0d e\u00a0humedad\u2013 calor,\u00a0la\u00a0deficiencia\u00a0\nde\u00a0qi\u00a0y\u00a0sangre\u00a0y\u00a0la\u00a0deficiencia\u00a0de\u00a0h\u00edgado\u00a0y\u00a0ri\u00f1\u00f3n .\u00a0El\u00a0dolor\u00a0que\u00a0empeora\u00a0con\u00a0el\u00a0\nesfuerzo\u00a0 y\u00a0 s e\u00a0 acompa\u00f1a\u00a0 de\u00a0 entumecimiento\u00a0 y\u00a0 debilidad\u00a0 de\u00a0 las\u00a0 extremi dades\u00a0\ninferiores,\u00a0cansan cio\u00a0y\u00a0palidez\u00a0de\u00a0\u00e9sta s\u00a0se\u00a0debe\u00a0a\u00a0una\u00a0def iciencia\u00a0de\u00a0Qi\u00a0y\u00a0sangre.\u00a0 \u00a0\nPrincipio\u00a0 del\u00a0 Tratamiento.\u00a0 Dispersar\u00a0 los\u00a0 factores\u00a0 externos \u00a0(fr\u00edo),\u00a0 favorecer\u00a0 la\u00a0\ncirculaci\u00f3n\u00a0en\u00a0lo s\u00a0meridianos\u00a0y\u00a0aliviar\u00a0el\u00a0dolor (15)\u00a0\n\u00a0\n1.4\u00a0Acupuntura \u00a0\u00a0\n1.4.1\u00a0T\u00e9cnica\u00a0de\u00a0punci\u00f3n: \u00a0\n\u00a0\nConsiste\u00a0en\u00a0insertar\u00a0agujas\u00a0muy\u00a0finas\u00a0a\u00a0trav\u00e9s\u00a0de\u00a0la \u00a0piel\u00a0con\u00a0la\u00a0intenci\u00f3n\u00a0de\u00a0\nestimular\u00a0 ciertos\u00a0 puntos\u00a0 anat\u00f3micos,\u00a0 los\u00a0 cuales\u00a0 se\u00a0 le s\u00a0 denomina\u00a0 puntos\u00a0\nacupunturales\u00a0o\u00a0acupuntos.\u00a0El\u00a0giro\u00a0manual\u00a0de\u00a0estas\u00a0a gujas\u00a0produce\u00a0dolor,\u00a0pesantez\u00a0\no\u00a0adormecimiento,\u00a0que\u00a0es\u00a0conocido\u00a0como\u00a0\u201c De\u00a0Qi\u201d.\u00a0Estos\u00a0puntos\u00a0no\u00a0se\u00a0definen\u00a0com o\u00a0\nestructuras\u00a0f\u00edsicas,\u00a0sino\u00a0que\u00a0se\u00a0definen\u00a0por\u00a0su\u00a0fun ci\u00f3n.\u00a0Hay\u00a0mas\u00a0de\u00a0365\u00a0puntos\u00a0de\u00a0\nacupuntura\u00a0identificables\u00a0en\u00a0el\u00a0cuerpo\u00a0humano.\u00a0Adem\u00e1s\u00a0 existen\u00a0v\u00edas\u00a0que\u00a0conectan\u00a0\nestos\u00a0puntos\u00a0entre\u00a0s\u00ed,\u00a0llamados\u00a0 Meridianos,\u00a0que\u00a0a\u00a0su\u00a0vez\u00a0se\u00a0subdividen\u00a0en\u00a0diferentes\u00a0\nniveles\u00a0 en\u00a0 ramas,\u00a0 llamadas\u00a0 Colaterales.\u00a0 El\u00a0 cuerpo\u00a0 es\u00a0 visto\u00a0 como\u00a0 un\u00a0 sistema\u00a0\ndin\u00e1mico\u00a0de\u00a0\u00f3rganos\u00a0conectados\u00a0por\u00a0el\u00a0flujo\u00a0de\u00a0 Qi\u00a0a\u00a0trav\u00e9s\u00a0de\u00a0los\u00a0 Meridianos\u00a0y\u00a0sus\u00a0\nColaterales.\u00a0El\u00a0Qi\u00a0es\u00a0la\u00a0energ\u00eda\u00a0que\u00a0fluye\u00a0a\u00a0trav\u00e9s\u00a0de\u00a0\u00e9stos.\u00a0Cuando\u00a0existe\u00a0un\u00a0flujo\u00a0\ninadecuado\u00a0o\u00a0estanca miento\u00a0del\u00a0 Qi\u00a0en\u00a0el\u00a0trayecto\u00a0de\u00a0los\u00a0 Meridianos,\u00a0puede\u00a0esto \u00a0\nresultar\u00a0en\u00a0dolor\u00a0o\u00a0enfermedad\u00a0 (16).\u00a0\nLa\u00a0unidad\u00a0de\u00a0medida\u00a0utilizada\u00a0para\u00a0localizar\u00a0los\u00a0pun tos\u00a0de\u00a0acupuntura\u00a0se\u00a0le\u00a0llama\u00a0\nCun,\u00a0que\u00a0equivale\u00a0al\u00a0ancho\u00a0de\u00a0la\u00a0articulaci\u00f3n\u00a0interfal\u00e1ngica\u00a0del\u00a0dedo\u00a0pulgar\u00a0d el\u00a0\npaciente.\u00a0\u00a0\n\u00a0 23\u00a01.4.2\u00a0Puntos\u00a0a\u00a0utilizar \u00a0\nPara\u00a0esto\u00a0se\u00a0usar\u00e1n\u00a0los\u00a0puntos\u00a0Qihai,\u00a0Zusanli,\u00a0Fenglong,\u00a0Sanyinjiao\u00a0y\u00a0Yanglingquan. \u00a0\n\u00a0\u00a0\u00a0\u00a0 \u00a0\n\u00a0\n\u2022 Qihai\u00a0 (RenMai\u00a0 6):\u00a0localizado\u00a0 en\u00a0 el\u00a0 abdomen\u00a0 bajo,\u00a0 a\u00a0 1.5\u00a0 cm\u00a0\ndirectamente\u00a0debajo\u00a0de\u00a0la\u00a0cicatriz\u00a0umbilical.\u00a0\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0 24\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\n\u00a0\n\u2022 Fenglong\u00a0(Est\u00f3mago\u00a040):\u00a0localizado\u00a0 en\u00a0 el\u00a0 lado\u00a0 lateral\u00a0 de\u00a0 la\u00a0\npantorrilla,\u00a0a\u00a08\u00a0cm\u00a0arriba\u00a0del\u00a0\u00e1rea\u00a0mas\u00a0prominente\u00a0del \u00a0mal\u00e9olo\u00a0\nexterno\u00a0y\u00a0a\u00a02\u00a0traveses\u00a0de\u00a0dedo\u00a0de\u00a0la\u00a0cresta\u00a0anterior\u00a0de\u00a0la\u00a0tibia. \u00a0\n\u00a0\n\u00a0\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\n\u2022 Zusanli\u00a0(Est\u00f3mago\u00a036):\u00a0 localizado \u00a0 3\u00a0 cm\u00a0 por\u00a0 debajo\u00a0 del\u00a0 \u00e1ngulo\u00a0\ninferolateral\u00a0de\u00a0la\u00a0r\u00f3tula\u00a0y\u00a01\u00a0trav\u00e9s\u00a0de\u00a0dedo\u00a0hacia\u00a0fuera. \u00a0\n\u00a0\u00a0\n\u00a0\n\u00a0 25\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\n\u2022 Yanglingquan\u00a0 (Ves\u00edcula\u00a0Biliar\u00a034) \u00a0:\u00a0Localizado\u00a0en\u00a0el\u00a0borde\u00a0lateral\u00a0de\u00a0\nla\u00a0pantorrilla\u00a0y\u00a0en\u00a0la\u00a0depresi\u00f3n\u00a0anterior\u00a0e\u00a0inferior\u00a0de\u00a0la\u00a0cabeza\u00a0de\u00a0la\u00a0\ntibia.\u00a0\u00a0\n\u00a0\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\n\u2022 Sanyinjiao\u00a0(Bazo\u00a06):\u00a0Localizado\u00a0en\u00a0la\u00a0parte\u00a0interna\u00a0de\u00a0la\u00a0pierna\u00a0a\u00a0tres\u00a0\ncun\u00a0proximales\u00a0de\u00a0la\u00a0prominencia\u00a0del\u00a0mal\u00e9olo\u00a0medial.\u00a0\u00a0\nLa\u00a0selecci\u00f3n\u00a0de\u00a0estos\u00a0puntos\u00a0se\u00a0bas\u00f3\u00a0en\u00a0las\u00a0manifest aciones\u00a0cl\u00ednicas\u00a0que\u00a0ocurren\u00a0\ncuando\u00a0existe\u00a0una\u00a0disfunci\u00f3n\u00a0del\u00a0flujo\u00a0del\u00a0 Qi\u00a0en\u00a0el\u00a0meridiano\u00a0al\u00a0que\u00a0pertenecen.\u00a0La\u00a0\nselecci\u00f3n\u00a0de\u00a0estos\u00a0puntos\u00a0se\u00a0bas\u00f3\u00a0en\u00a0los\u00a0meridianos\u00a0 relacionados.\u00a0\u00a0\n\u00a0\n\u00a0 26\u00a0\u00a0\n\u00a0\n2.\u00a0JUSTIFICACI \u00d3N\u00a0\nCon\u00a0el\u00a0paso\u00a0del\u00a0tiempo,\u00a0el\u00a0uso\u00a0de\u00a0la\u00a0acupuntura\u00a0se\u00a0h a\u00a0aceptado\u00a0cada\u00a0vez\u00a0m\u00e1s\u00a0en\u00a0la\u00a0\nMedicina\u00a0 O ccidental,\u00a0 utiliz\u00e1ndose\u00a0 como\u00a0 Medicina\u00a0 Complementaria\u00a0\u00a0 en\u00a0 diversas\u00a0\nenfermedades\u00a0y\u00a0condiciones.\u00a0Se\u00a0cree\u00a0que\u00a0su\u00a0eficacia\u00a0 se\u00a0deba\u00a0posiblemente\u00a0\u00a0 a\u00a0\nalteraciones\u00a0 en\u00a0 la\u00a0 bioqu\u00edmica\u00a0 cerebral\u00a0 incluyendo\u00a0 el \u00a0 intercambio\u00a0 de\u00a0\nneurotransmisores\u00a0y\u00a0hormonas,\u00a0resultando\u00a0as\u00ed\u00a0en\u00a0la\u00a0mod ulaci\u00f3n\u00a0de\u00a0la\u00a0presi\u00f3n\u00a0\narterial,\u00a0flujo\u00a0sangu\u00edneo\u00a0y\u00a0temperatura\u00a0corporal,\u00a0fa voreciendo\u00a0de\u00a0esta\u00a0manera\u00a0la\u00a0\ncirculaci\u00f3n\u00a0local,\u00a0ayudando\u00a0as\u00ed\u00a0al\u00a0alivio\u00a0del\u00a0dolor.\u00a0Es\u00a0la\u00a0raz\u00f3n\u00a0por\u00a0la\u00a0que\u00a0se\u00a0 plantea\u00a0\ndeterminar\u00a0la\u00a0existencia\u00a0de\u00a0cambios\u00a0en\u00a0la\u00a0perfu si\u00f3n\u00a0tisular\u00a0con\u00a0el\u00a0uso\u00a0de\u00a0la\u00a0\nAcupuntura\u00a0en\u00a0pacientes\u00a0con\u00a0enfermedad\u00a0arterial\u00a0perif \u00e9rica.\u00a0\n3.\u00a0HIP\u00d3TESIS\u00a0DE\u00a0LA\u00a0INVESTIGACI\u00d3N \u00a0\n\u00a0\nEl\u00a0tratamiento\u00a0con\u00a0Acupuntura\u00a0sobre\u00a0los\u00a0puntos\u00a0Qihai, \u00a0\u00a0Zusanli,\u00a0Yanglingquan,\u00a0\nSanyinjiao\u00a0y\u00a0Fenglong\u00a0 mejorar\u00e1\u00a0los\u00a0par\u00e1metros\u00a0de\u00a0\u00cd ndice\u00a0Tobillo\u00a0B razo,\u00a0\u00a0Oximetr\u00eda\u00a0\nTranscut\u00e1nea,\u00a0 adem\u00e1s\u00a0 reducir\u00e1\u00a0 la\u00a0 incidencia\u00a0 de\u00a0 s\u00edntomas\u00a0 isqu\u00e9micos\u00a0\ntraduci\u00e9ndose\u00a0esto\u00a0como\u00a0una\u00a0mejor\u00eda\u00a0en\u00a0la\u00a0microcircula ci\u00f3n\u00a0perif\u00e9rica\u00a0en\u00a0pacientes\u00a0\ncon\u00a0Enfermedad\u00a0Arterial\u00a0Perif\u00e9rica .\u00a0\n4.\u00a0OBJETIVOS\u00a0DEL\u00a0ESTUDIO \u00a0\n4.1\u00a0Objetivo\u00a0primario \u00a0\nEl\u00a0objetivo\u00a0primario\u00a0del\u00a0estudio\u00a0es\u00a0determinar\u00a0cambios\u00a0en\u00a0la \u00a0perfusi\u00f3n\u00a0tisular\u00a0\nposterior\u00a0al\u00a0tratamiento\u00a0con\u00a0acupuntura\u00a0en\u00a0pacientes \u00a0con\u00a0EAP,\u00a0medido\u00a0con\u00a0el\u00a0\n\u00cdndice\u00a0Tobillo\u00a0Brazo\u00a0y\u00a0Oximetr\u00eda\u00a0Transcut\u00e1nea.\u00a0\u00a0\n\u00a0 27\u00a04.2\u00a0Objetivos\u00a0Secundarios\u00a0\nLos\u00a0objetivos\u00a0secundarios\u00a0del\u00a0estu dio\u00a0son\u00a0para\u00a0valorar\u00a0el\u00a0efecto\u00a0del\u00a0tratamiento\u00a0\nestimulaci\u00f3n\u00a0de\u00a0los\u00a0puntos\u00a0 Qihai,\u00a0Zusanli,\u00a0Yanglingquan ,\u00a0Sanyinjiao,\u00a0Fenglong,\u00a0en\u00a0\npacientes\u00a0con\u00a0EAP\u00a0establecida\u00a0 en:\u00a0\n1.\u2010\u00a0Evaluar\u00a0la\u00a0progresi\u00f3 n\u00a0del\u00a0estado\u00a0hemodin\u00e1mico\u00a0de\u00a0la\u00a0extremidad\u00a0inferior\u00a0\u00a0\nmediante\u00a0 la\u00a0 reducci\u00f3n\u00a0 de\u00a0 s\u00edntomas\u00a0 isqu\u00e9micos\u00a0 utilizand o\u00a0 los\u00a0 estad\u00edos\u00a0 de\u00a0\nRutherford\u00a0y\u00a0Fontaine\u00a0como\u00a0par\u00e1metro.\u00a0\n3.\u2010\u00a0Evaluar\u00a0el\u00a0impacto\u00a0en\u00a0la\u00a0calidad\u00a0de\u00a0vida\u00a0relacionad o\u00a0con\u00a0la\u00a0salud\u00a0usando\u00a0el\u00a0\ncuestionario\u00a0de\u00a0calidad\u00a0de\u00a0vida\u00a0(EQ \u20105D).\u00a0\u00a0\n4.\u2010\u00a0Evaluaci\u00f3n\u00a0de\u00a0s\u00edntomas\u00a0con\u00a0el\u00a0cuestionario\u00a0de\u00a0enfer medad\u00a0arterial\u00a0perif\u00e9rica.\u00a0\n5.\u2010\u00a0La\u00a0comparaci\u00f3n\u00a0entre\u00a0el\u00a0efecto\u00a0cl\u00ednico\u00a0y\u00a0sintomatol\u00f3 gico\u00a0\u00a0al\u00a0utilizar\u00a0acupuntura\u00a0\nsobre\u00a0 los\u00a0 puntos\u00a0 y\u00a0Qihai,\u00a0Zusanli,\u00a0Yanglingquan \u00a0y\u00a0Fenglong\u00a0en\u00a0 pacientes\u00a0 con\u00a0\nenfermedad\u00a0arterial\u00a0perif\u00e9rica.\u00a0\n6.\u2010\u00a0Encontrar\u00a0una\u00a0t\u00e9c nica\u00a0terap\u00e9utica\u00a0efectiva\u00a0que\u00a0complemente\u00a0el\u00a0tratamien to\u00a0\nconvencional\u00a0con\u00a0la\u00a0enfermedad\u00a0arterial\u00a0perif\u00e9rica.\u00a0\n\u00a0\n5.\u00a0DISE\u00d1O\u00a0DEL\u00a0ESTUDIO .\u00a0\nEste\u00a0es\u00a0un\u00a0estudio\u00a0experimental\u00a0tipo\u00a0ensayo\u00a0cl\u00ednico,\u00a0prospecti vo,\u00a0de\u00a0casos\u00a0y\u00a0controles,\u00a0no\u00a0\nciego,\u00a0basado\u00a0en\u00a0objetivos\u00a0final es\u00a0para\u00a0evaluar\u00a0la\u00a0mejor\u00eda\u00a0en\u00a0la\u00a0sintomatolog\u00eda\u00a0y\u00a0en\u00a0la\u00a0\nmedici\u00f3n\u00a0de\u00a0Oximetr\u00eda\u00a0Transcut\u00e1nea\u00a0utilizando\u00a0la\u00a0acup untura.\u00a0\u00a0\nSe\u00a0utiliz\u00f3\u00a0una\u00a0f\u00f3rmula\u00a0para\u00a0prueba\u00a0de\u00a0hip\u00f3tesis\u00a0y\u00a0diferencia\u00a0de\u00a0dos\u00a0med ias,\u00a0con\u00a0un\u00a0valor\u00a0z\u03b1\u00a0\nde\u00a01.96\u00a0con\u00a0nivel\u00a0de\u00a0significancia\u00a0del\u00a095%\u00a0para\u00a0dos\u00a0colas,\u00a0y\u00a0un\u00a0valor \u00a0z\u03b2\u00a0de\u00a0\u00a00.84\u00a0con\u00a0una\u00a0\npotencia\u00a0de\u00a080%,\u00a0se\u00a0obtuvo\u00a0una\u00a0muestra\u00a0de\u00a016\u00a0participantes. \u00a0\u00a0\n\u00a0 28\u00a0\u00a0\n6.\u00a0PACIENTES\u00a0Y\u00a0M\u00c9TODOS \u00a0\n6.1\u00a0Reclutamiento\u00a0 \u00a0\nSe\u00a0reclutaron \u00a0\u00a0pacientes\u00a0sin\u00a0restricci\u00f3n\u00a0de\u00a0g\u00e9nero\u00a0mayores\u00a0de\u00a040\u00a0a\u00f1 os\u00a0de\u00a0edad\u00a0con\u00a0\nEAP.\u00a0Hubo\u00a0pacientes\u00a0con \u00a0antecedentes\u00a0de\u00a0Enfermedad\u00a0Arterial\u00a0Coronaria\u00a0(EAC)\u00a0\nsintom\u00e1tica\u00a0 (es\u00a0 decir,\u00a0 infarto\u00a0 del\u00a0 miocardio,\u00a0 s\u00edndrome \u00a0 coronario\u00a0 agudo\u00a0 o\u00a0\nrevascularizaci\u00f3n\u00a0coronaria),\u00a0sin\u00a0embargo,\u00a0la\u00a0EAP\u00a0ser\u00e1\u00a0su\u00a0 manifestaci\u00f3n\u00a0cl\u00ednica\u00a0\nprincipal.\u00a0\u00a0\nSe\u00a0reclutararon\u00a016\u00a0pacientes\u00a0sintom\u00e1ticos\u00a0y\u00a0no\u00a0sinto m\u00e1ticos\u00a0representativos\u00a0de\u00a0\nEAP\u00a0que\u00a0tengan\u00a0un\u00a0\u00cdndice\u00a0Tobillo\u00a0Brazo\u00a0<0.8,\u00a0\u00cdndice\u00a0 Dedo\u00a0Brazo\u00a0(IDB)\u00a0<\u00a00.6\u00a0y\u00a0que\u00a0\nest\u00e9n\u00a0llevando\u00a0tratamiento\u00a0convencional\u00a0con\u00a0aspirina\u00a0o\u00a0cilost azol\u00a0o\u00a0clopidogrel,\u00a0\nser\u00e1n\u00a0 pacientes\u00a0 que\u00a0 acudan\u00a0 a\u00a0 la\u00a0 consulta\u00a0 de\u00a0 Cirug\u00eda\u00a0 General\u00a0 del\u00a0 Hospital\u00a0\nUniversitario\u00a0de\u00a0los\u00a0cuales\u00a08\u00a0(Grupo\u00a01 ,\u00a0control)\u00a0continuar\u00e1n\u00a0este\u00a0manej o.\u00a0Los\u00a0otros\u00a0\n8\u00a0 pacientes\u00a0 (Grupo\u00a0 2,\u00a0casos)\u00a0 adicionalmente\u00a0 al\u00a0 tratamiento\u00a0 convencional\u00a0 se\u00a0\ntrataron\u00a0con\u00a010\u00a0sesiones\u00a0de\u00a0Acupuntura\u00a0con\u00a0una\u00a0sesi\u00f3n\u00a0cada\u00a0t ercer\u00a0d\u00eda.\u00a0El\u00a0tama\u00f1o\u00a0\nde\u00a0la\u00a0muestra\u00a0se\u00a0bas\u00f3\u00a0en\u00a0la\u00a0incidencia\u00a0y\u00a0prevalencia \u00a0de\u00a0la\u00a0Enfermedad\u00a0Arterial\u00a0\nPerif\u00e9rica\u00a0en\u00a0el\u00a0Hospital\u00a0Universitario\u00a0\u201cDr.\u00a0Jos \u00e9\u00a0Eleuterio\u00a0Gonz\u00e1lez\u201d\u00a0utilizando\u00a0una\u00a0\nf\u00f3rmula\u00a0para\u00a0prueba\u00a0de\u00a0hip\u00f3tesis\u00a0y\u00a0diferencia\u00a0de\u00a0dos \u00a0medias\u00a0con\u00a0valor\u00a0de\u00a0valor\u00a0z\u03b1\u00a0\nde\u00a01.96\u00a0con\u00a0nivel\u00a0de\u00a0significancia\u00a0del\u00a095%\u00a0para\u00a0dos\u00a0colas,\u00a0y\u00a0un\u00a0valor\u00a0z\u03b2\u00a0de\u00a00.84\u00a0con\u00a0\nuna\u00a0potencia\u00a0de\u00a080%. \u00a0\n\u00a0\n\u00a0 29\u00a06.2\u00a0Criterios\u00a0de\u00a0Inclusi\u00f3n \u00a0\n1.\u2010\u00a0Pacientes\u00a0varones\u00a0y\u00a0mujeres\u00a0\u2265 40\u00a0a\u00f1os\u00a0de\u00a0edad .\u00a0\n2.\u2010\u00a0Determinaci\u00f3n\u00a0del\u00a0\u00cd ndice\u00a0Tobillo\u00a0B razo\u00a0(ITB)\u00a0\u22640.80\u00a0en\u00a0la\u00a0visita\u00a01.\u00a0\u00a0 Si\u00a0el\u00a0ITB\u00a0es\u00a0\n\u22651.40\u00a0entonces\u00a0el\u00a0\u00edndice\u00a0dedo\u00a0brazo\u00a0(IDB)\u00a0debe\u00a0ser\u00a0\u22640.60\u00a0en\u00a0la\u00a0visita\u00a01. \u00a0Se\u00a0realiz\u00f3\u00a0\ncon\u00a0apoyo\u00a0de\u00a0ultrasonido\u00a0doppler. \u00a0\n3.\u2010\u00a0Firma\u00a0del\u00a0Consentimiento\u00a0Informa do.\u00a0\n\u00a0\n6.3\u00a0Criterios\u00a0de\u00a0exclusi\u00f3n\u00a0\n1. Pacientes\u00a0que\u00a0requieren\u00a0tratamiento\u00a0antiplaquetario\u00a0 doble\u00a0al\u00a0ingresar\u00a0al\u00a0\nestudio.\u00a0\n2. Necesidad\u00a0de\u00a0tratamiento\u00a0cr\u00f3nico\u00a0con\u00a0antico agulante\u00a0oral\u00a0cr\u00f3nico. \u00a0\n3. Uso\u00a0actual\u00a0de\u00a0Ginkgo\u00a0biloba. \u00a0\n4. Cualquier\u00a0padecimi ento\u00a0que\u00a0en\u00a0opini\u00f3n\u00a0del\u00a0investigador\u00a0har\u00eda\u00a0inseguro\u00a0e\u00a0\ninadecuado\u00a0que\u00a0el\u00a0paciente\u00a0participe\u00a0en\u00a0\u00e9 ste.\u00a0\n5. Expectativa\u00a0de\u00a0vida\u00a0<6\u00a0meses\u00a0con\u00a0base\u00a0en\u00a0la\u00a0opini\u00f3n\u00a0 del\u00a0investigador.\u00a0\n6. Pacientes\u00a0que\u00a0han\u00a0sufrido\u00a0una\u00a0enfermedad\u00a0vascular\u00a0ce rebral\u00a0durante\u00a0los\u00a0\n\u00faltimos\u00a03\u00a0meses.\u00a0\n7. Demencia\u00a0con\u00a0probabilidad\u00a0de\u00a0arriesgar\u00a0la\u00a0comprensi\u00f3n \u00a0de\u00a0la\u00a0informaci\u00f3n\u00a0\ncorrespondiente\u00a0a\u00a0la\u00a0realizaci\u00f3n\u00a0del\u00a0estudio\u00a0o\u00a0apeg o\u00a0a\u00a0los\u00a0procedimientos\u00a0\ndel\u00a0estudio.\u00a0\n8. Hipertensi\u00f3n\u00a0 arterial\u00a0severa.\u00a0\n9. S\u00edndrome\u00a0Isqu\u00e9mico\u00a0Coronario\u00a0Agudo\u00a0(SICA).\u00a0\n10. Di\u00e1tesis\u00a0 hemorr\u00e1gica\u00a0 confirmada,\u00a0 trastorno\u00a0 de\u00a0 coagula ci\u00f3n\u00a0 o\u00a0 sangrado\u00a0\nsist\u00e9mico,\u00a0resuelto\u00a0o\u00a0en\u00a0curso.\u00a0\n11. Antecedentes\u00a0de\u00a0trombocitopenia\u00a0o\u00a0neutropenia.\u00a0\n12. Mujeres\u00a0 en\u00a0 edad\u00a0 f\u00e9rtil\u00a0 que\u00a0 no\u00a0 est\u00e9n\u00a0 dispuestas\u00a0 a\u00a0 usar\u00a0 un\u00a0 m\u00e9todo\u00a0\nanticonceptivo\u00a0 o\u00a0mujeres\u00a0que\u00a0tengan\u00a0un\u00a0resultado\u00a0positivo\u00a0en\u00a0una\u00a0p rueba\u00a0de\u00a0\nembarazo\u00a0en\u00a0la\u00a0visita\u00a01.\u00a0\n\u00a0\u00a0\n\u00a0 30\u00a06.4\u00a0M\u00e9todos\u00a0\u00a0\nEn\u00a0la\u00a0primera\u00a0visita\u00a0se\u00a0les\u00a0hizo\u00a0una\u00a0toma\u00a0de\u00a0sus\u00a0sign os\u00a0vitales,\u00a0electrocardiograma\u00a0y\u00a0\noximetr\u00eda\u00a0transcut\u00e1nea,\u00a0adem\u00e1s\u00a0de\u00a0que\u00a0conte staron\u00a0el\u00a0Cuestionario\u00a0DE\u00a0\u201cCALIDAD\u00a0\nDE\u00a0VIDA\u00a0(EQ\u20105D)\u201d\u00a0y\u00a0Cuestionario\u00a0Walking\u00a0Impairment\u00a0Quie stionaire\u00a0(WIQ).\u00a0Los\u00a0\ndos\u00a0primeros\u00a0para\u00a0descartar\u00a0alguna\u00a0condici\u00f3n\u00a0que\u00a0pre disponga\u00a0al\u00a0paciente\u00a0a\u00a0una\u00a0\ncomplicaci\u00f3n,\u00a0 como\u00a0 s\u00edndrome\u00a0 isqu\u00e9mico\u00a0 coronario\u00a0 o\u00a0 hiper tensi\u00f3n\u00a0 arterial\u00a0\ndescontrolada. \u00a0En\u00a0cada\u00a0una\u00a0de\u00a0las\u00a0 10\u00a0visitas\u00a0se\u00a0tomaron\u00a0los\u00a0signos\u00a0vitale s\u00a0para\u00a0\nposteriormente\u00a0 realizar\u00a0 asepsia\u00a0 del\u00a0 \u00e1rea\u00a0 a\u00a0 puncionar\u00a0 primeramente\u00a0 con\u00a0 una\u00a0\ntorunda\u00a0 alcoholada\u00a0 seguida\u00a0 de\u00a0 isodine. \u00a0Se\u00a0 puncionaron \u00a0los\u00a0 puntos\u00a0 Qihai,\u00a0\nYanglingquan,\u00a0 Zusanli,\u00a0Fenglong\u00a0y \u00a0Sanyinjiao,\u00a0 con\u00a0aguja\u00a0para\u00a0acupuntura\u00a0\u00a0longitud\u00a0\n40mm\u00a0de\u00a0largo,\u00a0calibre\u00a022,\u00a0por\u00a020\u00a0minutos.\u00a0\nEn\u00a0la\u00a0quinta\u00a0visita,\u00a0se\u00a0les\u00a0tom\u00f3\u00a0nuevamente\u00a0el\u00a0\u00cd ndice\u00a0Tobillo\u00a0B razo,\u00a0el\u00a0Cuestionario\u00a0\nEQ\u20105D\u00a0y\u00a0el\u00a0Cuestionario\u00a0WIQ \u00a0para\u00a0asegurar\u00a0que\u00a0no\u00a0hubiera\u00a0empeoramiento\u00a0de\u00a0la\u00a0\nperfusi\u00f3n\u00a0y\u00a0pusiera\u00a0en\u00a0riesgo\u00a0la\u00a0integridad\u00a0del\u00a0paciente .\u00a0\nEn\u00a0la\u00a0d\u00e9cima\u00a0y\u00a0 posterior\u00a0a\u00a0la\u00a0 \u00faltima\u00a0sesi\u00f3n\u00a0de\u00a0acupuntura\u00a0se\u00a0realizaron\u00a0el\u00a0\u00cd ndice\u00a0\nTobillo\u00a0Brazo ,\u00a0Oximetr\u00eda\u00a0Transcut\u00e1nea,\u00a0Encuesta\u00a0EQ \u20105D\u00a0y\u00a0Cuestionario\u00a0WIQ. \u00a0\nLa\u00a0pen\u00faltima\u00a0Visita\u00a0( once)\u00a0Se\u00a0llev\u00f3\u00a0a\u00a0cabo\u00a07\u00a0d\u00edas\u00a0despu\u00e9s\u00a0de\u00a0la\u00a0\u00faltima\u00a0sesi\u00f3n\u00a0de\u00a0\nacupuntura\u00a0 realiz\u00e1ndose\u00a0una\u00a0m edici\u00f3n\u00a0del\u00a0\u00cd ndice\u00a0Tobillo/Brazo \u00a0con\u00a0apoyo\u00a0de\u00a0\nultrasonido\u00a0Doppler. \u00a0\n\u00a0\nEn\u00a0la\u00a0visita\u00a0de\u00a0Cierre\u00a0del\u00a0Estudio ,\u00a030\u00a0d\u00edas\u00a0posteriores\u00a0a\u00a0la\u00a0\u00faltima\u00a0sesi\u00f3n\u00a0de\u00a0\nacupuntura ,\u00a0se\u00a0realizaron\u00a0 Medici\u00f3n\u00a0del\u00a0\u00cd ndice\u00a0Tobillo/Brazo\u00a0o\u00a0Dedo/Brazo\u00a0con\u00a0\necograf\u00eda\u00a0 Dopp ler\u00a0 de\u00a0 extremidades\u00a0 inf eriores,\u00a0 Oximetr\u00eda\u00a0 Transcut\u00e1nea,\u00a0\nCuestionario\u00a0 DE\u00a0 \u201cCALIDAD\u00a0 DE\u00a0 VIDA\u00a0 (EQ\u20105D)\u201d\u00a0 y\u00a0 Cuestionari o\u00a0 de\u00a0 EAP.\u00a0\u00a0\n\u00a0\n\u00a0\u00a0\n\u00a0 31\u00a06.5\u00a0Suspensi\u00f3n\u00a0temporal\u00a0del\u00a0estudio \u00a0\u00a0\u00a0\n\u2022 Trombocitopenia\u00a0severa\u00a0(n\u00famero\u00a0de\u00a0plaquetas\u00a0<50,000/u L).\u00a0\u00a0\n\u2022 Sangrado\u00a0mayor.\u00a0\n\u2022 Necesidad\u00a0de\u00a0tratamiento\u00a0con\u00a0medicamentos\u00a0concomitantes \u00a0prohibidos.\u00a0\n\u2022 Evento\u00a0vascular\u00a0cerebral,\u00a0Infarto\u00a0Agudo\u00a0al\u00a0Miocardio \u00a0o\u00a0Hipertensi\u00f3n\u00a0arterial\u00a0\nno\u00a0controlada.\u00a0 \u00a0\n\u00a0\n6.6\u00a0Suspensi\u00f3n\u00a0permanente\u00a0del\u00a0estudio.\u00a0\n\u00a0\n\u2022 Decisi\u00f3n\u00a0 del\u00a0 paciente:\u00a0 En\u00a0 cualquier\u00a0 momento\u00a0 el\u00a0 pacien te\u00a0 es\u00a0 libre\u00a0 de\u00a0\nsuspender\u00a0el\u00a0tratamiento,\u00a0sin\u00a0afectar\u00a0su\u00a0tratamiento\u00a0 posterior.\u00a0\n\u2022 Decisi\u00f3n\u00a0del\u00a0investigador:\u00a0 \u00a0\n1. Paciente\u00a0reclutado\u00a0incorrectamente\u00a0\u00a0con\u00a0riesgo\u00a0exces ivo\u00a0por\u00a0no\u00a0cumplir\u00a0con\u00a0\nlos\u00a0criterios\u00a0de\u00a0inclusi\u00f3n/exclusi\u00f3n. \u00a0\n2. Eventos\u00a0adversos\u00a0que\u00a0de\u00a0acuerdo\u00a0con\u00a0el\u00a0investigador\u00a0ponen\u00a0al\u00a0paciente\u00a0en\u00a0\nriesgo\u00a0excesivo\u00a0si\u00a0contin\u00faa\u00a0el\u00a0tratamiento.\u00a0\n3. Falta\u00a0severa\u00a0de\u00a0apego\u00a0al\u00a0protocolo\u00a0del\u00a0estudio.\u00a0 \u00a0\n4. Embarazo.\u00a0\nSuspensi\u00f3n\u00a0del\u00a0\u00a0estudio\u00a0no\u00a0significa\u00a0suspensi\u00f3n\u00a0del \u00a0seguimiento\u00a0o\u00a0terminaci\u00f3n\u00a0de\u00a0la\u00a0\nparticipaci\u00f3n\u00a0en\u00a0el\u00a0estudio .\u00a0\nA\u00a0un\u00a0paciente\u00a0que\u00a0decida\u00a0suspender\u00a0el\u00a0estudio\u00a0siempre \u00a0se\u00a0le\u00a0debe\u00a0preguntar\u00a0los\u00a0\nmotivos\u00a0de\u00a0su\u00a0deseo\u00a0de\u00a0suspender\u00a0el\u00a0estudio\u00a0y\u00a0sobre\u00a0 la\u00a0presencia\u00a0(en\u00a0su\u00a0caso)\u00a0de\u00a0\u00a0\n\u00a0 32\u00a0eventos\u00a0adversos.\u00a0El\u00a0investigador\u00a0verificar\u00e1\u00a0y\u00a0docu mentar\u00e1\u00a0estos\u00a0datos\u00a0y\u00a0los\u00a0\nregistrar\u00e1.\u00a0\n7.\u00a0RESULTADOS\u00a0 \u00a0\nPosterior\u00a0a\u00a0las\u00a0mediciones\u00a0del\u00a0ITB\u00a0tanto\u00a0en\u00a0el\u00a0miembro \u00a0p\u00e9lvico\u00a0derecho\u00a0como\u00a0en\u00a0el\u00a0\nizquierdo,\u00a0tomando\u00a0como\u00a0criterio\u00a0de\u00a0selecci\u00f3n\u00a0que\u00a0fue ra\u00a0menor\u00a0de\u00a00.8,\u00a0esto\u00a0debido\u00a0\na\u00a0que\u00a0el\u00a0mismo\u00a0puede\u00a0variar\u00a0en\u00a0la\u00a0misma\u00a0persona\u00a0de\u00a0una\u00a0 extremidad\u00a0a\u00a0otra,\u00a0ya\u00a0que\u00a0\nla\u00a0arterioesclerosis\u00a0no\u00a0es\u00a0una\u00a0condici\u00f3n\u00a0sim\u00e9trica\u00a0 y\u00a0por\u00a0lo\u00a0tanto\u00a0puede\u00a0presentarse\u00a0\ncomo\u00a0un\u00a0elemento\u00a0que\u00a0pudieran\u00a0alterar\u00a0los\u00a0resultados\u00a0 o\u00a0sesgar\u00a0el\u00a0estudio.\u00a0 En\u00a0el\u00a0\nan\u00e1lisis\u00a0estad\u00edstico,\u00a0se\u00a0observa\u00a0que\u00a0al\u00a0principio\u00a0d el\u00a0estudio\u00a0ambos\u00a0grupos\u00a0inician\u00a0de\u00a0\nuna\u00a0manera\u00a0similar\u00a0con\u00a0una\u00a0P\u00a0de\u00a01\u00a0en\u00a0el\u00a0grupo\u00a01\u00a0y\u00a0una \u00a0P\u00a0de\u00a00.9\u00a0en\u00a0el\u00a0grupo\u00a02. \u00a0\nVale\u00a0la\u00a0pena\u00a0recordar\u00a0que\u00a0en\u00a0nuestro\u00a0estudio\u00a0el\u00a0cri terio\u00a0de\u00a0\u00e9xito\u00a0fue\u00a0un\u00a0aumento\u00a0en\u00a0\nel\u00a0ITB\u00a0de\u00a00.1,\u00a0por\u00a0lo\u00a0tanto,\u00a0encontramos\u00a0que\u00a0los\u00a0pac ientes\u00a0del\u00a0grupo\u00a01\u00a0no\u00a0alcanzaron\u00a0\nuna\u00a0mejor\u00eda\u00a0significativa,\u00a0ya\u00a0que\u00a0solo\u00a02\u00a0pacientes,\u00a0 es\u00a0decir\u00a0el\u00a02 5%,\u00a0lograron\u00a0el\u00a0\ncriterio\u00a0de\u00a0\u00e9xito\u00a0en\u00a0la\u00a0medici\u00f3n,\u00a0posteriormente\u00a0se\u00a0r ealiz\u00f3\u00a0un\u00a0an\u00e1lisis\u00a0estad\u00edstico\u00a0\nobteniendo\u00a0una\u00a0P\u00a0de\u00a00.307,\u00a0lo\u00a0cual\u00a0no\u00a0es\u00a0significativo. \u00a0\n\u00a0\nEn\u00a0el\u00a0grupo\u00a02,\u00a0se\u00a0observaron\u00a0varios\u00a0elementos\u00a0difere ntes\u00a0en\u00a0las\u00a0mediciones\u00a0a\u00a0los\u00a0\ndel\u00a0grupo\u00a0uno,\u00a0en\u00a0 \u00e9stos\u00a0pacientes\u00a0se\u00a0observ\u00f3\u00a0que\u00a0en\u00a0la\u00a0re visi\u00f3n\u00a0de\u00a0la\u00a0visita\u00a0n\u00famero\u00a0\n10\u00a0(\u00faltima\u00a0sesi\u00f3n\u00a0del\u00a0tratamiento)\u00a0y\u00a011(7\u00a0d\u00edas\u00a0posteriores\u00a0al \u00a0tratamiento),\u00a0en\u00a0todos\u00a0\nlos\u00a0pacientes\u00a0se\u00a0encontr\u00f3\u00a0una\u00a0mejor\u00eda\u00a0significativa\u00a0 ya\u00a0que\u00a0todos\u00a0presentaron\u00a0\nmediciones\u00a0mayores\u00a0a\u00a00.1\u00a0en\u00a0 el\u00a0ITB,\u00a0y\u00a0al\u00a0realizar\u00a0el\u00a0an\u00e1lisis\u00a0estad\u00edstico\u00a0se\u00a0obtuvo\u00a0\nuna\u00a0P\u00a0de\u00a00.002\u00a0y\u00a00.003\u00a0en\u00a0las\u00a0\u00faltimas\u00a0dos\u00a0mediciones\u00a0 respectivamente.\u00a0En\u00a0la\u00a0visita\u00a0\n12\u00a0de\u00a0este\u00a0grupo,\u00a0un\u00a0mes\u00a0despu\u00e9s\u00a0de\u00a0 haber\u00a0terminado\u00a0las\u00a0sesiones\u00a0de\u00a0acupuntura,\u00a0\naunque\u00a0en\u00a0algunos\u00a0pacientes\u00a0prese ntaron\u00a0una\u00a0regresi\u00f3n\u00a0del\u00a0ITB,\u00a0ninguno\u00a0lleg\u00f3\u00a0a\u00a0\nsus\u00a0niveles\u00a0basales.\u00a0En\u00a0este\u00a0grupo\u00a0el\u00a0100%\u00a0de\u00a0los\u00a0pacientes\u00a0 alcanzaron\u00a0el\u00a0criterio\u00a0de\u00a0\n\u00e9xito.\u00a0\u00a0\n\u00a0 33\u00a0\u00a0\n\u00a0\nEn\u00a0relaci\u00f3n\u00a0a\u00a0la\u00a0OXTC\u00a0no\u00a0se\u00a0pudo\u00a0alcanzar\u00a0los\u00a0crite rios\u00a0de\u00a0\u00e9xito\u00a0en\u00a0la\u00a0mayor\u00a0parte\u00a0\nde\u00a0 los\u00a0 pacientes\u00a0 de\u00a0 ambos\u00a0 grupos,\u00a0 por\u00a0 lo\u00a0 tanto\u00a0 no\u00a0 fu e\u00a0 estad\u00edsticamente\u00a0\nsignificativo. \u00a0\n\u00a0\nEn\u00a0la\u00a0encuesta\u00a0Walking\u00a0 Impairment\u00a0Quistionaire\u00a0(WIQ)\u00a0se\u00a0pudo\u00a0observar\u00a0que\u00a0en \u00a0\nambos\u00a0grupos\u00a0existi\u00f3\u00a0\u00a0una\u00a0mejor\u00eda\u00a0en\u00a0cuanto\u00a0al\u00a0dolor, \u00a0cuando\u00a0se\u00a0realiz\u00f3\u00a0el\u00a0an\u00e1lisis\u00a0\nestad\u00edstico,\u00a0los\u00a0resultados\u00a0fueron\u00a0satisf actorios\u00a0ya\u00a0que\u00a0en\u00a0el\u00a0grupo\u00a01\u00a0fue\u00a0 una\u00a0P\u00a0de\u00a0\n\u00a0\n\u00a0 34\u00a00.021\u00a0y\u00a0en\u00a0el\u00a0grupo\u00a02\u00a0fue\u00a0 una\u00a0P\u00a0de\u00a00.005,\u00a0existiendo\u00a0en\u00a0ambos\u00a0significancia\u00a0\nestad\u00edstica.\u00a0\nEn\u00a0cuanto\u00a0al\u00a0par\u00e1me tro\u00a0de\u00a0la\u00a0distancia\u00a0en\u00a0la\u00a0WIQ,\u00a0 no\u00a0hubo\u00a0mejor\u00eda\u00a0en\u00a0ambos\u00a0\ngrupos,\u00a0en\u00a0relaci\u00f3n\u00a0a\u00a0la\u00a0velocidad\u00a0la\u00a0mejor\u00eda\u00a0tan to\u00a0en\u00a0el\u00a0grupo\u00a01\u00a0y\u00a0el\u00a0grupo\u00a02\u00a0\npermaneci\u00f3\u00a0 similar,\u00a0 probablemente\u00a0 por\u00a0 el\u00a0 hecho\u00a0 de\u00a0 que\u00a0 en\u00a0 la\u00a0 selecci\u00f3n\u00a0 de\u00a0\npacientes\u00a0con\u00a0ITB\u00a0<0.8,\u00a02\u00a0pacientes\u00a0no\u00a0ten\u00edan\u00a0dolor\u00a0al\u00a0ca minar\u00a0a\u00a0pesar\u00a0de\u00a0tener\u00a0el\u00a0\nITB\u00a0 <0.8,\u00a0 cabe\u00a0 destacar\u00a0 que\u00a0 estos\u00a0 pacientes\u00a0 eran\u00a0 menores\u00a0 de\u00a0 55\u00a0 a\u00f1os\u00a0 co n\u00a0\ntabaquismo\u00a0importante.\u00a0\n\u00a0\nEn\u00a0el\u00a0grupo\u00a01,\u00a0la\u00a0encuesta\u00a0EQ\u00a05D\u00a0mostr\u00f3\u00a0una\u00a0mejor\u00eda\u00a0y \u00a0con\u00a0el\u00a0an\u00e1lisis\u00a0estad\u00edstico\u00a0\nuna\u00a0P\u00a0de\u00a00.262\u00a0y\u00a0mientras\u00a0que\u00a0en\u00a0el\u00a0grupo\u00a02\u00a0se\u00a0obtuv o\u00a0una\u00a0P\u00a0de\u00a00.003.\u00a0En\u00a0 relaci\u00f3n\u00a0a\u00a0\nla\u00a0encuesta\u00a0EQ \u2010EVA\u00a0el\u00a0grupo\u00a01\u00a0en\u00a0el\u00a0an\u00e1lisis\u00a0estad\u00edstico\u00a0obtuvo \u00a0una\u00a0P\u00a0de\u00a00.15\u00a0\nmientras\u00a0que\u00a0en\u00a0el\u00a0grupo\u00a02,\u00a0una\u00a0P\u00a0de\u00a00.001\u00a0utilizand o\u00a0la\u00a0t\u00a0de\u00a0Student\u00a0para\u00a0muestras\u00a0\nrelacionadas. \u00a0\nEn\u00a0 la\u00a0 comparaci\u00f3n\u00a0 de\u00a0 ambos\u00a0 grupos\u00a0 en\u00a0 las\u00a0 mediciones\u00a0 fi nales\u00a0 la\u00a0 diferencia\u00a0\nsignificativa\u00a0fue\u00a00.035\u00a0y\u00a0en\u00a0l a\u00a0EQ\u00a0EVA\u00a0de\u00a00.029,\u00a0us\u00e1ndose\u00a0la\u00a0 t\u00a0de\u00a0Student\u00a0para\u00a0\n\u00a0\n\u00a0 35\u00a0muestras\u00a0independientes,\u00a0por\u00a0lo\u00a0que\u00a0se\u00a0observa\u00a0una\u00a0me jor\u00eda\u00a0significativa\u00a0en\u00a0las\u00a0\ncondiciones\u00a0de\u00a0vida,\u00a0as\u00ed\u00a0como\u00a0en\u00a0la\u00a0percepci\u00f3n\u00a0de\u00a0sa lud\u00a0de\u00a0los\u00a0pacientes.\u00a0\n\u00a0\n*VAS\u00a0es\u00a0equivalente\u00a0a\u00a0EQ\u00a0EVA\u00a0\u00a0(Escala\u00a0Visual\u00a0An\u00e1loga). \u00a0\n\u00a0\n8.\u00a0DATOS\u00a0DEMOGR\u00c1FICOS \u00a0\nTodos\u00a0los\u00a0pa cientes\u00a0de\u00a0am bos\u00a0grupos\u00a0contaban\u00a0con\u00a0uno\u00a0o\u00a0m\u00e1 s\u00a0factores\u00a0de\u00a0riesgo\u00a0\npara\u00a0enfermedad\u00a0arterial\u00a0perif\u00e9rica.\u00a0En\u00a0el\u00a0grupo\u00a01,\u00a0 el\u00a0100%\u00a0tenian\u00a0diabetes\u00a0\u00f3\u00a0\nhipertensi\u00f3n\u00a0arterial. \u00a0\nEn\u00a0el\u00a0grupo\u00a02,\u00a0dos\u00a0de\u00a0ellos\u00a0eran\u00a0menores\u00a0de\u00a055\u00a0a\u00f1os, \u00a0con\u00a0tabaquismo\u00a0intenso,\u00a0no\u00a0\nten\u00edan\u00a0sintomatolog\u00eda\u00a0a\u00a0pesar\u00a0de\u00a0tener\u00a0in\u00a0ITB\u00a0bajo.\u00a0Tres\u00a0paci entes\u00a0ten\u00edan\u00a0di abetes\u00a0\nmellitus\u00a0 y\u00a0 dislipidemia,\u00a0 y\u00a0 cuatro\u00a0pacientes\u00a0ten\u00edan\u00a0 hipertensi\u00f3n\u00a0 arterial\u00a0 y\u00a0\ndislipidemia.\u00a0\nSe\u00a0excluyeron\u00a02\u00a0pacientes\u00a0que\u00a0presentaban\u00a0en\u00a0el\u00a0ele ctrocardiograma\u00a0una\u00a0depr esi\u00f3n\u00a0\ndel\u00a0segmento\u00a0S\u2010T\u00a0y\u00a0adem\u00e1s\u00a0 una\u00a0de\u00a0ellas\u00a0present\u00f3\u00a0dextrostix\u00a0de\u00a0250.\u00a0Se\u00a0les \u00a0refiri\u00f3\u00a0\ncon\u00a0su\u00a0m\u00e9dico\u00a0 de\u00a0cabecera\u00a0para\u00a0su\u00a0atenci\u00f3n. \u00a0\n\u00a0\n\u00a0\n\u00a0 36\u00a09.\u00a0DISCUSI\u00d3N \u00a0\u00a0\nLa\u00a0incidencia\u00a0de\u00a0enfermedades\u00a0cr\u00f3nico\u00a0degenerativa\u00a0v a\u00a0en\u00a0aumento\u00a0as\u00ed\u00a0como\u00a0\ntambi\u00e9n\u00a0cada\u00a0vez\u00a0hay\u00a0mas\u00a0personas\u00a0con\u00a0factores\u00a0de\u00a0rie sgo\u00a0para\u00a0enfermedad\u00a0\ncardiovascular,\u00a0como\u00a0la\u00a0enfermedad\u00a0arterial\u00a0perif\u00e9ric a,\u00a0cuyo\u00a0s\u00edntoma\u00a0cardinal\u00a0es\u00a0la\u00a0\nclaudicaci\u00f3n\u00a0 intermitente,\u00a0 que\u00a0 incluye\u00a0 dolor\u00a0 al\u00a0 ejer cicio,\u00a0 frialdad,\u00a0 palidez,\u00a0\nentumecimiento\u00a0y\u00a0espasmos\u00a0en\u00a0extremidades\u00a0inferiores.\u00a0L as\u00a0gu\u00edas\u00a0de\u00a0pr\u00e1ctic a\u00a0\ncl\u00ednica\u00a0dictan\u00a0el\u00a0manejo\u00a0de\u00a0esta\u00a0patolog\u00eda\u00a0en\u00a03\u00a0nive les\u00a0de\u00a0atenci\u00f3n,\u00a0con\u00a0tratamiento\u00a0\nfarmacol\u00f3gico\u00a0y\u00a0no\u00a0farmacol\u00f3gico.\u00a0Nuestro\u00a0inter\u00e9s\u00a0es\u00a0 determinar\u00a0si\u00a0es\u00a0posible\u00a0el\u00a0\nuso\u00a0de\u00a0la\u00a0acupuntura\u00a0para\u00a0favorecer\u00a0la\u00a0perfusi\u00f3n\u00a0ti sular\u00a0y\u00a0de\u00a0esta\u00a0manera\u00a0disminuir\u00a0\nla\u00a0 presencia\u00a0 de\u00a0 dolor\u00a0 lo\u00a0 que\u00a0 le\u00a0 permitir\u00e1\u00a0 lograr\u00a0 que\u00a0 el\u00a0 paciente\u00a0 tenga\u00a0 una\u00a0\ndeambulaci\u00f3n\u00a0mas\u00a0temprana\u00a0que\u00a0le\u00a0permita\u00a0llevar\u00a0a\u00a0cabo\u00a0 el\u00a0tratamiento\u00a0en\u00a0el\u00a0\nprimer\u00a0nivel\u00a0de\u00a0atenci\u00f3n.\u00a0Seg\u00fan\u00a0los\u00a0fundamentos\u00a0de\u00a0la \u00a0Medicina\u00a0Tradicional\u00a0China,\u00a0\nlos\u00a0s\u00edndromes\u00a0que\u00a0se\u00a0encuen tran\u00a0involucrados\u00a0en\u00a0los\u00a0pacientes\u00a0que\u00a0 este\u00a0estudio\u00a0\ncomprende,\u00a0son\u00a0la\u00a0invasi\u00f3n\u00a0de\u00a0fr\u00edo,\u00a0la\u00a0deficiencia\u00a0d e\u00a0Qi\u00a0adem\u00e1s\u00a0del\u00a0ac\u00famulo\u00a0de\u00a0\nflema.\u00a0\u00a0\nCuando\u00a0el\u00a0fr\u00edo\u00a0invade\u00a0las\u00a0extremidades\u00a0inferiores\u00a0se \u00a0produce\u00a0constricci\u00f3n\u00a0del\u00a0\nmeridiano\u00a0 y\u00a0 de\u00a0 los\u00a0 m\u00fasculos\u00a0 de\u00a0 la\u00a0 extremidad\u00a0 inferior, \u00a0 dando\u00a0 lugar\u00a0 a\u00a0 un\u00a0\nestancamiento\u00a0de\u00a0la\u00a0circulaci\u00f3n\u00a0del\u00a0Qi\u00a0en\u00a0los\u00a0meridia nos,\u00a0lo\u00a0cual\u00a0ocasiona\u00a0dolor\u00a0en\u00a0\nla\u00a0extremidad\u00a0inferior,\u00a0que\u00a0se\u00a0agrava\u00a0con\u00a0el\u00a0ejercic io.\u00a0El\u00a0ac\u00famulo\u00a0de\u00a0flema\u00a0obstruye\u00a0\nlas\u00a0colaterales\u00a0y\u00a0produce\u00a0tambi\u00e9n\u00a0dolor.\u00a0\u00a0\u00a0\nEstos\u00a0s\u00edndromes\u00a0son\u00a0abordados\u00a0en\u00a0este\u00a0estudio\u00a0mediante\u00a0la\u00a0punci\u00f3 n\u00a0de\u00a0los\u00a0puntos\u00a0\nQihai,\u00a0 Yanglingquan,\u00a0 Zusanli,\u00a0 Fenglong\u00a0 y\u00a0 Sanynjiao.\u00a0 La\u00a0 resoluci\u00f3n\u00a0 de\u00a0 tales\u00a0\ns\u00edndromes,\u00a0as\u00ed\u00a0como\u00a0la\u00a0liberaci\u00f3n\u00a0local\u00a0de\u00a0\u00f3xido\u00a0n\u00edtr ico,\u00a0ayudan\u00a0a\u00a0favorecer\u00a0el\u00a0flujo\u00a0\nsangu\u00edneo\u00a0y\u00a0complementan\u00a0de\u00a0manera\u00a0satisfactoria\u00a0el\u00a0tr atamiento\u00a0convencional\u00a0de\u00a0\nla\u00a0enfermedad\u00a0arterial\u00a0perif\u00e9rica\u00a0logrando\u00a0que\u00a0el\u00a0pa ciente\u00a0logre\u00a0la\u00a0deambulaci\u00f3n\u00a0de\u00a0\nuna\u00a0manera\u00a0mas\u00a0temprana,\u00a0en\u00a0el\u00a0primer\u00a0nivel\u00a0de\u00a0atenci\u00f3n \u00a0de\u00a0las\u00a0gu\u00edas\u00a0de\u00a0pr\u00e1ctica\u00a0\ncl\u00ednica.\u00a0Tratamos\u00a0de\u00a0evaluar\u00a0objetivamente\u00a0el\u00a0grado\u00a0d e\u00a0insuficiencia\u00a0arterial\u00a0con\u00a0el\u00a0\nITB\u00a0y\u00a0la\u00a0oximetr\u00eda\u00a0transcut\u00e1nea,\u00a0adem\u00e1s\u00a0de\u00a0usar\u00a0la\u00a0es cala\u00a0EQ5D\u00a0y\u00a0la\u00a0EQ\u00a0EVA.\u00a0\u00a0De\u00a0un\u00a0\ngrupo\u00a0de\u00a016\u00a0pacientes\u00a0se\u00a0dividieron\u00a0en\u00a0dos\u00a0grupos\u00a0de\u00a08\u00a0personas\u00a0cada\u00a0uno.\u00a0El\u00a0\u00a0\n\u00a0 37\u00a0grupo\u00a0 1\u00a0 se\u00a0 design\u00f3\u00a0 como\u00a0 grupo\u00a0 control,\u00a0 quienes\u00a0 lleva r\u00edan\u00a0 el\u00a0 tratamiento\u00a0\nconvencional\u00a0\u00fanicamente.\u00a0Este\u00a0grupo\u00a0no\u00a0alcanz\u00f3\u00a0una\u00a0me jor\u00eda\u00a0signific ativa,\u00a0teniendo\u00a0\nuna\u00a0P\u00a0de\u00a00.307,\u00a0 solo\u00a02\u00a0pacientes\u00a0lograron\u00a0cumplir\u00a0con\u00a0el\u00a0criterio\u00a0de \u00a0\u00e9xito\u00a0(25%),\u00a0\n\u00a0El\u00a0grupo\u00a02,\u00a0const\u00f3\u00a0de\u00a0pacientes\u00a0bajo\u00a0tratamiento\u00a0co nvencional\u00a0mas\u00a0 10\u00a0sesiones\u00a0de\u00a0\nacupuntura\u00a0en\u00a0los\u00a0que\u00a0se\u00a0encontr\u00f3\u00a0una\u00a0mejor\u00eda\u00a0en\u00a0el\u00a0 ITB\u00a0despu\u00e9s\u00a0de\u00a0las\u00a010\u00a0sesiones\u00a0\nde\u00a0acupuntura.\u00a0E n\u00a0la\u00a0revisi\u00f3n\u00a0de\u00a0la\u00a0visita\u00a010\u00a0( \u00faltima\u00a0sesi\u00f3n\u00a0del\u00a0tratamiento)\u00a0y\u00a011( 7\u00a0\nd\u00edas\u00a0posteriores\u00a0al\u00a0tratamiento),\u00a0el\u00a0grupo\u00a0tiene\u00a0una \u00a0mejor\u00eda\u00a0significativ a\u00a0con\u00a0una\u00a0P\u00a0\nde\u00a00.002\u00a0y\u00a00.003\u00a0respectivamente.\u00a0 En\u00a0la\u00a0visita\u00a012\u00a0de\u00a0este\u00a0grupo,\u00a0 un\u00a0mes\u00a0despu\u00e9s\u00a0de\u00a0\nterminado\u00a0las\u00a0sesiones\u00a0de\u00a0acupuntura\u00a0hubo\u00a0una\u00a0regres i\u00f3n\u00a0del\u00a0\u00edndice,\u00a0aunque\u00a0no\u00a0\nlleg\u00f3\u00a0a\u00a0los\u00a0niveles\u00a0basales.\u00a0En\u00a0este\u00a0grupo\u00a0todos\u00a0los\u00a0pacientes\u00a0alcanzaron\u00a0el\u00a0criter io\u00a0\nde\u00a0\u00e9xito\u00a0al\u00a0final\u00a0de\u00a0las\u00a0sesiones.\u00a0 \u00a0\n\u00a0\nCuando\u00a0se\u00a0compararon\u00a0ambos\u00a0grupos\u00a0en\u00a0las\u00a0mediciones\u00a0fi nales\u00a0la\u00a0diferencia\u00a0fue\u00a0\nsignificativa,\u00a0ob teni\u00e9ndose\u00a0en\u00a0la\u00a0encuesta\u00a0EQ\u00a05D\u00a0una\u00a0P\u00a0de\u00a0 0.035\u00a0y\u00a0en\u00a0la\u00a0EQ\u00a0EVA \u00a0una\u00a0\nP\u00a0de\u00a00.029,\u00a0us\u00e1ndose\u00a0la\u00a0 t\u00a0de\u00a0Student\u00a0para\u00a0muestras\u00a0inde pendientes,\u00a0por\u00a0lo\u00a0que\u00a0se\u00a0\nobserva\u00a0una\u00a0mejor\u00eda\u00a0significativa\u00a0en\u00a0las\u00a0condiciones \u00a0de\u00a0vida,\u00a0as\u00ed\u00a0como\u00a0en\u00a0la\u00a0\npercepci\u00f3n\u00a0de\u00a0salud\u00a0de\u00a0los\u00a0pacientes .\u00a0\nLa\u00a0enfermedad\u00a0arterial\u00a0perif\u00e9rica\u00a0es\u00a0una\u00a0condici\u00f3n\u00a0p rogresiva\u00a0que\u00a0requiere\u00a0de\u00a0\nseguimiento\u00a0y\u00a0revisiones\u00a0peri\u00f3dicas,\u00a0que\u00a0muchas\u00a0veces \u00a0requieren\u00a0de\u00a0estudios\u00a0de\u00a0\ngabinete.\u00a0El\u00a0tratamiento\u00a0de\u00a0primer\u00a0nivel\u00a0de\u00a0atenci\u00f3n\u00a0 consta\u00a0de\u00a0la\u00a0disminuci\u00f3n\u00a0de\u00a0\nlos\u00a0factores\u00a0de\u00a0riesgo\u00a0como\u00a0el\u00a0cese\u00a0de\u00a0tabaquismo,\u00a0di eta\u00a0baja\u00a0en\u00a0grasas,\u00a0manejo\u00a0de\u00a0\nhiperlipidemia,\u00a0as\u00ed\u00a0como\u00a0la\u00a0ingesta\u00a0de\u00a0antiagregan tes\u00a0plaquetarios\u00a0y\u00a0la\u00a0realizaci\u00f3n\u00a0\nde\u00a0ejercicio\u00a0supervisado,\u00a0en\u00a0la\u00a0modalidad\u00a0de\u00a0caminata .\u00a0\u00a0\nLa\u00a0enfermedad\u00a0arterial\u00a0perif\u00e9rica\u00a0puede\u00a0tratarse\u00a0\u00fani camente\u00a0con\u00a0acupuntura,\u00a0ya\u00a0\nque\u00a0requiere\u00a0de\u00a0supervisi\u00f3n\u00a0continua\u00a0dentro\u00a0de\u00a0la\u00a0me dicina\u00a0convencional.\u00a0\u00a0Sin\u00a0\nembargo\u00a0la\u00a0acupuntura\u00a0al\u00a0favorecer\u00a0la\u00a0disminuci\u00f3n\u00a0el\u00a0 dolor\u00a0de\u00a0la\u00a0claudicaci\u00f3n\u00a0\nintermitente\u00a0 puede\u00a0 utilizarse\u00a0 como\u00a0 una\u00a0 herramienta\u00a0 mas\u00a0 para\u00a0 lograr\u00a0 que\u00a0 el\u00a0\npaciente\u00a0pueda\u00a0llevar\u00a0a\u00a0cabo\u00a0la\u00a0fase\u00a0de\u00a0 ejercicio\u00a0del\u00a0tratamiento\u00a0convencional\u00a0de\u00a0la\u00a0\u00a0\n\u00a0 38\u00a0enfermedad\u00a0art erial\u00a0perif\u00e9ri ca,\u00a0as\u00ed\u00a0como\u00a0tambi\u00e9n\u00a0mejorar\u00a0la\u00a0percepci\u00f3n\u00a0de\u00a0la\u00a0\ncalidad\u00a0de\u00a0vida\u00a0del\u00a0paciente. \u00a0\u00a0\nEsto\u00a0nos\u00a0lle va\u00a0a\u00a0la\u00a0necesidad\u00a0de\u00a0realizar\u00a0m\u00e1 s\u00a0estudios\u00a0en\u00a0esta\u00a0poblaci\u00f3n\u00a0de\u00a0\npacientes\u00a0para\u00a0determinar\u00a0si\u00a0existe\u00a0adem\u00e1s\u00a0otros\u00a0sist emas\u00a0involucrados\u00a0en\u00a0la\u00a0\nmejor\u00eda\u00a0del\u00a0paciente\u00a0durante\u00a0la\u00a0realizaci\u00f3n\u00a0del\u00a0trat amiento\u00a0de\u00a0acupuntura.\u00a0\n\u00a0\n10.\u00a0CONCLUSIONES\u00a0 \u00a0\nEste\u00a0trabajo\u00a0busca\u00a0determinar\u00a0objetivamente\u00a0los\u00a0benef icios\u00a0que\u00a0puede\u00a0tener\u00a0la\u00a0\nacupuntura\u00a0en\u00a0la\u00a0enfermedad\u00a0arterial\u00a0perif\u00e9rica\u00a0para \u00a0lograr\u00a0el\u00a0posible\u00a0uso\u00a0como\u00a0\nterapia\u00a0coadyuvante\u00a0en\u00a0el\u00a0p rimer\u00a0nivel\u00a0de\u00a0atenci\u00f3n\u00a0del\u00a0tratamiento\u00a0convencional, \u00a0la\u00a0\nque\u00a0esencialmente\u00a0se\u00a0basa\u00a0en\u00a0la\u00a0realizaci\u00f3n\u00a0de\u00a0camina ta.\u00a0\nEl\u00a0tratamiento\u00a0con\u00a0acupuntura\u00a0en\u00a0los\u00a0puntos\u00a0Qihai,\u00a0Z usanli,\u00a0Yanglingquan,\u00a0Fenglong\u00a0\ny\u00a0 Sanyinjiao,\u00a0 complementa\u00a0 de\u00a0 manera\u00a0 significativa\u00a0 en\u00a0 e l\u00a0 tratamiento\u00a0 no\u00a0\nfarmacol\u00f3gico\u00a0de\u00a0la\u00a0enfermedad\u00a0arterial\u00a0perif\u00e9rica,\u00a0d onde\u00a0una\u00a0de\u00a0las\u00a0indicaciones\u00a0\ncoadyuvantes,\u00a0es\u00a0la\u00a0realizaci\u00f3n\u00a0de\u00a0caminata\u00a0supervis ada\u00a0en\u00a0una\u00a0banda\u00a0sin\u00a0fin\u00a0por\u00a0\n30\u00a0a\u00a060\u00a0minutos,\u00a0tres\u00a0veces\u00a0por\u00a0semana\u00a0durante\u00a0tres\u00a0me ses.\u00a0\nSi\u00a0bien\u00a0los\u00a0resultados \u00a0del\u00a0grupo\u00a02\u00a0mostraron\u00a0una\u00a0mejor\u00eda\u00a0mas\u00a0significativa\u00a0e n\u00a0el\u00a0ITB\u00a0\nas\u00ed\u00a0como\u00a0en\u00a0la\u00a0escala\u00a0EQ5D,\u00a0EQ\u2010EVA\u00a0y\u00a0 en\u00a0el\u00a0cuestionario\u00a0 WIQ\u00a0en\u00a0dolor\u00a0y\u00a0velocidad,\u00a0\nno\u00a0 podemos\u00a0 asegurar\u00a0 que\u00a0 con\u00a0 la\u00a0 acupuntura\u00a0 se\u00a0 reviert a\u00a0 el\u00a0 proceso\u00a0 de\u00a0\nateroesclerosis\u00a0ya\u00a0instalado,\u00a0mas\u00a0sin\u00a0embar go,\u00a0ante\u00a0los\u00a0resultados\u00a0positivos\u00a0con\u00a0\nrespecto\u00a0a\u00a0la\u00a0reducci\u00f3n\u00a0de\u00a0sintomatolog\u00eda,\u00a0considera mos\u00a0que\u00a0se\u00a0puede\u00a0utilizar\u00a0\ncomo\u00a0una\u00a0herramienta\u00a0m\u00e1s\u00a0en\u00a0el\u00a0manejo\u00a0de\u00a0primer\u00a0nivel,\u00a0y a\u00a0que\u00a0ayuda\u00a0a\u00a0lograr\u00a0una\u00a0\ndeambulaci\u00f3n\u00a0m\u00e1s\u00a0pronta,\u00a0y\u00a0as\u00ed\u00a0apegarse\u00a0al\u00a0tratamiento \u00a0convencional\u00a0de\u00a0una\u00a0\nmanera\u00a0\u00f3ptima.\u00a0\n\u00a0\u00a0\n\u00a0 39\u00a011.\u00a0REFERENCIAS \u00a0\n1.\u2010\u00a0Khot\u00a0UN,\u00a0Khot\u00a0MB,\u00a0Bajzer\u00a0CT,\u00a0Sapp\u00a0SK,\u00a0Ohman\u00a0EM,\u00a0Bre ner\u00a0SJ,\u00a0Ellis\u00a0SG,\u00a0Lincoff\u00a0\nAM,\u00a0Topol\u00a0EJ.\u00a0Prevalence\u00a0of\u00a0conventional\u00a0risk\u00a0factor s\u00a0inpatients\u00a0with\u00a0coronary\u00a0\nheart\u00a0disease\u00a0.\u00a0JAMA\u00a02003;\u00a0290(7):898\u2010 904.\u00a0\n2.\u2010\u00a0Kannel\u00a0WB.\u00a0The\u00a0demographics\u00a0of\u00a0claudication\u00a0and\u00a0the \u00a0aging\u00a0of\u00a0the\u00a0American\u00a0\nPopulation.\u00a0Vasc\u00a0Med\u00a01996;\u00a01(1):60 \u20104.\u00a0\n3.\u2010\u00a0Hirsch\u00a0AT,\u00a0Treat\u2010Jacobson\u00a0D,\u00a0Lando\u00a0HA,\u00a0Neaton,\u00a0Hatsuk ami\u00a0DK.\u00a0The\u00a0role\u00a0of\u00a0\ntobacco\u00a0cessation,\u00a0antiplatelet\u00a0and\u00a0lipid \u2010lowering\u00a0therapies\u00a0in\u00a0the\u00a0 treatment\u00a0of\u00a0\nperipheral\u00a0arterial\u00a0disease.\u00a0Vasc\u00a0Med.\u00a01997;\u00a02(3):243 \u201051.\u00a0\n4.\u2010\u00a0Quick\u00a0CRG,\u00a0Cotton\u00a0LT.\u00a0The\u00a0measured\u00a0effect\u00a0of\u00a0stoppi ng\u00a0smoking\u00a0on\u00a0intermittent\u00a0\nclaudication.\u00a0Br\u00a0J\u00a0Surg.\u00a01982;\u00a069\u00a0Suppl:S24 \u20106.\u00a0\n5.\u2010\u00a0Greenland\u00a0P,\u00a0Knoll\u00a0MD,\u00a0Stamler\u00a0J,et\u00a0al\u00a0Major\u00a0Risk\u00a0f actors\u00a0as\u00a0antecedents\u00a0of\u00a0fatal\u00a0\nand\u00a0non\u00a0fatal\u00a0coronary\u00a0heart\u00a0disease\u00a0events\u00a0JAMA\u00a02003 ;\u00a0Aug\u00a020;\u00a0290(7):\u00a0891\u2010 7.\u00a0\n6.\u2010\u00a0Murabito\u00a0JM,\u00a0Evans\u00a0JC,\u00a0Nieto\u00a0K,\u00a0Larson\u00a0MG,\u00a0Levy\u00a0D\u00a0y\u00a0col.\u00a0Prevalence\u00a0and\u00a0clinic al\u00a0\ncorrelates\u00a0of\u00a0peripheral\u00a0arteral\u00a0disease\u00a0in\u00a0the\u00a0Fra mnigham\u00a0Offspring\u00a0Study.\u00a0Am\u00a0\nHeart\u00a0J\u00a02002\u00a0Jun;\u00a0143(6):961 \u20105.\u00a0\n7.\u2010\u00a0Allen\u00a0JD,\u00a0Giordano\u00a0T,\u00a0Kevil\u00a0CG.\u00a0Nitrite\u00a0and\u00a0nitric\u00a0 oxide\u00a0metabolism\u00a0in\u00a0peripheral\u00a0\nartery\u00a0disease.\u00a0Nitric\u00a0Oxide.\u00a02012\u00a0May\u00a015;26(4):\u00a0217 \u201022.\u00a0\n8.\u2010\u00a0 Serrano\u00a0 Hernando\u00a0 FJ,Mart\u00edn\u00a0 Conejero\u00a0 A.\u00a0 Peripheral\u00a0 a rtery\u00a0 disease:\u00a0\npathofisiology,\u00a0diagnosis\u00a0and\u00a0treatment.\u00a0 Rev\u00a0Esp\u00a0Cardiol.\u00a02007\u00a0Sept;\u00a060(9):969 \u201082.\u00a0\u00a0\n9.\u2010\u00a0 Fife\u00a0 CE;\u00a0 Smart,\u00a0 DR;\u00a0 Sheffield,\u00a0 PJ;\u00a0 Hopf,\u00a0 HW;\u00a0 Hawkin s,\u00a0 G;\u00a0 Clarke,\u00a0 D\u00a0\nTranscutaneous\u00a0oximetry\u00a0in\u00a0clinical\u00a0practice:\u00a0consen sus\u00a0statements\u00a0from\u00a0an\u00a0expert\u00a0\npanel\u00a0base\u00a0don \u00a0evidence.\u00a0Undersea\u00a0Hyperb\u00a0Med. \u00a02009\u00a0Jan\u2010Feb;36(1):43 \u201053.\u00a0\n10\u2010\u00a0Guia\u00a0de\u00a0Practica\u00a0Cl\u00ednica\u00a0para\u00a0el\u00a0Diagnostico\u00a0y\u00a0Tra tamiento\u00a0de\u00a0la\u00a0Enfermedad\u00a0\nArterial\u00a0Perif\u00e9rica.\u00a0Catalogo\u00a0Maestro\u00a0de\u00a0Gu\u00edas\u00a0de\u00a0Pr actica\u00a0Cl\u00ednica\u00a0IMSS\u2010 08\u201008.\u00a0\nConsejo\u00a0de\u00a0Salubridad\u00a0General .\u00a015,21,\u00a02611.\u2010\u00a0Sitio\u00a0oficial\u00a0del\u00a0Departamento\u00a0de\u00a0\u00a0\n\u00a0 40\u00a0Salud\u00a0 para\u00a0 Medicinas\u00a0 Alternativas\u00a0 EUA.\u00a0 Revisado\u00a0 7\u00a0 de\u00a0 Junio\u00a0 2009.\u00a0\nwww.nccamnih.gov. \u00a0\u00a0\n12.\u2010\u00a0David\u00a0J.\u00a0Owen ,\u00a0M.L.S.,\u00a0Ph.D.,\u00a0Education\u00a0Coordinato r,\u00a0Basic\u00a0Sciences1\u00a0and\u00a0 Min\u2010\nLin\u00a0 E.\u00a0 Fang ,\u00a0 M.L.I.S\u00a0.\u00a0Information\u2010Seeking\u00a0 Behavior\u00a0 in\u00a0 Complementary\u00a0 and\u00a0\nAlternative\u00a0Medicine\u00a0(CAM):\u00a0An\u00a0online\u00a0survey\u00a0of\u00a0facult y\u00a0at\u00a0a\u00a0health\u00a0sciences\u00a0\ncampus;\u00a0\u00a0J\u00a0Med\u00a0Libr\u00a0Assoc.\u00a0Jul\u00a02003;\u00a091(3):\u00a0311\u2013 321.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n13.\u2010\u00a0Yoshaki\u00a0Omura;\u00a0Electrotherapeut\u00a0Pathofisiology\u00a0of\u00a0Ac upuncture\u00a0Treatment:\u00a0\nEffects\u00a0of\u00a0Acupuncture\u00a0on\u00a0Cardiovascular\u00a0and\u00a0Nervous \u00a0Systems;\u00a0Acupuncture\u00a0and\u00a0\nRes.;\u00a01975,Vol\u00a01,:\u00a0\u00a051 \u2010140\u00a0\u00a0\n14.\u2010\u00a0Complier\u00a0i n\u00a0Chief\u00a0Wu\u00a0Changguo.\u00a0Textbook\u00a0of\u00a0Basic\u00a0Theory\u00a0of\u00a0Traditional\u00a0\nChinese\u00a0Medicine.\u00a0Nanjing\u00a0University\u00a0of\u00a0TCM.\u00a02011\u00a0;\u00a0184 \u2010167.\u00a0\n15.\u2010\u00a0Sun\u00a0Peilin;\u00a0Tratamiento\u00a0del\u00a0Dolor\u00a0con\u00a0Fitoterapia\u00a0C hina\u00a0y\u00a0Acupuntura;\u00a02\u00aa\u00a0Ed.\u00a0\u00a0\nElsevier\u00a0masson;\u00a0470\u2010 480.\u00a0\n16.\u2010\u00a0Complementary\u00a0therapies\u00a0for\u00a0peripheral\u00a0arterial\u00a0dise ase:\u00a0systematic\u00a0review.\u00a0\nPittler\u00a0MH,\u00a0Ernst\u00a0E.;\u00a0Atherosclerosis,\u00a0Jul\u00a02005;\u00a0181 (1);\u00a01\u20107.\u00a0\n17.\u2010Helene\u00a0M.\u00a0Langevin\u00a0and\u00a0Jason\u00a0A.\u00a0Yandow.\u00a0The\u00a0Anatomical \u00a0Record:\u00a0Relationship\u00a0\nof\u00a0Acupuncture\u00a0Points\u00a0and\u00a0Meridians\u00a0t o\u00a0Connective\u00a0Tissue\u00a0Planes.\u00a02002,\u00a0269:257. \u00a0\n18\u2010\u00a0Tsuchiya\u00a0M,\u00a0Sato\u00a0EF,\u00a0Inoue\u00a0M,\u00a0Asada\u00a0A.\u00a0Acupuncture\u00a0 enhances\u00a0generation\u00a0of\u00a0\nnitric\u00a0oxide\u00a0and\u00a0increases\u00a0local\u00a0circulation.\u00a0Anesth \u00a0Analg\u00a02007;Fe b;\u00a0104(2):301\u22127. \u00a0\n19.\u2010\u00a0Chen\u00a0Jia\u2010xu.\u00a0Gu\u00edas\u00a0de\u00a0estudio\u00a0de\u00a0Medicina\u00a0China:\u00a0Diagn\u00f3stico,\u00a02010:140 \u2010\n142,152.\u00a0Sistema\u00a0de\u00a0Clasificaci\u00f3n\u00a0de\u00a0las\u00a0rec omendaciones\u00a0 \u00a0\n\u00a0\n\u00a0\n\u00a0\u00a0\n\u00a0 41\u00a012.\u00a0ANEXOS\u00a0\u00a0\u00a0\u00a0\u00a0\nEscala\u00a0de\u00a0Calidad\u00a0de\u00a0Vida\u00a0Euro\u00a0Qol\u00a05\u00a0D\u00a0\n\u00a0\n\u00a0\n\u00a0 42\u00a0\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0 43\u00a0Euro\u00a0Qol\u00a0VAS\u00a0(Escala\u00a0Visual\u00a0An\u00e1loga)\u00a0Mid e\u00a0la\u00a0percepci\u00f3n\u00a0de\u00a0la\u00a0Salud \u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0 44\u00a0Walking\u00a0Impairment\u00a0Questionaire\u00a0\u00a0(WIQ)\u00a0\n\u00a0\n\u00a0\n\u00a0\n", "language": "PDF", "image": "PDF", "pagetype": "PDF", "links": "PDF"}